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Abstract
The aim of this work was to identify proteins which interact with the herpes 
simplex virus type 1 (HSV-1) protein IE63 in virus infected cells. This 
information has allowed insights as to how IE63 can exert its various 
activities and will help in the understanding of how transcription, RNA 
processing and RNA export are co-ordinated in infected and uninfected cells.
HSV-1 is one of eight different herpesviruses to infect humans, the others are 
HSV-2, varicella-zoster virus, Epstein-Barr virus, human cytomegalovirus and 
human herpesviruses 6-8. Serological studies show that commonly throughout the 
world many individuals have been infected with one or more of these viruses. 
Although herpesviruses are generally not a problem in healthy individuals, in the 
immunocompromised they can cause life-threatening disease. As the immediate 
early (IE) protein of HSV-1, IE63 is the only HSV IE gene with homologues in all 
sequenced herpesviruses; studies of this essential protein, which may have similar 
functions throughout the Herpesviridae, are important to key questions about 
herpes biology and the development of effective therapies.
During HSV-1 infection expression of different classes of viral genes is co- 
ordinately regulated and sequentially ordered. The three major classes of genes, 
IE, early (E) and late (L), can be separated on the basis of the kinetics of their 
expression and requirements for ongoing viral DNA synthesis. At the core of this 
regulation are three of the IE proteins, IE175, IE110 and IE63. Both IE175 and 
IE63 are essential for viral growth and IE110, while not essential, confers growth 
advantage in cell culture and is essential for establishment and reactivation from 
latency. IE63 is thought to repress expression of viral IE and E genes, enhance 
expression of viral L genes, repress expression of cellular genes and is required 
for viral DNA replication. IE63 regulates gene expression at the level of 
transcriptional and post-transcriptional control. Transcriptionally it can act on its 
own or with IE 175; post-transcriptionally IE63 inhibits splicing, redistributes
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splicing factors, increases RNA 3 ’ processing at weak virus poly (A) sites, binds 
RNA and shuttles between the nucleus and the cytoplasm.
Presented here are the results of co-immunoprecipitation and fusion protein pull 
down assays, which confirm that IE63 interacts with four cellular proteins, 
namely: heterogeneous ribonucleoprotein K (hnRNP K), casein kinase 2 (CK2), 
p32 and splicing associated protein 145 (SAP145). Further, hnRNP K, CK2 and 
either p32 or SAP 145 are complexed together only in the presence of IE63, and 
interaction of IE63 with p32 or SAP 145 excluded interaction with the other. 
Immunofluoresence demonstrated that IE63 causes p32 to redistribute from the 
cytoplasm to the nucleus, and that SAP 145 and IE63 co-localise in punctate spots 
in the nucleus. Interestingly, when CK2 was co-immunoprecipitated with IE63 
monoclonal antibody, this activity could phosphorylate other proteins in the co- 
immunoprecipitated complex including IE63, hnRNP K and p32. Phosphorylation 
of IE63 by CK2 increased the affinity of IE63 for hnRNP K.
A fifth protein was present in the complex. The viral thymidine kinase (vTK) was 
identified by Laser Mass Map Spectroscopy, and confirmed to be associated with 
the IE63 complex by Western blotting o f the IE63 co-immunoprecipitates, and 
fusion protein pull downs. Whether IE63 interacts directly with vTK or indirectly 
as a consequence of its interaction with one of IE63’s partners remains to be 
determined.
How these various interactions contribute to IE63 function can be inferred from 
the known roles for each interacting protein; but their identification points to 
IE63, like a growing number of proteins involved in gene regulation, being a 
multifunctional protein which interacts with several proteins to carry out its 
functions.
Interaction with transcription factors, hnRNP K and possibly p32, may account 
for IE63s transcriptional activity acting to enhance L gene expression and repress 
that of viral IE and E genes. However most of the IE63 activity is seen at the post- 
transcriptional level.
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Inhibition o f splicing (via p32 and/or SAP 145), probably blocks expression of 
cellular genes and may also allow viral transcripts to bypass the splicing 
machinery before export to the cytoplasm. The redistribution of splicing factors in 
infected cell nuclei is most likely a reflection of the build up of viral transcripts at 
inactive splice sites.
Export o f viral mRNA serves to enhance viral gene expression and may occur via 
interaction with hnRNP K or p32, alternatively interaction with these proteins 
may block cellular mRNA export allowing viral mRNA to saturate the export 
pathways. IE63 almost certainly uses more than one route to facilitate export of 
viral mRNA.
The affect o f IE63 on viral DNA replication is likely to reflect its requirement for 
expression o f DNA replication factors, but conceivably there could be a role for 
the IE63-TK interaction here.
Multiple interactions by IE63 may be facilitated by its ability to oligomerise 
enabling the formation of large complexes of proteins. Moreover, the particular 
patterns of protein:protein interaction may be dynamic, changing at different 
intracellular locations or times post-infection to facilitate the various functions of 
IE63.
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Chapter 1 Introduction
Chapter 1: Introduction
Part A. The Herpesviridae 
1A1 The family Herpesviridae 
1A1.1 Herpesviruses are highly dispersed in nature
Nearly 100 herpesviruses have been described and most animal species including 
fish, amphibians, reptiles, birds and especially mammals, including cattle, pigs 
and man, have yielded at least one herpesvirus (Roizman, 1993). Herpesviruses of 
humans, their properties and the diseases they cause are shown in Table 1A 1.1.
1A1.2 Definition and distinctive structural features
Herpes virions vary considerably in size from 120nm to 300nm in diameter, but 
all have a similar design. Classification as a member of the Herpesviridae is based 
on the architecture of the virion (Fig 1A1.2). All herpes virions consist of a core 
containing a double stranded linear DNA genome encased in an icosohedral 
capsid (Wildy et al., 1960). An amorphous, sometimes asymmetric, material 
surrounds the capsid and has been designated the tegument (Roizman & Furlong, 
1974). Surrounding the tegument is an envelope containing viral glycoprotein 
spikes on its surface (Spear & Roizman, 1972). Virion structure is reviewed in 
Rixon (1993).
Most investigations of virion structure have been carried out with herpes simplex 
virus type 1 (HSV-1), but the morphology of all herpesviruses is similar. O f the 
162 capsomeres making up the icosohedral capsid, 150 are hexameric and 12 are 
pentameric. The hexomeres occupy the faces and the edges of the capsid, while 
the pentamers are positioned at the vertices (Schrag et al., 1989). Studies of HSV- 
1 capsid assembly have become more amenable with the development of an in 
vitro assembly system (Newcomb et al., 1994) and a recombinant baculovirus 
assembly system in insect cells (Tatman et al., 1994). In HSV-1, the hexons in the 
capsid are made from six molecules of the major capsid protein VP5 and the 
vertex protein VP26, the pentons are composed of VP5. A triplex
1
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Table 1A1.1 Human herpesviruses
Common
name
Subfamily Group G+C
%
Size
(kbp)
Common disease/symptoms
HSV-1 a E 68.3 152 cold sores + other occasional 
symptoms
HSV-2 a E 69 152 genital lesions
VZV a D 46 125 chicken pox/ shingles
EBV y C 60 172 infectious mononucleosis 
(glandular fever), Burkitt’s 
lymphoma + other cancers.
HCMV P E 57 229 mononucleosis
HHV-6 P A 42 162 roseda
HHV-7 P A 45 145 none known
HHV-8 y B 53 140.5 Kaposi’s sarcoma
Abbreviations: Human herpesviruses (HHV), herpes simplex virus (HSV), varicella-zoster virus 
(VZV), Epstein-Barr virus (EBV), human cytomegalovirus (HCMV). Group refers to classification 
based on reiterated genome sequences (see Fig. 1A1.3)
Fig 1A1.2 Schematic representation of a herpesvirus virion showing structural 
components
HSV Virion
tegument
capsid
envelope
Viral DNA
Double stranded DNA is encased in an icosohedral capsid, which is surrounded by the tegument 
proteins and viral envelope, containing glycoprotein spikes.
Taken from (Clements & Brown, 1997)
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structure made up of VP 19 and VP23 co-ordinates the hexons in 3-fold symmetry 
(Rixon, 1993; Zhou et al., 1994).
The virion tegument structure and the process by which it is acquired is poorly 
understood. Viral structural proteins are assigned to the tegument if  they are 
known not to be components of the capsid or envelope (Rixon, 1993). It is clear 
that while purified herpes DNA is capable of initiating infection, certain tegument 
proteins can influence the process of infection; for example, the a -trans inducing 
factor (a-T IF , VP 16 or U l4 8 ) and a virion associated host shut-off function (VHS 
or U l4 1 ) (Batterson & Roizman, 1983; Read & Frenkel, 1983).
The virion envelope has a trilaminar appearance in electron micrographs (Epstein, 
1962) and appears to be derived from patches of altered host cell membrane 
(Morgan et al., 1959). The glycoprotein spikes contained in the virion envelope 
are approximately 8nm long and vary in number and relative amount between 
different herpesviruses, HSV-1 encodes at least eleven. Some have been 
implicated in the early stages of infection e.g. gB, gC, gD, gH, and gL. These and 
others also appear to have roles in immune modulation and in preventing 
secondary infection of cells (reviewed by Spear, 1993).
Herpesvirus DNA within the capsid is densely packaged in a liquid crystalline, 
phage-like manner as found with double-stranded DNA phage (Booy et al., 1991).
1A1.3 Biological properties
Four significant biological properties are shared by all herpesviruses.
(i) A large array of virally encoded enzymes are used for nucleic acid 
metabolism.
(ii) The synthesis of viral DNA and assembly o f capsids occurs in the nucleus.
(iii) Production of infectious virus progeny causes destruction of the host cell.
(iv) Virus can remain latent in their natural hosts.
Biological variation occurs at the level of range of host species, speed of 
multiplication in the host, host cell specificity and clinical manifestations.
2
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1A1.4 Classification and nomenclature of herpesviruses
Current classification
Current classification is based upon biological properties and splits the 
Herpesviridae family into three sub-families (alpha, beta and gamma) (Roizman 
et al., 1981).
Alphaherpesvirinae
e.g. HSV-1, and varicella-zoster virus (VZV).
All members of this subfamily have a variable host range, a relatively short 
reproductive cycle, show rapid spread in culture, efficient destruction of cells and 
establish latent infections primarily but not exclusively in sensory ganglia.
Betaherpesvirinae
e.g. human cytomegalovirus (HCMV).
These viruses generally have a restricted host range, a long reproductive cycle and 
infect cells slowly in culture. Infected cells frequently become enlarged and 
latency occurs in secretory glands, lymphoreticular cells, kidneys and other 
tissues.
Gammaherpesvirinae 
e.g. Epstein-Barr virus (EBV)
Experimentally, members of this family can only infect the same family or order 
to which the natural host belongs. They replicate in lymphoblastoid cells in vitro, 
and can infect some epithelial and fibroblastic cells. Latency often occurs in the 
lymphoid tissue. Viruses are specific for either B or T lymphocytes where lytic or 
latent infection is frequently found without production o f infectious progeny.
Alternative Classification
The current classification is based on biological properties of the viruses; With the 
availability of complete nucleotide sequences for several herpesviruses it is now 
possible to review their classification. Classifications based on conservation of 
genes and gene clusters and the arrangement of these clusters relative to each 
other, the arrangement of terminal sequences (see Fig 1A1.4) or the presence and 
distribution of nucleotides which are subject to methylation have been suggested.
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Fig. 1A1.5 Schematic diagram of the sequence arrangements in the six classes of 
Herpesviridae
Example
(No of isom ers)
CCV (1)
h v s (i )
EBV (1) gj- 
VZV (2) _
HSV (4) S. 
MCMV (1)
a’a’-
IBS
G roup
A
B
D
* 4 ~  a
•I— H E
F
Single lines represent unique sequences and lines with arrowheads show the 
sequence inversions. Repeats of > lkb are represented by open boxes and small 
reiterated sequences are represented by lined boxes. Arrows above boxes denote 
whether repeats are direct or inverted. The relative positioning of “a” sequences are 
indicated. See text for details.
Abbreviations: CCV: channel catfish virus, HVS: herpesvirus saimiri, EBV: 
Epstein-Barr virus, VZV: varicella-zoster virus, HSV: herpes simplex virus, MCMV: 
murine cytomegalovirus
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Fortuitously, reclassification based on sequence data puts most viruses into the 
same subfamilies as biological properties do. Exceptions are Marek’s disease 
virus, biologically like a gammaherpesvirus but based upon conservation and co­
linearity of gene clusters, considered an alphaherpesvirus (Buckmaster et al.,
1988), and HHV-6, biologically a gammaherpesvirus but by sequence analysis it 
bears homology to a betaherpesvirus (Lindquester et al., 1997).
It is debatable whether classification based purely on genes has a value if this does 
not reflect important and obvious biological differences, especially while the 
genomic sequence of all the Herpesviridae is not known.
1A1.5 Herpesvirus DNAs
Structure
When extracted from virions, herpesvirus DNAs are double-stranded linear 
molecules, which can circularise immediately upon release into host cell nuclei. 
Between different herpesviruses, DNA size and base composition can vary. DNA 
size ranges between 120 kbp to 230 kbp, base composition varies from 31 % G+C 
to 75% G+C. Variation in the genome size of any one herpesvirus seems to be 
minimal but significant, terminal and internal repeated sequences and spontaneous 
deletions both contribute to variation (Roizman, 1996).
Sequence arrangement in herpesvirus DNAs
Variation in the sequence arrangement of herpesvirus DNAs with respect to the 
presence and location of reiterated sequences is an interesting feature which can 
be used to split the viruses into six groups (Davison, 1993; Roizman, 1996); 
however, these do not correlate with evolutionary relatedness of the viruses. The 
genome arrangements of herpesviruses are illustrated in Fig. 1A1.4.
Genomes which contain a single unique region which is flanked by direct repeats 
are designated as group A genomes. Channel catfish virus has a genome of this 
type.
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Group B genomes have multiple copies of a terminal repeat sequence at their 
termini. Group B genomes include the genome of herpesvirus saimiri (HVS).
EBV has a characteristic group C genome having a set o f internal repeats which 
are unrelated to the terminal repeats.
Group D genomes have two unique regions which are flanked by inverted repeats. 
The repeats are not related and the repeat flanking the unique long region ( U l )  is 
significantly shorter than that flanking the short unique region (U s). This leads to 
two genomic orientations o f Us but one (either completely or predominantly) for 
Ul- VZV has a characteristic group D genome structure.
Group E is similar to group D except that the inverted repeats flanking the Ul 
region are larger and an additional repeat sequence known as the “a” sequence is 
found at the termini and at the junction between the L and S repeats. The presence 
of a larger Ul flanking repeat also means that the Ul region is freely invertable 
leading to the occurrence of four equimolar genomic isomers. HSV-1 and HSV-2 
are examples of herpesviruses with group E genomes.
Group F genomes consist of a single unique sequence which lacks either internal 
or terminal repeat regions. The genome of the tree shrew herpesvirus is 
characteristic of this group of genomes.
1A1.2 Herpes Simplex Viruses - General features 
1A2.1 Definition and serotypes
The two herpes simplex virus serotypes (HSV-1 and HSV-2) belong to the 
subfamily Alphaherpesvirinae and the genus Simplexvirus. As such, they are 
typical alphaherpesviruses, displaying structural (Fig. 1A1.2) and biological 
properties as detailed above (section 1A1.3). HSV-1 and HSV-2 (Dolan et a l
1998) DNAs share 47% - 50% base sequence homology and their genetic maps 
are largely co-linear. They differ in restriction endonuclease (RE) cleavage sites 
and apparent size of viral proteins (Roizman & Sears, 1996). Antigenic 
differences can be detected (Roizman et al., 1984) and distinctive biological 
markers include virus titres, plaque size and growth in cultured cells.
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Due to occasional base substitutions/deletions resulting in changes in RE sites or 
amino acid sequence and to variability in certain repeated sequences, 
epidemiologically unrelated isolates of the same HSV serotype are not identical 
(Chou & Roizman, 1990). Intratypical differences can be detected with 
monoclonal antibodies and isolates may differ in neurovirulence. However, 
individual strains are stable during culture in vitro. This property has an important 
diagnostic use and has been used to examine modes o f transmission and 
epidemiology of HSV-1 and HSV-2 in human populations (Sakaoka et al., 1994). 
Work in this thesis considers infection with the HSV-1 Glasgow isolate strain 
17syn+ (Brown et al., 1973).
1A2.2 Epidemiology, transmission, pathology and clinical features.
The natural host of HSV-1 is humans. Primary infection usually occurs in the 
mucosa of the mouth or throat, although HSV-1 is also capable o f infecting the 
mucosa of the genital tract. Primary infection is usually asymptomatic but can 
lead to illness which is characterised by lesions in the mouth and throat, fever and 
a general malaise. Following replication at the site of primary infection, virus is 
transported by neurones to dorsal root ganglia where latency is established (Rock, 
1993). Replication in the ganglia can, infrequently, lead to life threatening central 
nervous system (CNS) infection (Olson et al., 1967) but latency generally 
predominates. Reactivation from latency is often associated with stress, fever, 
exposure to UV light, tissue damage and/or immunosuppression. Reactivated 
virus infection usually results in lesions of the skin in the area served by the 
trigeminal ganglia e.g. herpes labialis (cold sores). HSV-1 infection can also result 
in encephalitis, although this is usually restricted to neonatal and immuno­
compromised individuals. Other rare complications can include keratitis and a 
disseminated infection involving organs such as the liver and adrenal glands. 
(Whitley, 1996).
HSV-1 infections occur world wide, all year round. In the developing world and 
lower socio-economic groups of the developed world some 30% of the population 
have sero-converted by the age of five and 70-90% by the end o f adolescence. In
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more affluent groups in the developed world this is delayed and sero-prevalence 
by 30 years of age is around 60% (Wentworth & Alexander, 1971).
1A2.3 Host immune responses
Host response to HSV-1 occurs in two phases, a non-specific containment phase 
and a later HSV-1 specific effector phase. Host genetic background, macrophages, 
natural killer cells, specific T cell sub-populations, specific antibodies and 
lympokine responses have been implicated as important factors in host defences 
against HSV-1 infections (Lopez et al., 1993). The relative contribution of each 
depends on the experimental model system and route o f inoculation.
1A2.4 Prevention and therapy
Although various vaccines against HSV-1 recurrent and primary infection have 
been developed (Burke, 1993) none manage to protect against cutaneous disease, 
neither can any known agent protect from latency. Goals for treatment of HSV-1 
disease are therefore directed at reducing the time to resolve clinical symptoms, 
reducing the likelihood and severity of complications and reducing the time of 
virus shedding and therefore the likelihood of transmission.
The only non-cytotoxic agent currently available for the treatment of HSV-1 
infection is acyclovir (Schaffer et al., 1979), available in topical, intravenous and 
oral formulations. Acyclovir is phosphorylated by HSV thymidine kinase (vTK) 
at a rate 106 fold faster than by the cellular enzyme. Furthermore, acyclovir 
triphosphate, the active form of the drug, is recognised by HSV DNA polymerase 
much more readily than by the host cell polymerase. Acylovir triphosphate blocks 
DNA synthesis by acting as an inhibitor of polymerase activity as well as being its 
substrate, becoming incorporated into the growing DNA chain and causing 
termination of chain growth. As DNA synthesis is required for acyclovir to 
function, the drug cannot destroy the virus during the latent period.
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1A3.2 The HSV-1 genome
The HSV-1 genome is 152 kbp (McGeoch et al., 1986, McGeoch et al., 1988, 
Perry & McGeoch, 1988). Like all herpes DNAs it comprises of linear, double 
stranded DNA (Becker et al., 1968) but has an unusually high G+C content 
(McGeoch et al., 1986, McGeoch et al., 1988, Perry & McGeoch, 1988). It 
encodes at least 77 genes, 59 mapping to the U l region, 13 to the Us region and 
two copies of four genes to the repeated sequences. The locations o f the IE genes 
and the latency associated transcripts (LATs) are shown in Fig. 1 A3.2. The DNA 
arrangement for HSV-1 genome and its repeated sequences is shown in Fig. 
1A1.3.
1A3.3 Viral life cycle and particles
The viral life cycle is summarised in Fig. 1A3.3 (as reviewed in Roizman & 
Sears, 1996). From initial infection to final viral release takes approximately 18 h 
-20 h in fully permissive tissue culture cells. Infected cells produce three types of 
HSV-related particle, but only one, the virion, is capable o f infecting another cell. 
L-particles (Szilagyi & Cunningham, 1991) lack the nucleocapsid and viral DNA, 
hence are non-infectious. Pre-DNA replication or PREP particles (Dargan et al.,
1995) are synthesised when DNA synthesis is blocked; they are similar to L 
particles but lack true late proteins or only possess them in minute quantities.
1A3.4 Latency and reactivation
Following primary infection, the virus is transported via retrograde axonal 
transport (Kristensson et al., 1986) to the cell bodies o f sensory neurones within 
the dorsal root ganglia. Here latent infection can be established. Subsequently in 
response to external stimuli reactivation occurs and virus passes down the axons 
to replicate at or near the initial site of infection.
Latency can be divided into 3 stages, viz. establishment, maintenance and 
reactivation (reviewed in Rock, 1993).
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Fig. 1A3.2 Location of Immediate Early (IE) and Latency Associated 
Transcripts (LATs) on HSV-1 genome
Rl2 i e i i o Rs 1 IE] 74
LATs
Ul48 Ul 54 
a-TIF IE63
----- ►
LATs
Us and Ul are unique regions, Rl and Rs, IRl and IRs are reiterated inverted repeated 
sequences see Fig. 1A1.3. Genes are shown in plain print proteins encoded are 
shown in italics.
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Fig.lA3.3 Schematic representation of HSV-1 replication in susceptible cells
1. The virus initiates infection by fusion of the viral envelope with the plasma 
membrane following attachment to the cell surface. 2. Fusion of the membranes 
releases two proteins from the virion. VHS shuts off protein synthesis and a-TIF is 
transported to the cell nucleus. 3. The capsid is transported to the nuclear pore where 
viral DNA is released into the nucleus and immediately circularises. 4. The 
transcription of IE genes by RNA polymerase II is induced by a-TIF. 5. The five a  
mRNAs are transported to the cytoplasm, translated and the proteins brought back to 
the nucleus, where they regulate E and L gene expression. 6. A new round of 
transcription results in the synthesis of E proteins. 7. At this stage in infection host 
cell chromatin (c) is degraded and displaced to the nuclear membrane and nucleoli 
become disaggregated. 8. Viral replication is by a rolling circle mechanism, which 
yields head-to-tail concatemers of viral DNA. 9. A new round of 
transcription/translation yields the L proteins, consisting primarily o f  structural 
proteins. 10. The capsid proteins form procapsids. 11. Unit length viral DNA is 
cleaved and packaged into the preformed capsids. 12. Capsids containing viral DNA 
acquire a new protein. 13. Viral glycoproteins and tegument proteins accumulate and 
form patches in cellular membranes. The capsids containing DNA attach to the 
underside of the membrane patches and are enveloped. 14. The enveloped proteins 
accumulate in the endoplasmic recticulum and are transported to the extracellular 
space.
Taken from (Roizman & Sears, 1996).
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Establishment
It is not clear how latency is established but there are two hypotheses,
(i) Neurones harbouring latent virus lack host factors required for 
transcription of viral genes
(ii) Or, within the infected neurone, a specific viral gene product arrests the 
viral gene expression cascade, thus leading to establishment.
Maintenance
Latent HSV genomes are maintained in a non-integrated, non-linear, endless form 
and have a nucleosomal structure similar to cellular chromatin (Rock & Fraser, 
1983). DNA copy number in neurones is estimated to be between 10-100 
(Roizman & Sears, 1987). Only a single region o f the genome is transcribed into 
LAT RNAs, (Stevens et al., 1988). These are depicted in Fig. 1 A3.2. The long 8.3 
kb LAT is anti-sense to the genes for ICP34.5 and IE110, the latter is a gene 
which may be required for reactivation from latency (Leib et al., 1989a). The 
relevance of the LAT transcripts is not clear as mutants in these regions show that 
LAT RNA expression is not essential for the establishment and maintenance of 
latency (Sederati et al., 1989, Steiner et al., 1989).
Reactivation
The molecular basis for reactivation is poorly understood but viral proteins IE110 
and IE65 as well as cellular proteins Octl and Bm3 have been implicated (Rock,
1993). Infectious virus particles are carried back to peripheral tissues by axonal 
transport (Cook & Stevens, 1973). LATs have also been reported to be involved 
in reactivation (Leib et al., 1989b) but again mutants not expressing LAT RNAs 
can be seen to reactivate (Rodahl & Stevens, 1992). Reactivation takes 3-5 days 
and is triggered by stimuli such as sunlight, stress and possibly hormonal 
irregularities (Whitley, 1996).
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1A3.5 HSV-1 DNA replication
DNA replication functions are conserved throughout the alphaherpesviruses. For 
HSV-1, the complete set of seven viral genes required for replication is known 
(Challberg, 1991) and replication of a HSV-1 replication origin containing 
plasmid can be reconstituted using these proteins expressed from baculovirus 
vectors (Stow, 1992). A diagram showing the functions o f these proteins is shown 
in Fig. 1 A3.5. It is not known if additional host cell factors are required; however, 
two functions essential for cellular DNA replication, DNA topoisomerase and 
DNA ligase, are not encoded by HSV-1.
Viral replication typically peaks between 10 h and 20 h post-infection. It is 
initiated from one of three origins (ori) of replication via the binding to one of 
them of the ori binding protein U l9 . The helicase/primase complex (U l5 , U l  8 
and Ul 52 gene products) subsequently associates with the UL9/ori complex and 
the hydrolysis of ATP creates an initiation bubble which permits association of 
the DNA polymerase/DNA binding protein complex (U l3 0 /U l4 2 ) . DNA synthesis 
is continuous along one strand and discontinuous along the lagging strand with the 
major DNA binding protein U l2 9  maintaining the growing forks. Other virally 
encoded enzymes are also involved in nucleic acid metabolism; e.g. vTK, 
ribonucleotide reductase, uracil-DNA glycosylase and dUTPase (reviewed in 
Roizman & Sears, 1996).
Replication occurs by a rolling circle mechanism, head to tail DNA concatemers 
accumulate in the nucleus, at specific sites defined by host cell nuclear 
architecture termed viral replication sites (de Bruyn Kops & Knipe, 1994). If viral 
replication is blocked, the replication proteins form a punctate pattern of sites 
called viral pre-replicative sites (Quinlan et al., 1984). Host cell replication factors 
co-localise with viral pre-replicative sites, which appear to be sites of assembly 
for viral replication factors, that under the correct conditions can progress to being 
active replication sites. These are dynamic structures whose patterns are reversible 
depending on the status of viral replication (de Bruyn Kops & Knipe, 1994). The 
predefined sites where viral replication foci form are suggested to correlate with 
ND10 sites, which are occupied by the regulatory cellular proteins PML, SplOO 
and NDP55 (Maul et a l, 1996).
10
Chapter 1 Introduction
Fig. 1A3.5 Virus encoded functions directly required for HSV DNA replication
Single Strand 
DNA Binding Protein
Polymerase
HeterodimerHelicase/PrimaseComplex
Single stranded binding protein is U l2 9 , the helicase/primase complex comprises 
U l5 /U l8 /U l52 , and polymerase is a dimer of U l3 0 /U l42 .
Taken from (Clements & Brown, 1997).
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In uninfected cells, cellular RNA transcription and DNA replication have been 
shown to occur at the same nuclear location (Zhang et al., 1994) and RNA 
polymerases have been implicated in the initiation o f replication (Hassan & Cook,
1994).When the spatial relationship between HSV-1 replication and transcription 
is analysed using methods which label DNA and RNA synthesis in vivo it is found 
that viral DNA replication and transcription sites co-localise at early times in 
infection, with splicing machinery being largely removed from these sites. At later 
times more replication sites develop and while some sites have both transcription 
and replication occurring concurrently, others are committed solely to DNA 
replication (Phelan et al., 1997). It is suggested that the initial number of 
replication/transcription sites is restricted due to the number of pre-existing ND10 
sites (Maul et al., 1996) and that the additional replication sites represent sites 
where the replicated DNA genome is in turn replicated.
1A4 HSV-1 proteins 
1A4.1 General features and classification
HSV-1 expresses more than 70 distinct proteins during lytic infection; only a 
minority of these (30-35) are absolutely required for virus replication in cultured 
cells. The remainder function in a number of ways to increase host range and 
tissue tropism, replication and plaquing efficiency, and to control or subvert the 
host response to infection. Due to their high G+C content, HSV-1 proteins are 
often proline rich (typically 10% -14%) and thus migrate anomalously slowly in 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). In addition, they tend to 
be rich in basic amino acids (aa). It is not known if either of these characteristics 
has a role in HSV-1 pathogenesis.
Herpesvirus genes (and hence the corresponding proteins) can be classified into at 
least three regulatory classes by the kinetics of their expression and their 
requirement for DNA replication ( Honess & Roizman, 1974; Honess & Roizman, 
1975; Clements et al., 1977). Immediate early (IE) (also known as a )  genes can 
be transcribed in the absence of de novo viral protein synthesis and DNA 
replication, their expression peaks around 2 h -  4 h post-infection. IE proteins 
regulate expression of early and late genes. Early (E) (also known as P) genes are 
expressed soon after IE and peak expression is at 5 h -  7 h post-infection. E
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proteins are involved in DNA metabolism and replication, their expression signals 
the start of viral DNA synthesis. Viral DNA synthesis is the signal for late (L) 
(also known as y) gene expression. L genes can be further divided into two classes 
based on the stringency of their requirement for DNA synthesis. The leaky L (yi) 
class of genes are expressed (all be it at low levels) prior to DNA replication but 
the strict L fe )  genes are only expressed once viral replication has commenced. L 
proteins generally are structural components of the virion.
1A4.2 Protein modifications
The majority of HSV-1 proteins examined to data are post-translationally 
modified. These modifications include cleavage (e.g. U l2 6 ) , phosphorylation (e.g. 
IE63 and IE175), sulphation (glycoproteins), glycosylation (glycoproteins), 
myristylation (U lI  1), poly(ADP)-ribosylation (IE175, U l1 8 )  and nucleotidylation 
(IE175, IE68, IE63) (Roizman & Sears, 1996).
1A4.3 Protein Nomenclature
A number o f systems have been used to describe the proteins of HSV-1. Namely,
(i) The order of the open reading frames (ORFS) occurring in various regions 
of the genome e.g. UlI 9 which corresponds the protein encoded by ORF19 in the 
Ul region of the genome.
(ii) A system based on protein function e.g. ribonucleotide reductase.
(iii) The Glasgow system, based on the apparent molecular weight o f the 
protein as determined by the migration of viral proteins on an SDS-PAGE. The 
kinetics of expression of that particular protein can then be included in its name 
e.g. a protein expressed with IE kinetics and migrating with an apparent molecular 
weight of 63 kDa, is called IE63.
(iv) The Chicago or Infected Cell Protein (ICP) system. This is distinct and 
represents a number corresponding to location on SDS-PAGE rather than the 
actual molecular weight of the protein e.g. ICP27 which corresponds to IE63.
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Table 1A4.3 Glasgow and Chicago nomenclature for HSV-1 gene products 
expressed at immediate early times in infection
GLASGOW CHICAGO
IE110 ICPO
IE 175 ICP4
IE68 ICP22
IE63 ICP27
IE12 ICP47
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In this thesis, the Glasgow system will be used to refer to IE proteins. Table 
1 A4.3 shows the corresponding Chicago system nomenclature for the IE genes. 
The majority of other proteins have or will be referred to on the basis of their ORF 
location or function. The exception to this are certain virion polypeptides (VP) 
which are numbered in their order as separated on SDS-PAGE. e.g. VP 16 is 16th 
virus protein from the top of the gel obtained from purified virions.
1A5 HSV-1 Transcription and mRNAs 
1A5.1 Transcripts
HSV-1 genes are transcribed by the host cell RNA polymerase II (RNA Pol II) 
(Costanzo et al., 1977). Locations of the IE genes on the HSV-1 genome can be 
seen in Fig. 1A1.3. Viral mRNAs are capped, methylated and polyadenylated, 
methylation is more common in E transcripts than L ones (Hann et al., 1998), 
alternative polyadenylation may be a mechanism of regulating gene expression 
(McGregor et al., 1996). Only four viral transcripts IE 110, IE68, IE12 and U l1 5  
are spliced. Transcripts sharing 5’ and particularly 3 ’ termini have been described 
(Wagner, 1985) and several genes appear to have multiple initiation sites e.g. 
(Murchie & McGeoch, 1982).
The abundance and stability of HSV-1 mRNAs varies but in general mRNAs of 
IE and E genes appear to be more stable than those o f L genes (Roizman & Sears,
1996).
1A5.2 Regulation of gene expression
Regulation of gene expression is represented in Fig. 1 A5.2a.
Induction o f  IE gene expression
Expression of IE genes can proceed without de novo viral protein synthesis, and is 
stimulated by the action of the virion protein a -T IF  (also known as Vmw 65 or 
VP 16). Upstream of IE promoters is a TAATGART sequence which is the cis 
acting site for a-TIF-driven expression of IE genes. The cellular factor Oct-1
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Fig. lA5.2a Schematic representation of HSV-1 gene expression
Open and filled arrows represent events in the reproductive cycle which turn gene 
expression on and off respectively. 1. Turning on IE gene transcription by a-TIF 
packaged in the virion. 2. Autoregulation of gene expression. 3. Turning on E gene 
transcription. 4. Turning on L gene transcription by IE and E gene products. 5. 
Turning off IE and E gene expression by the products of L genes.
Taken from (Roizman & Sears, 1996)
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binds to the cis acting site, a complex of a -T IF  and another cellular protein 
(designated C l) then binds to the Oct-1/DNA complex and is stabilised by 
interactions between both Oct-1 and a -T IF  and a -T IF  and the GARAT sequence 
(reviewed in O'Hare, 1993). Binding of a-TIF to IE gene initiation sites is shown 
in Fig. lA5.2b.
Regulatory functions o f  IE genes products
IE gene products are responsible for the regulated expression of E and L gene 
expression. IE 175, IE 110 and IE63 in particular are key to this.
IE175:
IE 175 autoregulates itself, an activity which correlates with the binding of IE 175 
at its own transcription initiation site (Roberts et al., 1988); consensus IE 175 
binding sites are also found in the promoter of IE110. IE 175 may down regulate 
expression of IE110 by binding to its promoter (Faber & Wilcox, 1986).
IE 175 is also strictly required for expression of E and L genes. This is taken to 
mean that it regulates them in a positive way. IE 175 can bind to DNA, a strong 
consensus site of IE 175 binding (Faber & Wilcox, 1986) is ATCGTCnnnnCnGnn 
(n is any nucleotide), but subsequent reports have revealed numerous HSV-1 
binding sites which do not correspond to this consensus (Michael & Roizman,
1989).The various forms of IE175 differ in their affinity for DNA binding 
(Michael et al., 1988). Dephosphorylated IE 175 is reported to bind to 
IE promoters, while the phosphorylated form binds to E and L promoters 
(Papavassiliou et al., 1991). Further evidence of IE175 involvement in 
transactivation of HSV-1 genes comes from its interaction with TATA binding 
protein and transcription factor IIB (TFIIB), both components o f the RNA Pol II 
transcription complex (Smith et al., 1993).
IE110:
IE110 is a non-essential protein but defects in this protein delay expression of E 
and L genes and impair viral replication (Chen & Silverstein, 1992). From 
transient expression experiments, IE110 is thought to enhance the activity of 
IE 175, as well as possibly transactivating gene expression in its own right 
(Everett, 1984, O'Hare & Hayward, 1985, Quinlan & Knipe, 1985).
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Fig. lA5.2b Binding of a -T IF  (Vmw65) to IE gene initiation sites.
Vmw65
/
( H C F
( OCT-1
TAATGARAT. rTATA
TM. J ’ TAF60)
TAF40K, — '^'|TAF26()
TBR
1
Other proteins in the complex are the cellular factor Oct-1 (see text), host cell factor 
(HCF), transcription activating factors 40, 60 and 260 (TAF40, TAF60 and 
TAF260), TATA binding protein (TBP), and transcription factor IIB (IIB).
(Fig. produced by C. Loney, dept. Virology, Glasgow University.)
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IE68:
IE68 appears to be dispensable to HSV-1 infection. Viral mutants in the gene for 
IE68, multiply in Vero and Hep-2 cells as effectively as the parent virus. However 
in BHK, RAT-1 cell lines and human embryonic lung cells the plating efficiency 
is reduced and yield is multiplicity dependent. Moreover in these cells E protein 
synthesis is delayed and the expression of L proteins and the number of capsids 
detected in the infected cells is reduced. Deletion o f IE68 has no effect on viral 
DNA synthesis (Sears et al., 1985).
IE63:
IE63 is discussed later in this thesis (1B8-1B12) but briefly, this essential IE 
protein activates and represses expression of viral IE and E proteins, enhances 
expression of viral L genes, represses expression o f cellular genes and is required 
for viral DNA replication. The majority of its activities are thought to occur at the 
post-transcriptional level.
IE 12:
This non-essential protein is not involved in the regulation o f viral gene 
expression but down regulates the host immune response. Expression of 
sequences containing the IE 12 gene cause the infected cell to be resistant to lysis 
by CD8+ T cells, due to retention of the MHC class I molecules in the cytoplasm 
and a lack of peptide presentation at the cell surface (York et al., 1994).
Induction o f  E  genes
The sequence elements for expression of E genes consist of a a TATA box, a cap 
site (McKnight & Tijan, 1986), and binding sites for cellular factors, (for example 
the HSV-1 vTK gene contains binding sites for SP1 and CCAAT binding protein 
(CBP)), these sites are clustered upstream of the TATA box (Pande et al., 1998). 
Initiation of transcription requires both release from the repressed state and 
transactivation. Viral mutants in IE 175 do not produce any E genes (Dixon & 
Schaffer, 1980; Watson & Clements, 1980); IE 175 is almost certainly involved in
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transactivation of E genes but the mechanism is not clear. The binding of IE 175 to 
E genes requires cellular factors and is determined by both its concentration and 
phosphorylation (Papavassiliou et al., 1991). It has been suggested that IE175 
interacts with cellular factors both enhancing their binding and requiring them for 
its own stable DNA binding.
Induction o f  L genes
The structure of L genes is the least well understood and is likely to vary from 
gene to gene. Analyses of several genes have suggest that sequences required for 
efficient expression include the TATA box, and extend into the 5’ transcribed 
non-coding domain (Dennis & Smiley, 1984, Everett & Dunlop, 1984, Guzowski 
& Wagner, 1993; Wagner et.al, 1998). Additional sequences downstream from 
the TATA box appear to be required by strict L genes (Greaves & O’Hare, 1989; 
Wagner et.al, 1998).
Embedded in the transcribed domains as well as in the 5’ non-coding regions are 
IE 175 binding sites (Michael et al., 1988). The role of these sites is unclear as is 
IE 175 involvement. In infected cells, IE 175 is required but not sufficient for 
efficient and timely expression o f L genes especially not of strict L genes.
One of the key observations in understanding expression of L genes has been the 
observation that deletions in the 5’ transcribed non-coding domain of a L gene 
caused it to be expressed as an IE gene (Roizman & Sears, 1996). This can be 
explained in two ways; either the non-coding domain contains a site that allows 
binding of a transactivating repressor or the region may form a secondary 
structure which affects expression of L genes. Either way, the data suggests that 
the 5’ transcribed region binds a repressor of some sort. This repressor must 
preclude expression of L genes under conditions which allow expression of IE and 
E genes and bind an activator which allows their expression in the absence o f the 
repressor. As L gene expression can not occur in the absence o f viral DNA 
synthesis, it has been suggested that replication removes the block and/or 
produces/modifies the transactivating factor. Alternatively removal of the block 
may be essential to DNA replication.
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1A6.1 Cytopathology
Within a few hours of HSV-1 infection, noticeable modifications o f the host cell 
nucleus occur. Host chromatin condenses and is marginalised at the nuclear 
membrane. This is followed by accumulation of semi-crystalline arrays of empty 
viral capsids in the nucleus, leading to formation of macroscopic inclusion bodies. 
Other changes include re-duplication of the nuclear membrane as viral capsids 
associate with it, and the formation of excessive syncytia which occurs with many 
but not all virus strains (reviewed in Roizman & Sears, 1996).
1A6.2 Virion host shut-off function
A characteristic of HSV infection is the rapid shut-off of host macromolecular 
metabolism, host DNA synthesis is shut-off, host protein synthesis declines very 
quickly and glycosylation of host cell proteins ceases. Shut-off occurs in two 
phases. The first phase is the result o f a virion protein activity, virion host shut-off 
(vhs), this activity is responsible for the destabilisation and degradation of both 
host and viral mRNA (Kwong & Kruper, 1988; Elgadi et al., 1999; Karr & Read,
1999). The second function requires the presence o f viral IE proteins such as IE68 
and IE63 and is less well understood. Host shut-off confers two advantages; 
firstly, the host cell mRNA pool is quickly depleted allowing viral mRNAs to take 
over and secondly, destabilisation of viral mRNA allows rapid transition from 
gene expression of one class of protein to the next.
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Chapter 1 Part B. From DNA to protein; IE63 can 
disrupt normal cellular function and plays a key role in 
viral gene expression.
Mammalian mRNA is transcribed from DNA as a pre-mRNA molecule. Before 
being translated into protein this pre-mRNA is processed. During processing, pre- 
mRNA generally is 5’capped (not discussed here), spliced and polyadenylated 
before being exported to the cytoplasm and translated into protein (Fig.IB). IE63 
is known to carry out many of its viral and cellular gene regulatory functions via 
control of post-transcriptional processes, as well as by directly influencing 
transcription of viral and cellular genes. What follows is an overview of 
mammalian pre-mRNA processing focusing on the protein factors involved and 
then a description o f the ways in which IE63 disrupts these processes. Regulation 
of transcription itself by IE63 is discussed and the functional domains of IE63 are 
described. Finally, post-transcriptional regulation of gene expression in several 
other virus systems is outlined.
1B1 hnRNPs play a key role in all stages of mRNA processing.
Newly transcribed mRNAs are associated with heterogeneous nuclear ribonuclear 
(hnRNP) proteins. As a family of at least 20 different proteins (Pinol-Roma et at., 
1988), they are located predominantly throughout the nucleus, although a subset 
can be detected in the cytoplasm (Dreyfuss et al., 1984). hnRNP proteins remain 
associated with pre-mRNA until processing is complete (Dreyfuss et al., 1993) 
and can associate with mature mRNAs during cytoplasmic transport (Pinol-Roma,
1997). By associating with pre-mRNAs, hnRNP proteins, as well as having a 
direct processing role, regulate the interactions o f pre-mRNAs with components 
of the RNA processing pathway including those involved in splicing, 3’ end 
formation and RNA export (Dreyfuss et al., 1993). hnRNP proteins, like many 
other proteins involved in RNA processing, bind RNA via a ribonuclear protein 
domain (RNP) and show different sequence specificities (Dreyfuss et al., 1993). 
Through either direct protein:RNA interactions or through co-operative binding of 
hnRNPs to each other, the array of hnRNP proteins bound to a given transcript is 
therefore determined by its RNA sequence. Hence different transcripts will be
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Fig. IB RNA processing in mammalian cells
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Mammalian mRNA is transcribed from DNA as a pre-mRNA molecule. Before 
being translated into protein this pre-mRNA is processed. During processing pre- 
mRNA is spliced, polyadenylated, and 5’capped before it can be exported to the 
cytoplasm and translated into protein. Each of these steps can be regulated and 
together they allow a complex regulation of gene expression.
(Fig. produced by C. Loney, dept. Virology, Glasgow University.)
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expected to associate with a unique set of hnRNP proteins, the composition of 
which will change during mRNA maturation directing processing events (Varani 
& Nagai, 1998). hnRNPs therefore play a key role in regulated gene expression.
1B2 Mammalian pre-mRNA undergoes splicing
Pre-mRNA splicing is the process by which non-coding, intervening sequences or 
introns are removed from pre-mRNA molecules and exon sequences are joined.
1B2.1 The splicing reaction
Pre-mRNAs are spliced in a two step reaction (Fig. 1B2.1) (Padgett et al., 1984, 
Ruskin et a l,  1984). In the first step, pre-mRNA is cleaved at the 5’ splice site, 
generating a linear first exon RNA species and an intron-second exon RNA 
species in a lariat formation. The lariat is the result o f a 2 ’-5’ phosphodiester bond 
between the G at the 5’ splice site and 3’ end of the intron, the point at which this 
bond forms is termed the branch point site (BPS). In the second step, the 3’ splice 
site is cleaved and concomitantly the exons are ligated together, generating the 
spliced mRNA.
1B2.2 Mammalian pre-mRNA splicing factors
The splicing reaction is catalysed by the spliceosome, a macromolecular complex 
made up of five small nuclear ribonucleoprotein particles (snRNPs) and non 
snRNP proteins, whose number is estimated to be in the hundreds. During 
splicing, snRNPs and non-snRNP proteins undergo a series o f interactions with 
each other and with pre-mRNA to cause conformational alterations which drive 
the reaction forward (reviewed in Green, 1991). Changes in RNA:RNA 
interactions between small nuclear RNAs (snRNAs) form at least part of the 
catalyst to splicing. Spliceosomes assemble on the pre-mRNA in a stepwise 
manner, forming four discrete complexes E - A - B - C (in that order) which are 
functional intermediates in the pathway (Fig.lB2.2). Much o f the work which 
uncovered proteins involved in the splicing reaction has been carried out by 
reconstitution of an in vitro splicing reaction e.g. (Krainer & Maniatis, 1985) and 
through the use of yeast e.g. (Siliciano et al., 1987) These two allow a combined 
genetic and biochemical approach.
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Fig. 1B2.1 The splicing reaction
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Splicing occurs in a two step reaction (see text for details). Boxes represent exons 1 
and 2, the single line represents intronic sequences to be removed. In step one, OH is 
a hydroxyl group of the A residue at the branch point site and P is the phosphate of 
G. In step 2, OH is the hydroxyl group of the last residue of exon 1 and P is the 
phosphate group of the first residue of exon 2.
Taken from (Green, 1991)
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Fig.lB2.2 Proteins involved in the mammalian splicing pathway
U 2 A F
Two snRNP/pre-mRNA interactions form the basis of the spliceosome. Firstly, U1 
snRNP binds to the 5’ splice site while at the same time the splicing associated factor 
U2AF binds to the pyrimidine tract between the branch point site (BPS) and the 3 ’ 
splice site, thus forming complex E. Secondly, U2 snRNP, recruited by U2AF 
(Gozani & Potashkin, 1998), binds to a region encompassing the BPS. This step 
irreversibly commits the pre-mRNA to the splicing pathway and forms complex A. 
Complexes A and E are also called pre-spliceosomes. Thirdly, a pre-existing 
(U4/U6/U5) particle enters to form complex B, and just prior to splicing a 
conformational change occurs that significantly destabilises the association o f  U4 
snRNP with the complex transforming it into complex C. Following splicing, the 
snRNPs remain associated with the intron, and are recycled. Excised introns are 
degraded by a phosphodiesterase specific to the lariat structure.
GU and AG are the 5’ and 3 ’ conserved residues recognised by splicing factors, A is 
the residue at the branch point site.
Taken from (Green, 1991)
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1B2.3 Regulation of splicing - SR proteins
Modulation of gene expression by the use of alternative splice sites is a common 
mechanism. However, despite knowledge of the proteins involved in the basic 
splicing reaction (see above), our understanding of the proteins involved in the 
regulation of splicing has been limited in several ways. First, the combined 
biochemical and genetic methods so successfully employed to study basic splicing 
in yeast are not applicable, as alternative splicing appears not to occur in yeast. 
Second, identification of the cis acting sequences responsible for splicing has been 
difficult and therefore isolation of specific RNA binding proteins slow. Finally, 
only a small number of alternative splicing events have proved to be reproducible 
in vitro, adding to the problems of identifying splicing regulatory molecules.
The group of proteins most studied and implicated in splice site selection and 
spliceosome assembly is a family termed SR proteins (Fu, 1995). The name SR 
comes from the presence o f a characteristic carboxy terminal serine/arginine rich 
domain responsible for protein:protein interactions between family members. This 
domain is thought to allow SR proteins to aid the recruitment and stabilisation of 
snRNPs with pre-mRNA at multiple and distinct points during the splicing cycle. 
The other distinctive feature o f SR proteins is their ability to interact with RNA; 
which occurs via an amino terminal RNP domain. SR proteins are considered to 
have distinct, functionally significant RNA binding activities allowing them to 
recognise splicing enhancer or repressor sequences, (reviewed in Manley &
Tacke, 1996).
ASF/SF2 is a typical SR protein
The way in which ASF/SF2 is involved in splicing is illustrated in Fig. 1B2.3, and 
is thought to be typical o f SR protein control of splicing. ASF/SF2, a 33 kDa 
protein, has constitutive splicing activity in vitro (Krainer et al., 1990b) and also 
strongly influences splice site selection in a concentration-dependent manner. 
Addition of ASF/SF2 to nuclear extracts, switches splice site selection of pre- 
mRNA bearing competing 5’ splice sites towards the proximal 5’ site (Ge & 
Manley, 1990, Krainer et al., 1990a). ASF/SF2 interacts with other SR proteins, 
namely, a U1 specific protein o f 70 k D a , the SC35 protein and the small subunit
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Fig. 1B2.3 Role of ASF/SF2 in splicing
-3'
SR proteins are involved in several steps of spliceosome assembly. ASF/SF2 and 
SC35 connect 5’ and 3 ’ splice site complexes though a network of protein:protein 
interactions, stabilising and facilitating assembly of the spliceosome. ASF/SF2 
contacts the 70 kDa subunit of U1 snRNP and the U2 associated protein U2AF 
Taken from (Manley & Tacke, 1996).
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of the essential splicing factor U2AF. SC35 and ASF/SF2 are functionally 
interchangeable in vitro (Fu et al., 1992). The interaction with U1 is indirect, but 
as ASF/SF2 also binds U2AF at the 3’ splice site, it forms a link between the 5’ 
and 3’ splice sites (Wu & Maniatis, 1993). ASF/SF2 has been shown to 
specifically recognise RNA fragments containing intact 5’ splice sites (Zuo & 
Manley, 1994), and to bind to and enhance expression from a purine rich bovine 
exonic enhancer sequence (Sun et al., 1993). ASF/SF2 interacts with RNA via an 
RNP domain and with other proteins via an RS domain.
1B3 Polyadenvlation
A poly (A) tail is found at the 3’ end of most fully processed eukaryotic mRNAs.
It has been proposed that this tail confers mRNA stability, promotes mRNA 
translational efficiency and has a role in the transport of processed mRNA from 
the nucleus to the cytoplasm (reviewed in Wikens et al., 1997). mRNA 3’ end 
formation occurs in a coupled two step reaction; firstly, the 3 ’ end is cleaved and 
then poly (A) addition takes place. This reaction is carried out by a surprisingly 
large complex of multi-subunit proteins (Manley, 1995).
1B3.1 Polyadenylation elements
There are two sequence elements that specify pre-mRNA cleavage and poly (A) 
addition. Located 10 to 30 bases upstream of the cleavage/polyadenylation site is 
the sequence AAUAAA, and 20-40 bases downstream of the cleavage site is a 
G+U-rich motif. These two sequence motifs and their spacing from each other 
specify the site and strength of a poly (A) signal (Chen et al., 1995, MacDonald et 
al., 1994). Like splicing, use of alternative polyadenylation sites is a relatively 
common means of regulating gene expression. In addition to the AAUAAA and 
GU rich motifs, some mRNAs contain other genetic elements which influence the 
efficiency of polyadenylation, Such as in the genomes of viruses and in the human 
C2 complement gene and mouse calcitonin/calcitonin gene related peptide 
(reviewed inProudfoot, 1996).
21
Chapter 1 Introduction
1B3.2 Proteins involved in polyadenylation.
A functional polyadenylation complex is illustrated in Fig.lB3, and is composed 
o f....
Cleavage/Polyadenylation Specificity Factor (CPSF)
CPSF is made up of four polypeptides, one of which, CPSF-160, recognises 
AAUAAA, but can only weakly bind to it. Formation of a stable complex requires 
the presence of the other CPSF polypeptides and another factor CstF. Together the 
two factors function to recruit other components of the polyadenylation machinery 
to the cleavage site (Manley, 1995). Additional functions for CPSF are the co­
ordination of nuclear polyadenylation with transcription (Dantonel et al., 1997), 
participation in cytoplasmic polyadenylation (Bilger et al., 1994), limitation of 
poly (A) tail length (Wahle, 1995) and in the interaction of proteins associated 
with the splicing apparatus (Lutz et al., 1996).
Cleavage stimulation factor (CstF)
CstF is a heterotrimeric protein with three subunits of 77 kDa, 64 kDa, and 50 
kDa. In the presence of CPSF, binding of the precursor RNA is mediated by CstF- 
64. CstF-64 binds specifically to the G+U-rich motif via a RNP binding domain 
(MacDonald et al., 1994). Binding of CstF stabilises CPSF interaction with 
AAUAAA and is thought to determine the efficiency of polyadenylation 
(Takagaki et al., 1989).
Cleavage factors I  and II  (CFI and CFII)
Two additional factors, CFI and CFII, are required for cleavage but not 
polyadenylation (Takagaki et al., 1989). These factors are poorly characterised, 
and although endonuclease activity has not been demonstrated for any of the 
subunits of CFI or II, the process of elimination makes them likely to be cleavage 
proteins.
Poly (A) Polymerase (PAP)
PAP contains at its amino terminal the catalytic activity required for addition of 
the poly (A) tail (Martin & Keller, 1996). PAP interacts with one o f the CPSF 
subunits, however these two polypeptides alone are not enough to reconstitute 
AAUAAA-dependent polyadenylation (Murthy & Manley, 1995).
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Fig. 1B3 The polyadenylation complex
CPSF CstF
m7
GpppG
K 70kd  >
M yN l' ' '
Cleavage and polyadenylation components assembled on pre-mRNA. CPSF is made 
up of 4 components 30 kDa,73 kDa, 100 kDa and 160 kDa polypeptides, it binds to 
AAUAAA via the 160 kDa subunit. CstF is made up o f 3 polypeptides of 70 kDa, 50 
kDa and 64 kDa. Binding to UUUU sequence is via the 64 kDa subunit. CFI and 
CFII probably cleave RNA and PAP catalyses addition of the poly (A) tail.
(Fig. Produced by C. Loney, dept. Virology, University of Glasgow.)
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Poly (A) binding protein II  (PABII)
PAB II binds to poly (A) RNA and acts by co-operating with CPSF to hold PAP 
in place on the primer RNA. These interactions are disrupted after the tail has 
reached a distinct length and so PAB II both supports progressive synthesis of a 
long poly (A) tail (Bienroth et al., 1993) and restricts the length of poly (A) tail to 
200-300 residues (Wahle et al., 1993).
1B4 Export of mRNA from the nucleus
In order to exit the nucleus, mature mRNA must pass though the nuclear 
envelope, through protein lined channels called nuclear pore complexes (NPCs). 
RNA within cells is associated with proteins as ribonucleoprotein particles 
(RNPs), and it is these RNP complexes which are transported. Once exported, the 
transport proteins need to be re-imported into the nucleus to pick up a new load. 
The signals within proteins which cause nuclear localisation are termed nuclear 
localisation signals (NLSs) and those which allow export of proteins are nuclear 
export signals (NESs). The classical NLS, first identified in simian virus 40 
(Kalderon et al., 1984), consists of a short stretch of basic amino acids and is 
found in a large number of viral and cellular nuclear proteins. Two other classes 
of NLS are known, the M9 and KNS domains and these two sequences also 
function as NESs; the M9 NLS is unique in being RNA pol II transcription 
dependent (Pinol-Roma & Dreyfuss, 1991). Three different classes of NES are 
known, the Rev-like NES (Bogerd et al., 1996), the M9 domain (Siomi & 
Dreyfuss, 1995) and the bi-directional KNS domain (Michael et al., 1997). The 
model for transport of proteins containing these signals requires that signal 
containing proteins bind to receptors which then translocate through the NPC, as 
illustrated in Fig.lB4. Most transport processes are thought to require the small 
GTPase Ran. The signals, as far as we know, do not compete with each other and 
utilise separate pathways to/receptors in the nuclear membrane (reviewed in 
Izaurralde & Adam, 1998).
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Fig.lB4 Shuttling receptor model
nucleus
cytoplasm
IMPORT EXPORT
Nuclear export and import are mediated by shuttling receptors (R), which recognise 
and bind to nuclear localisation sequences (NLS) or export sequences (NES). An 
import receptor binds its cargo (C) in the cytoplasm, translocates though the nuclear 
pore complex (NPC), and releases the cargo into the nucleoplasm. The receptor is 
then recycled back to the cytoplasm to initiate another round of  import. Conversely, 
an export receptor binds its cargo in the nucleoplasm and releases it in the cytoplasm 
Taken from (Izaurralde & Adam, 1998).
1B4.1 Nuclear Export Signals
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Rev-like NES:
This is a leucine rich sequence found not only in HIV-1 Rev, a protein which 
promotes the export of partially and unspliced viral RNAs (see HIV), but also in 
several cellular proteins including TFIIIA which is involved in 5S RNA export 
(Fischer et al., 1995, Fridell et al., 1996). The export receptor for the Rev-like 
NES has been identified as CRM 1 (Fomerod et al., 1997a). Consistent with being 
a receptor, CRM 1 is a Ran binding protein and interacts with a nucleoporin 
Nup214/CAN (Fomerod et al., 1997b). The cytotoxin leptomycin B (LMB) 
inhibits Rev-NES mediated transport (Wolff et al., 1997). In higher eukaryotes, 
mRNA transport is not inhibited with LMB (Fomerod et al., 1997a) which 
strongly suggests that cellular mRNAs are not exported via this pathway.
M9 domain:
This sequence consists of a glycine rich sequence of 38 aa and is required for the 
export and import of hnRNP A l (Michael et al., 1995). As mRNAs are coated 
with numerous hnRNP molecules and because hnRNP A l remains bound to the 
mRNA during translocation, it has been suggested that hnRNP A l promotes 
export of the mRNA via the M9 domain (reviewed in Pinol-Roma, 1997). The 
export receptor for the M9 domain is not known. hnRNP A l re-import into the 
nucleus is transcription dependent; this is consistent with hnRNP A l exporting 
mRNA as, in the absence of transcription, energy would not be wasted re­
importing export factors (Michael et al., 1995). Export o f some mRNAs is not 
inhibited by an excess of hnRNP A l (Saavedra et al., 1997), implying that mRNA 
export may not occur by a single mechanism. Export of an individual mRNA 
could depend on the pattern of associated hnRNP proteins and the type of export 
signals they carry.
KNS domain:
Identified in another hnRNP protein hnRNP K (Michael et al., 1997). It is not 
known which, if any, mRNA utilises the KNS for export (see hnRNP K - Section 
1C1)
24
Chapter 1 Introduction
1B4.2 Nuclear retention and export
Binding of export factors is probably the first step in the commitment of a mRNA 
to a transport pathway, however it is not sufficient for export. For example, 
unspliced mRNAs associated with hnRNP A l are not exported (Legrain & 
Rosbash, 1989). This observation leads to a suggestion that the removal of other 
factors which cause nuclear retention is also required. Evidence for such factors 
came from the identification of a dominant nuclear retention signal present in 
hnRNP C (Nakielny & Dreyfuss, 1997).
1B5 Cellular location of processing events
1B5.1 Transcription, splicing and polyadenylation
The transcription machinery co-localises with nuclear structures termed 
perichromatic fibrials (PF) found at the boundaries o f condensed chromatin 
domains. When cells are pulse labelled, PFs are enriched in nascent pre-mRNA 
radiolabelled with bromouridine or [3H]-uridine and fibrial density correlates with 
transcriptional activity ( Faken et al., 1984; Faken, 1994; Van Driel et al., 1995). 
The splicing machinery is also found in PFs (Faken et al., 1984) consistent with 
assembly of splicing machinery initiating at the site of transcription.
Although transcription and splicing happen in PFs, only a minority of splicing 
factors are found there. Immunofluorescent staining for splicing factors (Faken et 
al., 1984) (Fig. lB9.1a) has shown them to be present in 20-50 nuclear domains or 
speckles set against a more diffuse nucleoplasmic pool of splicing factors. The 
diffuse staining corresponds to PFs, and the majority o f speckles correspond in 
location to interchromatin granule clusters (ICGs). This data suggests that ICGs 
act as storage/assembly sites for splicing factors which can be recruited on 
demand (reviewed in Mattaj, 1994). Although speckles do not incorporate 
bromouridine, they do contain intron containing pre-mRNA and polyadenylated 
mRNA. Alternative scenarios are that the speckles have a role in the export of 
mRNAs or that speckles accumulate snRNPs bound to partially spliced mRNAs 
or excised introns after release from spliceosomes (reviewed Lamond &
Eamshaw, 1998). The location of splicing factors is therefore dynamic, moving 
between nuclear structures. This has been illustrated by visualisation of splicing
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factor ASF/SF2 fused to green fluorescent protein (GFP) in living cells (Misteli et 
al., 1997). Organisation of the functional components within a set framework 
provides more opportunities for cell regulation as compared to a freely diffusible 
state.
1B5.2 Transport of mature mRNA from the site of processing to the NPC
There are two theories as to how mature mRNA reaches the nuclear membrane. 
Estimates of the rate of movement of a highly expressed hybrid gene in 
Drosophila salivary glands suggest that simple diffusion could account for the 
dispersal of mRNA (Zachar et al., 1993). However, the need for structural 
features in mRNA for their movement (Elliot et al., 1994), and the tight 
association of transcripts, hnRNPs, and functional processing components with 
the nuclear matrix argue for directed mRNA movement. mRNA can be tracked 
moving though the nucleus but results of these types of experiment are not 
consistent with one model or the other (Huang & Spector, 1991, Zachar et al.,
1993).
1B6 Cross talk between mRNA processing events
1B6.1 Interactions between specific processing components
The co-localisation of processing factories suggests that there is some level of 
cross talk between them and this is indeed the case. For example, CPSF binds to 
TFIID, allowing recruitment to the RNA Pol II pre-initiation complex, where, 
after phosphorylation of the large subunit of RNA Pol II, CPSF dissociates from 
TFIIA and becomes associated with the elongating RNA pol II. CPSF appears to 
travel with RNA pol II until the polyadenylation event (Dantonel et al., 1997); 
perhaps the presence of poly (A) factors influences termination of elongation. 
Polyadenylation and transcription are therefore linked together by CPSF (Zhao et 
al., 1999).
In a similar way to CPSF, the splicing machinery has been shown to be associated 
with the RNA pol II carboxy terminal domain (Steinmetz, 1997). This role for the 
C-terminal domain may ensure that the nascent transcript is presented directly to
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the pre-mRNA processing machinery even as its synthesis continues and allows 
co-ordination of transcription and RNA processing.
Another example of cross talk is that splicing can be linked to polyadenylation. In 
vitro, a functional polyadenylation signal can enhance splicing of the 5’ terminal 
intron and vice versa, implying that excision of most 3’ intron o f pre-mRNA and 
polyadenylation are functionally linked (Niwa et al., 1990).
1B6.2 Promoters can influence the post-transcriptional fate of transcripts.
One example of promoters influencing the post-transcriptional fate of mRNA is in 
the immunoglobulin p gene. Transfection of the u gene, cloned as cDNA with its 
introns removed, has been shown to result in very little secreted protein. This 
effect however is promoter-dependent, as when the endogenous promoter is 
replaced by a HCMV promoter, expression is comparable to that obtained when 
introns are included (Neuberger & Williams, 1988).
1B6.3 Multifunctional proteins
As well as interactions between components of the processing pathway, there are 
multifunctional proteins which are involved in transcriptional and post- 
transcriptional processes and provide further evidence for links between them.
The list of these multifunctional proteins is growing (reviewed Ladomery, 1997). 
Some well characterised examples include Y box proteins, W ilm’s tumour protein 
(WT) and hnRNP K (see Section 1C1).
Y box proteins
All Y box proteins contain a cold shock domain which is thought to switch on 
genes required for the cold shock response and to act as an RNA chaperone, 
favouring translation at low temperature. Y box proteins also have a number of 
other domains, and have been implicated in the upregulation o f cell proliferation 
genes, repression of MHC class II genes and in binding to and masking of 
cytoplasmic mRNA in Xenopus oocytes; this masking prevents expression before 
the correct time in development. A similar phenomenon occurs in the developing
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haploid spermatid, and Y box protein can be detected binding to mRNA in mouse 
spermatids. Finally, Y box proteins bind to somatic mRNP and may therefore 
have a general role in mRNA packaging.
The Wilm’s tumour gene (WT1)
WT1, first identified as a tumour suppresser, produces a protein, which can exist 
as sixteen known isoforms. It is a transcriptional activator and binds to DNA such 
as epidermal growth factor receptor consensus and similar sequences. The mouse 
cell line M l 5 contains at least two of the isoforms of WT1, with or without the 
three aa KTS. The KTS+ form is found preferentially in nuclear speckles and co- 
localises with snRNPs, suggesting a role in splicing, while the KTS' isoform 
preferentially co-localises with the transcription factors SP1 and TFIIB. Thus, 
WT1 may exert its effects at the transcriptional and post-transcriptional levels via 
different isoforms.
1B7 Phosphorylation and the regulation of mRNA processing
Regulation of SR protein activity and splicing factor location may be controlled at 
least in part by phosphorylation. SR protein specific kinases have been identified, 
SR protein kinase 1 (Gui et al., 1994), and Clk/Sty kinase (Colwill et al., 1996). 
Both kinases when over expressed cause redistribution of splicing factors within 
the nucleus. Phosphorylation is also important for functionality of splicing factors. 
When nuclear extracts are treated with protein phosphatase 1, the formation of 
spliceosomes on RNA templates is dramatically decreased (Mermound et al.,
1994) and in the presence of phosphatase inhibitors (Mermound et al., 1992) or 
exogenously added hyperphosphorylated U 1 70 kDa (Tazi et al., 1993) 
spliceosomes form correctly but the splicing reaction does not proceed. A further 
example is ASF/SF2 which must be phosphorylated in order to function in 
spliceosome assembly (Xiao & Manley, 1997). Cycles o f phosphorylation and 
dephosphorylation are likely to regulate SR protein function and in turn splicing. 
Similarly, other RNA processing events are probably regulated by 
phosphorylation.
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1B8 HSV-1 protein IE63 is essential for viral replication and growth.
IE63 mutant viruses have a range of phenotypes, suggesting IE63 has several 
distinct functions. Some mutants show decreased levels of late viral proteins 
(Sacks et al., 1985; McCarthy et al., 1989; Rice & Knipe, 1990; McGregor et al., 
1996), others show a decrease in viral DNA synthesis (Rice & Knipe, 1990) 
promoted via a decrease in delayed E proteins involved in DNA replication; a 
third group show impaired host protein synthesis shut-off (McCarthy et al., 1989). 
IE63 is thought to repress expression of viral IE and E proteins, enhance 
expression of viral L genes, repress expression of cellular genes and affect viral 
DNA replication. What makes IE63 essential is probably its requirement for the 
switch from E to L virus gene expression and hence the knock-on effects on viral 
replication. IE63 accomplishes this by regulating transcriptional and post- 
transcriptional events.
1B9 IE63 acts at the post-transcriptional level to regulate gene expression
1B9.1 IE63 redistributes splicing factors and causes inhibition of host cell 
splicing.
In cells infected with IE63 mutants, spliced cellular mRNA levels are higher, than 
in those infected with the wt virus (Hardwicke & Sandri-Goldin, 1994), this 
cannot be attributed to effects on transcription or RNA stability and suggests that 
IE63 impairs splicing function. Further, precursor mRNA from the viral genes 
which do require splicing (IE110 and Ul15), accumulate in the presence of IE63, 
suggesting that transport o f the gene products is not being affected (Hardy & 
Sandri-Goldin, 1994).
Using indirect immunofluorescence, the nuclear distribution of host snRNP 
antigens is shown to alter in HSV-1 infection (Martin, et a l  1987), reorganisation 
is illustrated in Fig. 1B9.1. This redistribution is similar to that seen in uninfected 
cells when transcription is reduced or splicing is inhibited (Carmo-Fonseca et al., 
1992, O'Keefe et al., 1994). During infection, the snRNP antigens form prominent 
clusters which condense throughout the nucleus, then migrate to the nuclear 
periphery. These punctate snRNP clusters correspond to clusters o f interchromatin 
granules. IE63 co-localises with the redistributed snRNPs and its expression is 
necessary and sufficient to cause snRNP redistribution (Phelan et al., 1993,
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Fig. 1B9.1 Schematic representation of the reorganisation of cellular splicing 
factors during HSV-1 infection
A
snRNP
NUCLEOLU5
con fd Roryy
NUCLEUS
Uninfected cell labelled 
with an anti-snRNP antibody
K tO lSDISINTEGRATION OF 
NUCLEOLUS
CYTOPLASM
NUCLEUS
HSV-1 Infected cell 
labelled with an 
anti-snRNP antibody
Location of splicing factors is seen to redistribute with HSV-1 infection, from a wide 
spread speckled pattern to a highly punctate organisation. IE63 has been shown to be 
both necessary and sufficient to cause this effect. A: uninfected cells. B: infected 
cells 8h post infection.
Taken from (Clements & Brown, 1997).
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Sandri-Goldin et al., 1995). The C-terminal repressor region of IE63, which is 
required for inhibitory effects on splicing is also involved in redistributing 
snRNPs (Sandri-Goldin et al., 1995).
Co-localisation suggests that IE63 interacts with one or more of the components 
of the splicing machinery. More direct evidence for interaction between IE63 and 
splicing factors has come from anti-Sm co-immunoprecipitations from wt infected 
cell extracts (Sandri-Goldin & Hibbard, 1996). IE63 co-immunoprecipitates with 
Sm containing proteins, but as Sm is an epitope common to many snRNPs, it is 
not possible to identify the specific partner of IE63.
As IE63 viral mutants are defective in host shut-off (Hardwicke & Sandri- 
Golding, 1994), it is possible that IE63 induced redistribution of splicing factors 
causes inhibition of splicing and this contributes to host shut-off. Alternatively, 
inhibition of splicing may cause redistribution of splicing factors again leading to 
host shut-off. While the majority of mammalian genes contain introns, HSV-1 
genes, with the exception of IE110, IE68, IE 12 and Ul15 do not. So this proposed 
mechanism of host shut-off would have little effect on viral gene expression.
Suprisingly, snRNP redistribution and splicing inhibition can be uncoupled. 
Redistribution is seen during infection with an IE63 mutant virus containing a 
base substitution at aa 480; however, splicing in cells infected with this virus is 
not inhibited (Sandri-Goldin et al., 1995). This suggests that despite the 
correlation between inhibition of splicing and redistribution o f splicing factors, 
alterations in snRNP location observed are not sufficient to inhibit splicing.
In uninfected cells, regulation of splicing activity and location of splicing factors 
has been shown to be dependent on phosphorylation (reviewed in Manley & 
Tacke, 1996). In wt HSV-1 infected cells compared to cells infected with an IE63 
null mutant, studies have shown an increase in the phosphorylation o f two 
proteins which co-immunoprecipitate with IE63 using anti-Sm serum (Sandri- 
Goldin & Hibbard, 1996), and one of these may be the U1 snRNP 70 kDa protein. 
Phosphorylation induced by the presence of IE63 therefore may contribute to the 
inhibition and relocalisation o f splicing factors.
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1B9.2 IE63 increases RNA 3’ processing at inherently weak virus poly(A) 
sites
Like cellular gene expression, viral gene expression is regulated at the level of 
polyadenylation.
In vitro assays, using extracts from tissue culture cells, demonstrate that 
processing of the poly(A) site of the U l38 gene (a L gene) increases due to a virus 
induced factor, late processing factor (LPF); however, processing at the poly (A) 
site of Us 12 (an IE gene) does not increase, (McLauchlan 1989). Increased usage 
of this site was dependent on IE63. ICP27 also causes an increased usage of 
certain poly (A) sites in transfected reporter genes (Sandri-Goldin et al. 1992).
Using in vitro assays (McGregor et al., 1996), the processing efficiencies at poly 
(A) sites of two L genes U l38 and U l44, shown to be inherently weak processing 
sites, have been shown to be increased by an IE63 induced activity. In contrast, 3 ’ 
processing at the poly (A) sites of selected IE and E genes, stronger processing 
sites, is unaffected by IE63 expression. In the same report, UV cross linking 
experiments demonstrated enhanced binding of the 64 kDa component of CstF to 
poly (A) sites of RNAs from genes of all temporal classes and this enhanced 
binding requires expression of IE63. Location of 64 kDa in the polyadenylation 
complex can be seen in Fig. 1B3.
As suggested by these data, IE63 may increase the binding of 64 kDa CstF to viral 
polyadenylation sites. This will not affect the use of already strong sites but will 
increase the efficiency of use of inherently weak L poly(A) sites. By this 
mechanism, IE63 therefore may regulate the switch between E and L expression, 
one of its known roles in infection ( Rice & Knipe, 1990; Rice & Lam, 1994; 
Hibbard & Sandri-Goldin, 1995). Further evidence for this comes from the study 
of expression from the HSV-1 UL24 gene (Hann et al., 1998). Two transcripts are 
produced from the U l24 gene, 1.4 kb and 5.6 kb; these initiate from the same 
promoter but utilise separate poly (A) sites and are expressed with E and L 
kinetics. Accumulation of the 5.6 kb transcript, unlike that o f the 1.4 kb transcript, 
requires IE63, Although IE63 has not been shown directly to alter poly (A) site 
selection, this seems a most likely scenario.
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1B9.3 IE63 and nucleocytoplasmic transport of mRNAs
IE63 reduces cellular mRNA levels and causes unspliced pre-mRNAs to 
accumulate in the nucleus (Hibbard & Sandri-Goldin, 1995). It also results in 
nuclear export of some unspliced cellular mRNAs (Hibbard & Sandri-Goldin,
1995) and causes nuclear retention of intron-containing viral transcripts while 
intron-less transcripts are seen to be predominantly cytoplasmic (Phelan et al.,
1996). Further, the unspliced retained transcripts co-localise with the redistributed 
snRNPs and with IE63.
IE63 shuttles from the nucleus to the cytoplasm (Mears & Rice, 1998, Phelan & 
Clements, 1997, Soliman et al., 1997) and can bind to RNA (Ingram et al., 1996) 
and these observations have led to the suggestion that it has a role in the export of 
viral mRNAs. To support this, IE63 was shown to UV-cross link to intronless 
HSV-1 RNAs in vivo, while no binding was seen with two viral transcripts which 
undergo splicing; export of intronless HSV-1 transcripts has been shown to be 
reduced in infections when IE63 is not expressed (Sandri-Goldin, 1998). It has 
been suggested that IE63 shuttles specifically with L viral transcripts and thereby 
upregulates L viral protein synthesis (Soliman et al., 1997), although a second 
report (Sandri-Goldin, 1998) observes RNA binding and shuttling of IE63 with all 
classes o f intronless HSV-1 transcripts.
The binding of hnRNP A l to poly(A)+ RNA is significantly reduced following 
HSV-1 infection (Sandri-Goldin, 1998), suggesting that as well as promoting 
export of viral transcripts IE63 increases nuclear retention of cellular RNA.
1B10 IE63 can also affect the transcription of viral and cellular genes during 
infection
IE63 may act with/upon IE 175 in order to up or down regulate viral/cellular 
mRNA transcription. IE 175 and IE63 have been reported to physically interact 
(Pangiotidis et al., 1997) but this interaction has not been independently 
confirmed. Despite this, a functional association between IE63 and IE 175 does 
exist; the electrophoretic mobility of IE 175 is altered in the presence of IE63 (Su 
& Knipe, 1989), as is its intracellular localisation (Zhu & Schaffer, 1995) and in 
transient expression systems IE63 can inhibit or augment the transcriptional
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activity of IE 175 (Su & Knipe, 1989). Since differently phosphorylated forms of 
IE 175 have been shown to have different DNA binding activities (Papavassiliou 
et al., 1991), IE63 may facilitate phosphorylation of IE 175, thus modulating its 
promoter binding and activation activities.
Although most transcription effects, require expression of IE 175 with IE63 acting 
modulate this protein; under certain conditions IE63 alone can increase the 
number of transcripts detected from a viral glycoprotein B promoter fused to a 
chloramphenicol acetyltransferase (CAT) reporter gene (Rice & Knipe, 1988). 
However, increased stability of mRNA in the presence of IE63 cannot be ruled 
out. IE63 may act directly to decrease transcription from some cellular genes, for 
example, histone H2b (Pangiotodis et al. 1997). Down regulation of H2b, is 
suggested to be at the level of transcription because the gene does not contain any 
introns or poly (A) signals.
IE63 has also been shown to have a direct role in activation o f transcription, via 
TFIIIC, by increasing RNA Pol III transcription o f Alu repeated sequences (Jang 
& Latchman, 1992). The relevance of this observation is not clear as no HSV-1 
genes are known to be transcribed by RNA Pol III. However genes encoding 
snRNAs transcribed by RNA Pol III are encoded by other herpesviruses such as 
EBV and by adenovirus.
1B11 Phosphorylation sites in IE63
IE63 is known to be phosphorylated both with stable phosphate groups and with 
phosphates that cycle on and off during infection (Wilcox et al., 1980). On SDS- 
PAGE, two forms of IE63 can be detected (more often only one is seen), and as 
many as 5 species heterogeneous with respect to charge are separated by 2D 
isoelectric focusing ( Pereira et al., 1977; Ackerman et al., 1984). Phosphoamino 
acid analysis has shown that serine is the only IE63 amino acid phosphorylated 
during infection; transfected DNA expressing IE63 yielded the same 
phosphorylated pattern, implicating cellular kinases in this process (Zhi & Sandri- 
Goldin, 1999). The same study shows that Ser 114 is highly phosphorylated by 
protein kinase A (PKA) and that Ser at positions 16 and 18 serve as 
phosphorylation sites for casein kinase 2 (CK2).
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Known and potential phosphorylation sites on IE63 protein are shown in Fig. 
lB12b.
A role for phosphorylation of IE63 in infection is unclear; mutations in known 
phosphorylation sites still allow these mutant viruses to complement IE63 null 
mutant growth but phosphorylation of Ser 114 modulates the efficiency of nuclear 
import of IE63 (Zhi & Sandri-Goldin, 1999). Given the key role phosphorylation 
plays in the regulation of cellular RNA processing, it is likely to be important for 
viral RNA processing also.
1B12 Functional domains of IE63
Mutation of various IE63 regions has allowed several separable activities to be 
identified with a discrete domain and these domains are featured in Figs. IB 12a 
and b. This dissection and reconstruction of IE63 activity can provide an 
understanding of how these separate activities contribute to IE63 function.
1B12.1 Essential acidic domain
At the amino terminus of IE63 (aa 4-64) and present in all the IE63 homologues 
(Appendix 2) lies a high concentration of acidic residues. Deletion o f this domain 
renders the mutant virus unable to rescue an IE63 null mutant indicating its 
essential nature (Rice et al., 1993). These mutants are defective in viral DNA 
replication (3-8 fold reduction), show a decrease in L gene expression and a delay 
in E gene expression; this function is separate from an activity in the C-terminus 
which also stimulates L gene expression. A number of transcriptional activators, 
such as HSV-1 VP 16, have been shown to contain a similar acidic domain 
through which they stimulate transcription by interaction with one or more 
components o f RNA Pol II (Struhl, 1991). The high degree of conservation of this 
domain throughout the herpesviruses further suggests its essential function 
(Appendix 2)
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Fig. lB12a Schematic of functional domains of IE63
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IE63 contains a number of functional domains including nuclear and nucleolar 
localisation signals, an RNA binding domain (RGG), C terminal activation and 
repression regions and a nuclear export signal (NES).
(Taken from Phelan & Clements, 1998)
Fig. lB12b Amino acid sequence of IE63
1 M A ^ D  I  DML I  D L G L D L ^ D ^ D L D E D  P P E  P A E ^ R R D D L E  S D ^ S G E C S S ^ D E D  5 0  
5 1  E D P H G E D G P E P I L D A A R P A V R P g j R P E D P G V P S T Q T P R P T E R Q G P N D P Q P A  1 0 0  
1 0 1  P H S V W S R L G A R R P S . C S P E Q H G G K V A R L Q P P P T K A Q P A R G G R R G R R R G R G R  1 5 0  
1 5 1  G G P G A A D G L S D P R R R A P R T N R N P G G P R P G A G W T D G P G A P H G E A W R G S E Q P  2 0 0  
2 0 1  D P P G G Q R T R G V R Q A P  P P L M T L A I A P  P P A D  P R A P A P  E R K A P A A D T I D A T T R  2 5 0  
2 5 1  L V L R ^ I  S . E R A A V D R  I  S E S F G R S A Q V M H D  P F G G Q  P F P A  A N  S P W A P V L A G Q G  3 0 0  
3 0 1  G P F D A E T R R V S W E T L V A H G P S L Y R T F A G N P R A A S T A K A M R D C V L R O E N F I  3 5 0  
3 5 1  E A L A ^ A D E T L A W C K M C I H H N L P L R P Q D P I I G T T A A V L D N L A T R L R P  F L Q C  4 0 0  
4 0 1  Y L K A R G L C G L D E L C S R R R L A D I K D I A S F V F V I L A R L A N R V E R G V A E I D Y A  4 5 0  
4 5 1  T L G V G V G E K M H F Y L P G A C M A G L I E I  L D T H R Q E C S  S . R V C E L T A S H I  V A P  P Y 5 0 0  
5 0 1  V H G K Y F Y  C N S L F  5 1 2
Residues conserved through out the alphaherpesviridae homolgues are in bold (see 
Appedix 2). Potential nuclear export signals are shaded: N-terminal and C-terminal 
signals are Leu rich NESs, the central one has homology to the KNS domain in 
hnRNP K. Potential CK2 phosphorylation sites are boxed, sites for phosphorylation 
by other kinases are underlined: kinases examined were Casein kinase 1, PKC, PICA, 
Calmodulin dependent kinase 2, and Src type tyrosine kinase.
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1B12.2 A Potential zinc finger, activator and repressor regions
Metal chelate affinity chromatography shows that IE63 (aa 407-512) binds zinc in 
vitro (Vaughan et al., 1992) and mutation analysis (Vaughan et al., 1992) 
demonstrates that the same region encodes a potential zinc finger m otif (C(483)-X4- 
C(488)-Xi3-H(502)-X5-C(508)). This motif has similarity to the type o f zinc finger 
which is involved in proteimprotein interactions e.g. GATA-1 binding to FOG 
(Fox et al., 1998; MacKay & Crossley, 1998).
The zinc finger containing C-terminal region is responsible for the gene activation 
and repression effects exerted by IE63 (Hardwicke et al., 1989, McMahan & 
Schaffer, 1990). Later studies show that most activation is correlated with 
increased polyadenylation and that repression is correlated inhibition of splicing 
(Chapman et a l, 1992, Hardwicke & Sandri-Golding, 1994, McLauchlan et al., 
1992, Sandri-Goldin & Mendoza, 1992).
So the data which implicate or map specific proteimprotein interactions 
correlating with activation/repression point to this domain, reinforcing the idea 
that proteimprotein interactions are responsible for the activation and repression 
activities of this region. The C-terminal region is required for redistribution of 
snRNPs (Hibbard & Sandri-Goldin, 1995) and in anti-Sm co- 
immunoprecipitations the region required for co-immunoprecipitation of IE63 has 
been demonstrated to be aa 450-504 (Sandri-Goldin & Hibbard, 1996). Further, 
self interaction of IE63 requires the residues which make up the zinc finger (Zhi et 
a l, 1999).
1B12.3 Nuclear localisation signals
IE63 is a predominantly nuclear protein, it contains a classical NLS (aa 110-137) 
along with several weaker ones mapping to the C terminal portion of the protein.
In addition, it contains a nucleolar targeting signal (aa 110-152), suggesting it 
interacts with the cell nucleoli (Mears et al., 1995).
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1B12.4 Nuclear export signal
IE63 shuttles rapidly from the nucleus to the cytoplasm (seen in a heterokaryon 
assay in less than 1 h Mears & Rice, 1998), and shuttling is therefore expected to 
be mediated by a NES or by binding to another protein which can shuttle. IE63 
does not contain any sequence resembling M9, but does possess several sequences 
which resemble Leu-rich NESs (Fig.IB 12b).
Studies of viral mutants in the heterokaryon assay, have shown that deletion of the 
amino terminus (aa 12-63) containing the first Leu rich NES (aa 7-20) or 
substitutions of aa 340 and 341 slightly decrease shuttling. However, the most 
deleterious mutation for shuttling is a substitution of aa 469 and 476 (PG to LE) 
(Mears & Rice, 1998). These mutations may affect a nearby putative Leu rich 
NES, could disrupt binding to a cellular shuttling molecule, or may increase 
nuclear retention o f IE63. The possibility also exists that IE63 contains an as yet 
uncharacterised NES: These data suggest that IE63 shuttles via at least 2 separate 
pathways, one driven by the N-terminal Leu rich NES, another involving aa 469 
and 476.
In contrast to the heterokaryon experiments, other studies have shown that LMB 
inhibits IE63 shuttling (B. Soliman, personal communication), that mutations in 
the N-terminal NES abolish shuttling and that this same region is able to promote 
shuttling when coupled to a heterologous nuclear protein (Sandri-Goldin, 1998). 
These data therefore suggest that shuttling is driven solely by the N-terminal Leu- 
rich NES.
1B12.5 RGG box and KH domains
IE63 binds directly to RNA (Ingram et al., 1996) and non-specific RNA binding 
by IE63 has been shown (Ingram et al., 1996). However in a different report IE63 
is shown to bind to intronless HSV-1 RNAs while no binding is seen with two 
viral transcripts which undergo splicing (Sandri-Goldin, 1998).
Two types of RNA binding motif are present in IE63. The first is an RGG motif, 
rich in Arg and Gly residues and post-translationally modified by methylation 
(Mears & Rice, 1996). RGG motifs commonly mediate RNA binding in hnRNPs
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and other proteins involved in pre-mRNA processing (Bimey et al., 1993). The 
RGG motif in IE63 protein overlaps with the NLS. However even when correctly 
localised to the nucleus, viral mutants lacking the RGG m otif are defective in L 
gene expression (Hibbard & Sandri-Goldin, 1995).
The second type of RNA binding motif present in the C-terminal region o f IE63 
has homology to a series o f hnRNP K homology (KH) domains. IE63 contains 
three KH domains and in IE63 they are required for the expression of HSV-1 L 
genes (B. Soliman, personal communication). These domains were first identified 
in hnRNP K where they constitute a unique RNA binding domain (section 1C1). 
KH domains are also found in other RNA binding proteins and RNA binding of 
the FMR1 protein from a severely retarded fragile X patient is impaired by a 
single point mutation in one of the KH domains (Siomi et al., 1994).
1B13 IE63 and DNA replication
HSV-1 mutants with certain lesions in IE63 show a 5- to 10-fold reduction in viral 
DNA synthesis due to insufficient expression of most of the essential replication 
genes (Uprichard & Knipe, 1996). In addition, IE63 affects the localisation o f the 
single stranded binding DNA protein (UL29), a component of the replication 
complex and thus promotes replication complex formation (Curtin & Knipe,
1993). Using the same methods but with an IE63 mutant virus, it has been shown 
that IE63 is essential for efficient DNA replication foci formation but made no 
difference to transcription site formation. It is possible that IE63, by redistributing 
the snRNPs to the nuclear periphery, facilitates formation and spatial arrangement 
of viral transcription and replication complexes. As splicing, splicing factors, 
transport routes and replication factories are associated with the nucleoskeleton in 
uninfected cells (Hozak et a l, 1993) and IE63 affects splicing, splicing factors, 
transport routes and replication factories, maybe IE63 alters the nucleoskeleton 
causing a diverse number of effects.
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1B14 IE63 homologues
HSV-1 IE63 protein is the only HSV-1 IE gene which has homologues throughout 
the Herpesviridae and this suggests that aspects of the regulatory role of IE63 are 
maintained throughout the herpesvirus family. Comparisons o f functional and 
structural characteristics of IE63 and its positional homologues aids understanding 
of each homologue’s function and of regulatory protein evolution during the 
emergence of the different herpesvirus species.
Sequence alignments of IE63 homologues in alphaherpesviruses can be found in 
appendix 2.
From the N to C termini, the alphaherpesviruses consist of
• An acidic region
• A basic region
• A linker
• A conserved domain
The gammaherpes viruses have a similar structure but contain an additional N 
terminal region from an additional exon. The betaherpesviruses do not have this 
structure. There appears to be a large non-conserved C terminal extension of 
variable length containing an acidic domain. The amino termini are not conserved 
and contain basic residues. The central region is conserved and certain residues in 
this region are conserved in alpha-, beta-, and gamma-herpesviruses.
VZV and BHV-1 are alphaherpesviruses, HCMV is a betaherpesvirus and EBV, 
HVS and HHV-8 are all gammaherpesviruses.
1B14.1 VZV ORF 4
HSV-1 IE63 protein and VZV ORF 4 IE gene product - IE4 (Defechereux et a l ,
1997), are positionally homologous (Moriuchi et al., 1994). Although IE4 cannot 
complement an IE63-defective HSV-1 mutant (Moriuchi et al., 1994), and is 
predominantly cytoplasmic as opposed to IE63 which is predominantly nuclear,
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the amino-terminal region of IE4 can efficiently replace that o f IE63 (Moriuchi et 
al., 1995). Unlike IE63, IE4 does not exhibit any fra«s-repressing activities but is 
capable of stimulating gene expression either alone or in synergy with the major 
VZV regulatory protein IE62 (Defechereux et al., 1993, Inchauspe et al., 1989, 
Perera et al., 1992). Analysis of IE4-mediated transactivation in transient 
transfection assays at the RNA level also suggest that IE4 is a multifunctional 
protein which can stimulate heterologus and autologus gene expression through 
more than one mechanism, one of which involves post-transcriptional regulation 
(Defechereux et al., 1997). Unlike HSV-1 IE63 (Yao & Courtney, 1992), IE4 is a 
component of the VZV virion (Moriuchi et al., 1994).
1B14.2 BHV-1 BICP27
The bovine herpes virus homologue of IE63 - BICP27, is expressed with E 
kinetics and accumulates in the nuclei of cells. Transient expression assays using 
target genes differing only in their poly (A) sites showed that BICP, like IE63, 
may be involved in increasing the processing efficiency of mRNA containing 
weak poly (A) sites (Singh et al., 1996).
1B14.3 HCMV Ul 69
Like VZV ORF 4 gene, the ORF U l69 of HCMV, is a positional homologue of 
HSV-1 IE63, and is located in the HCMV virion (Winkler & Stamminger, 1996). 
In contrast to HSV-1 IE63, the U l69 gene product is expressed with E-L kinetics 
during HCMV replicative cycle. However, it can function as a transactivator of 
several viral and cellular promoters (Winkler et al., 1994).
1B14.4 EBV BMLF1/EB2/SM
SM is expressed at E times in EBV lytic infection. Like IE63, SM binds RNA and 
regulates gene expression at a post-transcriptional level, via control of splicing 
and RNA export (Ruvolo et al., 1998). SM inhibits cytoplasmic accumulation of 
polyadenylated RNAs when they are generated by the use o f cryptic 5’ splice 
sites, and induces cytoplasmic accumulation o f both intronless and intron
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containing RNAs generated by use o f constitutive splice sites (Buisson et al., 
1999). Thus expression of many E and L intronless viral genes may be enhanced, 
while expression of certain intron containing IE and latent genes may be 
repressed. EBV SM co-localises with SC35 and shuttles between the nucleus and 
the cytoplasm (Semmes et al., 1998). Both the transactivation function and
shuttling are dependent on association with CRM1 (Boyle et al., 1999).
Homology between IE63 and SM is at the C terminal region o f IE63, the region of 
IE63 responsible for post-transcriptional gene activation and repression activities 
of IE63 (Appendix 2).
1B14.5 HVS ORF 57
HVS ORF57 gene product can activate and repress expression from a range of 
both E and L HVS promoters; levels of mRNA do not correlate with the 
increase/decrease in CAT activity seen in the presence of the ORF57 gene 
product. In the same experiments, repression o f gene expression was shown to be 
dependent on the presence of an intron within the gene encoding region 
(Whitehouse et al., 1998). Like HSV-1, HVS infection results in the redistribution 
of SC-35 and snRNP U2 spliceosome components in the infected cell nucleus, the 
ORF57 gene product is enough to cause this redistribution and co-localises with 
the redistributed spliceosome components (Cooper et.al., 1999). Taken together 
these data suggest that, like IE63, the ORF57 gene product of HVS regulates gene 
expression in a way which involves disruption of RNA splicing.
1B14.6 HHV 8 ORF 57
HHV 8 ORF57 is also a regulatory gene, it co-localises with SC-35 but unlike 
IE63 (Sandri-Goldin, 1998), it does not shuttle from the nucleus to the cytoplasm 
in the presence of actinomycin D. It has been, however, seen to shuttle in an 
interspecies heterokaryon assay (Bello et al., 1999). This would suggest shuttling 
is transcription independent.
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1B15.1 HIV-1
HIV-1-Rev and RNA export
HIV-1 encodes a range o f mRNA species derived by partial or complete splicing 
o f a single primary transcript (Fig. IB 15. la). This means that gene regulation 
must occur at the post-transcriptional level.
If  a cellular mRNA contains an intron, interaction with a subset of splicing factors 
is induced , which commits the transcript to being spliced and exported or, if the 
signal is redundant, to degradation. This presents a problem for HIV-1 gene 
regulation as for production of some proteins splice sites must be recognised by 
the splicing machinery and for others the splicing machinery must be by-passed, 
while RNA export must still occur (reviewed by Cullen, 1998b).
This problem is solved by HIV-1 Rev protein. Produced E in infection from a 
transcript which is fully spliced, it facilitates expression of L viral proteins 
produced from a primary transcript which is partially- or un-spliced. Domains of 
HIV-1 Rev are shown in Fig. lB15.1b.
HIV-1 Rev and nuclear export o f  viral transcripts
HIV-1 Rev acts to transport incompletely and unspliced HIV-1 RNAs that contain 
the cis acting Rev response element (RRE) (Malim et al., 1989). This activity 
requires Rev to shuttle between the nucleus and the cytoplasm, exporting viral 
transcripts and then being reimported again. Nuclear export is mediated by a Leu- 
rich NES (Fig. lB15.1b) (Fischer et al., 1995; Wen et al., 1995), and requires the 
cellular co-factor Rab (Bogerd et al., 1995). The Rev-Rab-RNA complex then 
binds to the export receptor CRM 1 (Fomerod et al., 1997a) and exits the nucleus. 
Once in the cytoplasm, the complex dissociates, presumably exposing the NLS, 
and Rev is reimported into the nucleus. HIV-1 transcripts bound to Rev are thus 
exported from the nucleus. This shuttling process requires the GTP bound form of 
Ran (Richards et al., 1997). This model is consistent with the shuttling receptor 
model illustrated in Fig. 1B4, where the receptor is CRM1 and the NES is the 
Leu-rich signal in Rev.
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Fig. lB15.1a Genomic organisation of HIV-1
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The genome is flanked by terminal repeats (LTR). All mRNAs are derived from one 
precursor RNA, dotted lines join exonic sequences of genes Rev and Tat, expressed 
after complete splicing of the precursor RNA. N ef is also expressed after complete 
splicing, Env, Vif, Vpr and Vpu are expressed from mRNAs derived by partial 
splicing of the precursor RNA, while Gag and Pol are expressed from unspliced 
precursor RNA.
Fig. 1B15.1 b Functional domains of HIV-1 Rev
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RNA binding domain and NLS (aa 34-50); activation domain and Leu-rich NES (aa 
75-84); multimerisation domain (aa 12-60). Taken from (Cullen, 1998a)
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HIV-1 Rev and splicing
HIV-1 Rev has a second functional domain. A basic domain (aa 34-50) (Fig.
IB 15. lb) which binds RNA, and contributes to the ability of Rev to oligomerise; 
this domain is also able to inhibit splicing of RRE containing transcripts in vitro 
(Kjems et al., 1991; Kjems & Sharp, 1993). Exogenously added p32 protein is 
seen to specifically relieve this inhibition of splicing in-vitro, and a model (Fig.
IB 15.1c) of Rev bound to RRE interacting with p32, which is associated to 
ASF/SF2 at the 5’ splice site, therefore stabilising the interaction of U1 snRNP 
with the 5’ splice site and inhibiting assembly of functional spliceosomes, has 
been proposed (Tange et al., 1996). As the Rev-ASF/SF2-p32 interaction has also 
been implicated in mRNA export via Rev NES (Gilmartin et al., 1992; Yu et al., 
1995b; Tange et al., 1996), it is unclear whether inhibition of splicing is a direct 
or an indirect effect of Rev shuttling.
HIV-1 does not only affect the activity of cellular splicing factors, expression of 
the SR protein SC35 is also seen to be upregulated during infection (Maldarelli et 
al., 1998). In vitro and in vivo alteration of the amount of SC35 can influence the 
selection of alternative splice sites (Fu & Maniatis, 1992; Wang & Manely, 1995). 
As HIV-1 transcripts contain multiple 5’ and 3’ splice sites, some of which are 
cryptic, utilisation of alternative splicing sites would influence the relative 
abundance of viral transcripts. It is not known if increases in SC35 alter the 
pattern of splicing in HIV-1 transcripts but it seems a likely scenario. If increased 
levels of SC35 are recruited to the spliceosome, where normally SC35/ASF/SF2 
and p32 are associated, Rev could be involved in recruiting SC35 and so in the 
selection of viral transcript splice site (compare Figs. IB 15.1c and 1B2.3).
The effects of HIV-Rev on splicing and mRNA export which contribute to HIV 
gene regulation can be seen in Fig. IB 15.Id.
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Fig.IB15.lc Putative model for p32-Rev interaction
3'-exon
RRE
p ev Intron
p 32
SF25'-exon
Rev protein bound to RRE interacts with p32 protein associated with ASF/SF2 at the 
5’ splice site. This interaction could stabilise the interaction of the U1 snRNP with 
the 5’ splice site and inhibit assembly of functional spliceosomes. The arrested 
complexes may subsequently function as a substrate for Rev-mediated nuclear 
export.
Taken from (Tange et al., 1996).
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Fig. IB15.1d HIV-1 Rev action
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While fully spliced RNAs are readily exported from the nucleus, RNAs containing 
introns are retained in the nucleus by commitment factors, such as the U 1 snRNP or 
SR proteins, until fully spliced or degraded. Rev induces the nuclear export o f  Rev 
response element containing viral RNAs and thereby either prevents or reverses 
nuclear retention. Taken from (Cullen, 1998a).
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1B15.2 Adenovirus
Although transcriptional control is important in adenovirus infection, only nine 
viral promoters are used by the virus and so post-transcriptional control 
mechanisms are needed to produce the required numbers o f viral proteins. 
Adenovirus infection produces changes in the activity of cellular splicing and 
polyadenylation factors and as infection proceeds the pattern o f processing alters, 
in general towards the production of smaller mRNAs (reviewed in Leppard,
1998). Two viral proteins ORF6 and 55K have been shown to be essential for the 
transport of viral L mRNAs, in a way substantially similar to HIV-1 Rev 
(Williams & Leppard, 1996). The same proteins are required to prevent 
commitment of host cell mRNA to the export pathway, but whether the two 
events are linked is not known.
O f particular interest is the redistribution of snRNPs (Bridge et al., 1993). In 
contrast to HSV-1 transcripts which are not spliced, adenovirus transcripts are 
extensively spliced. At E times, splicing factors have a general distribution but at 
later times (when there is increased splicing) they are recruited into virus 
transcription and processing sites. Following this, splicing factors form large foci, 
similar to those observed in HSV-1 infected cells, but corresponding to an 
increase in, rather than a block in, splicing. These foci contain late viral mRNA 
enriched in exon sequences, i.e. which may already be spliced. Although their role 
is not clear, it has been proposed that these foci could reflect host splicing 
machinery/transport pathways being saturated with viral transcripts and so 
“backing up” in the nucleus or that they are a result o f increased recycling of 
splicing factors caused by the increased splicing activity or that they may be in 
some way related to the block on nuclear transport of host RNA. It may be the 
redistribution of snRNPs with viral L transcripts that acts to disrupt host mRNA 
export. A yet unknown viral protein may drive nuclear reorganisation or 
reorganisation may be secondary to disruption of another RNA processing event.
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1B15.3 Influenza
The genome of Influenza viruses consists of eight single-stranded RNAs of 
negative polarity, present as ribonucleoproteins. Each one is transcribed as an 
individual unit in the nucleus of infected cells. A significant amount of viral gene 
expression regulation occurs post-transcriptionally.
NS1 in splicing
NS1 has been reported to be involved in the modulation o f mRNA splicing, it 
both inhibits cellular mRNA splicing (Qiu et al., 1995) and alters the usage of 5’ 
splice sites in alternatively spliced transcripts (Fortes et al., 1994). It has been 
suggested that interaction of NS1 with U6 snRNA (Qiu et al., 1995) inhibits
splicing by preventing base pairing between U6, U2 and U4 snRNAs and that 5’ 
site selection is regulated by an alteration of activity o f soluble splicing factors 
such as ASF/SF2, perhaps by phosphorylation. In line with these observations, 
NS1 protein expression alters the nuclear localisation o f splicing factors (Fortes et 
al., 1995), reorganising them in a similar way to that which occurs in HSV 
infected cells. The reorganised snRNPs in influenza infected cells are thought to 
represent dysfunctional aggregates of splicing factors. Given the similarities of 
reorganisation in HSV-1 and adenovirus, it is not unfeasible to suggest that NS1 
interacts with a similar array of proteins to disrupt/modulate splicing.
NS1 in polyadenylation and mRNA export
NS1 is required for the nuclear retention of cellular poly (A)+ mRNA, where they 
are degraded (Katze & Krug, 1984) allowing viral polymerase access to cap 
snatching substrates (Katze & Krug, 1984). NS1 binds to poly (A) (Qui & Krug, 
1994), to the CPSF-30 subunit (Nemeroff et al., 1998) and to PAB II (Chen et al., 
1999), inhibiting both polyadenylation and cleavage of the 3’ end of mRNA; the 
combined approaches cause nuclear retention of cellular mRNA. NS1 has been 
shown to be transdominant over the Rev-NES (Chen et al., 1998b) and this points 
to a mechanism involving specific nuclear retention rather than disruption of 
export. As splicing, polyadenylation and transport are linked, redistribution of
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splicing factors may also be the cause of nuclear retention or, alternatively, 
redistribution maybe be secondary to inhibition of transport.
NS2 mediates nuclear export o f  viral mRNAs
NS2 can substitute for HIV-1-Rev and mediate nuclear export of a heterologous 
protein cross linked to it, in addition injection of antibodies against NS2 prevents 
viral mRNA reaching the cytoplasm (O’Neil et al., 1998). NS2 can also interact 
with nucleoporins (O'Neil et al., 1998) acting like HIV-1 Rev as a mediator of 
viral mRNA export. Transport of viral mRNA can be blocked by methylation or 
phosphorylation inhibitors (Vogel et al., 1994), suggesting that these processes 
are important.
1B15.4 Summary of viral post-transcriptional gene regulation.
In other virus systems gene expression is controlled post-transcriptionally. 
Examination of post-transcriptional regulation in the viral systems discussed 
shows that IE63 is not unusual in its effects and comparisons reveal common 
themes in viral disruption of RNA processing, namely,
(i) Reorganisation of snRNPs, either leading to modulation o f splicing 
function or secondary to alterations in the activity of cellular splicing factors.
(ii) Use of an alternative pathway for mRNA export, often via a viral protein, 
concurrent with disruption of cellular mRNA export.
(iii) Viral induced changes in phosphorylation appear to play a role in the 
changes of function/location of cellular factors
(iv) Control is often exerted at several points in processing by a 
multifunctional viral protein.
(v) Effects on different RNA processing events are often linked.
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Chapter 1 Part C. Proteins found to interact with IE63 
and aims of the study
This study identifies 4 cellular proteins which interact with IE63, all o f which 
have proposed roles in RNA transcription/processing. One viral protein is also 
found in a complex with IE63. Properties of these 5 proteins are summarised 
below.
1C1hnRNP K
hnRNP K, first discovered as a component of the hnRNP particle (Matunis et al., 
1992), can be found as at least five alternatively spliced isoforms (Dejgaard et al., 
1994). The relevance of different isoforms is unclear. A function for hnRNP K in 
the hnRNP particle has yet to be defined. It has a wide intracellular distribution 
and can be easily obtained from cytoplasmic and nuclear extracts (Dejgaard et al., 
1994, Ostrowski et al., 1994); a large fraction of hnRNP K is not associated with 
the hnRNP particle. Like IE63, hnRNP K is a multifunctional protein and has 
multiple domains. Functional domains of hnRNP K are illustrated in Fig. 1C la.
hnRNP K binds RNA with a preference for poly (rC) RNA (Matunis et al., 1992). 
The binding of RNA is via KH domains (Siomi et al., 1994), KH (hnRNP K 
homology) domains were first identified as an RNA binding motif in hnRNP K, 
which has three copies of the conserved 65-70aa motif. Phosphorylation of 
hnRNP K decreases its binding to RNA (Dejgaard et al., 1994).
hnRNP K contains another novel motif, the KNS. The KNS domain is a 38 aa 
domain which mediates bi-directional transport between the nucleus and the 
cytoplasm. hnRNP K shuttling, unlike that o f hnRNP A l which is mediated by the 
M9 motif, is transcription-independent. However, hnRNP K also contains a 
classic nuclear localisation signal which when deleted renders hnRNP K 
dependent on RNA pol II transcription for nuclear localisation. Thus hnRNP K 
can access a transcription-dependent pathway, raising the possibility that hnRNP 
K shuttles mRNA, the tie to transcription preventing wasteful reimporting of
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Fig. lC la  Domains of hnRNP K
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NLS: nuclear localisation signal (aa 21-37), KH1-KH3: KH domains-novel RNA 
binding domains (aa 46-98, 149-197, and 391-439), GRRG box: classic RNA 
binding domain (aa 236-273), KNS: novel bi-directional nuclear export signal (aa 
323-390), SH3: interaction site for proteins containing an SH3 domain (aa 289-315). 
(Taken from Bomsztyk et al., 1997).
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export factors. hnRNP K cannot be shown to utilise any of the known nuclear 
import receptors (Michael et al., 1997).
hnRNP K also binds to DNA which is the preferred ligand over RNA in vitro 
(Tomonaga & Levens, 1995). This binding is sequence specific to G+C rich 
sequences. hnRNP K has been suggested to be a transcription factor. For example, 
HNRNP K binds to the (CCCC/GGGG) tract present in the CT motif found in c- 
myc promoter PI and transactivates transcription from this promoter in vitro 
(Takimoto et al., 1993). The CT element is a naturally occurring C rich 
homopyrimidine motif, consisting of four imperfect direct repeats of the sequence 
CCCTCCCCA, and a fifth repeat, 9-bp downstream of the first 4, which acts as a 
cis enhancing element for c-myc in vivo (DesJardins & Hay, 1993). hnRNP K can 
interact with TBP (TATA binding protein) and when hnRNP K and TBP are over 
expressed in vivo, transcription from a CT element dependent reporter is 
synergistically activated (Michelotti et al., 1996). Chemical and enzymatic probes 
selective for single stranded DNA indicate that the CT element of the c-myc 
promoter adopts an under-wound and flexible conformation in the presence o f 
hnRNP K (Tomonaga et al., 1998), which allows bending of DNA to bring 
together cis elements facilitating transcription (Fig. 1C lb).
Using chimeric constructs and a variety of different promoters, it is suggested that 
hnRNP K can transactivate a number o f genes (Lee et al., 1996). In one case when 
the adenovirus E2 promoter is used, hnRNP K is seen to lower rather than activate 
transcription. This is reminiscent of Y-box proteins, another set of multifunctional 
proteins where activation or repression are promoter dependent. As well as 
interacting with the transcriptional activator TBP, hnRNP K interacts with a 
transcriptional repressor Zikl. Interaction is blocked by the binding of poly (A) 
RNA to hnRNP K (Denisenko et al., 1996), raising the possibility that RNA 
binding to hnRNP K can regulate transcription.
hnRNP K is phosphorylated by and interacts with hnRNP K protein kinase 
(KPK). Phosphorylation of hnRNP K by KPK is DNA- or RNA- dependent and 
interleukin 1 responsive. KPK activity towards hnRNP K is activated by 
phosphorylation (Van Seuningen et al., 1995a). hnRNP K can also interact with 
signalling molecules such as c-src (Weng et al., 1994; Van Seuningen et al.,
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Fig. lC Ib Possible mechanism of action of hnRNP K
[Activati
hnRNP K
hnRNP K binds to the CT element of c-myc, causing bending o f DNA and bringing 
together activator proteins and basal transcription factors which are bound to 
spatially separate promoter and enhancer/repressor regions. Taken from (Tomonaga 
et al., 1998).
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1995b) and vav (Bustello et al., 1995) via SH3 domains; these domains are known 
to facilitate proteimprotein interactions between signalling molecules. Binding of 
KPK and c-src may be able to occur concurrently as the regions involved in 
binding lie adjacent to each other. KPK can be phosphorylated by c-src in vitro 
(Van Seuningen et al., 1995a).
It has been suggested that hnRNP K provides a molecular docking platform for 
proteins to interact. If this is true, formation o f multimers of hnRNP K would 
provide it with the capacity to interact with transcriptional activators and 
repressors, KPK and signalling molecules (and possibly mRNA processing 
factors) simultaneously in a way which is regulated by nucleic acid. In turn, 
interaction with different kinases would be expected to alter hnRNP K 
phosphorylation and so its partner proteins. This arrangement would provide a 
cross talk mechanism between transcription, signalling, and mRNA processing.
Finally, hnRNP K has been implicated in regulation of translation. It interacts 
with the elongation factor-la (Densisenko and Bomsztyk, Personal 
Communication) and together with hnRNP E l, interacts with and causes 
translational silencing on erythroid 15-lipoxygenase (LOX) mRNA (Ostareck et 
al., 1997). In vitro data suggests this is achieved by specific inhibition of 80S 
ribosome assembly on LOX mRNA.
hnRNP K  and viruses
Hepatitis C core protein can relieve hnRNP K ’s repression o f the human 
thymidine kinase (TK) gene (Hsieh et al., 1998). Binding o f core has been shown 
to be in a region of hnRNP K which may cause disruption o f hnRNP K binding to 
other cellular factors, and this may therefore be how suppression is lifted. In 
addition, the binding of core protein to a transcription factor (hnRNP K) may 
account for its ability to modulate the promoter activities o f other genes. Hep C 
core is not only involved in transcriptional regulation, it is a multifunctional 
protein which besides being a viral nucleocapsid protein has RNA binding ability, 
can oligomerise, binds to the tails of cytoplasmic lymphotoxin p receptor and 
tumour necrosis factor receptor and sensitises cells to tumour necrosis factor and 
fas  mediated cell death. Core has also been linked to cellular lipid metabolism.
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The progressive life cycle of the human papillomavirus, is linked to the 
differentiation o f the stratified epithelium. Late viral protein L2 is restricted to 
terminally differentiated epithelial cells in the superficial layers of the squamous 
epithelium, while mRNA can be found in the lower levels. Recombinant hnRNP 
K, over expressed and purified, binds to HPV-16 L2 mRNA in a sequence 
specific manner. This binding efficiently inhibits translation of L2 mRNA in vitro 
(Collier et al., 1998). HPV-16 therefore appears to utilise hnRNP K to control 
gene expression at the level of translation.
1C2 P32
P32, first isolated as a protein tightly associated with ASF/SF2 purified from 
HeLa cells (Krainer et al., 1990b), has recently been shown to regulate RNA 
splicing by inhibiting phosphorylation of and RNA binding by ASF/SF2 
(Peterson-Mahrt et al., 1999).
Despite this, the distribution o f p32, like its function, is controversial. P32 is 
reported to have a mitochondrial distribution (Matthews & Russell, 1998, Muta et 
al., 1997) but can also be found in the nucleus as granules and tubules (Matthews 
& Russell, 1998). Further, the distribution o f p32 is altered during adenovirus 
infection where, with viral core protein V, it redistributes to the nucleus 
(Matthews & Russell, 1998).
p32 interacts with a variety of cellular and viral proteins adding to the confusion 
regarding its function. Interacting proteins include lamin B receptor (Simos & 
Georgatos, 1994), TFIIB (Yu et al., 1995a), the globular head domain o f the 
plasma complement component C lq, whose haemolytic activity is inhibited as a 
result (Ghebrehiwet et al., 1994), high molecular weight kininogen and factor XII 
(Herwald et al., 1996), vitronectin (Lim et al., 1996), hyaluronic acid (Deb & 
Datta, 1996), HSV-1 ORF-P protein (Bruni & Roizman, 1996), Epstein-Barr 
virus EBNAI protein (Chen et al., 1998a, Wang et al., 1997) adenovirus 
polypeptide V (Matthews & Russell, 1998), and HIV-1 proteins Rev and Tat (Luo 
et al., 1994, Tange et al., 1996, Yu et al., 1995b) (see HIV-1 section). Together, 
these interactions have suggested a role for p32 not only in splicing (Luo et al., 
1994, Peterson-Mahrt et al., 1999, Tange et al., 1996, Yu et al., 1995b) but also in
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nucleocytoplasmic transport (Matthews & Russell, 1998, Peterson-Mahrt et al.,
1999), transport to and from the mitochondria (Jiang et al., 1999, Matthews & 
Russell, 1998) and in maintaining oxidative phosphorylation (Muta et al., 1997).
1C3 SAP145
Splicing associated protein 145 (SAP 145), is one of the seven splicing associated 
polypeptides found within the U2 snRNP where it acts to tether the snRNP to the 
intron of pre-mRNA (Fig. 1C3) (Champion-Amaud & Reed, 1996).
1C4 Casein Kinase II (CK2)
CK2 can use either ATP or GTP to phosphorylate serine or threonine residues that 
are N-terminal to acidic amino acids. CK2 is known to phosphorylate and in some 
cases modulate the activity of over 160 proteins (and the list is growing!), 
including transcription factors e.g., Spl (Pugh & Tijian, 1990), signalling 
molecules e.g. A-Raf kinase (Hageman et al., 1997), ribosomal proteins e.g. L5 
(Kim et al., 1996), and a great number of nuclear proteins. From its substrates it is 
implicated in the regulation of signal transduction, transcriptional control, 
apoptosis, cell cycle and consequently cancer. CK2 is classically known as a 
heterotetrameric holoenzyme that can exist as 3 forms (X2P2 ot’2 P2 or a  a ’p2, a  
and a ’ are the catalytic subunits and p is the regulatory subunit. Yet individual 
subunits have recently been shown to have their own activities which may go 
some way to explaining CK2’s many and varied roles (reviewed in Guerra & 
Issinger, 1999).
CK2 and viruses
CK2 has been shown to phosphorylate a number of viral proteins (table 1C4) and 
to modulate their behaviour. On examination of this list two points are obvious. 
Firstly, for the majority of viruses investigated the CK2 target protein is involved 
in transcription, e.g. P proteins of Mononegavirales (non-segmented negative 
strand viruses), hepatitis delta and influenza. Secondly, in the same virus different 
proteins are modified by CK2 (at different time points or simultaneously during 
infection). For example, in HSV-1 the structural proteins VP22 and VP 16, the R1 
subunit of ribonucleotide reductase and glycoprotein E are all CK2
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Fig. 1C3 Position of SAP145 in U2 snRNP
p A complex
py tract 3'
SAP 145 interacts with pre-mRNA and other spliceosome proteins to tether the 
snRNP U2 complex to the intron. Shown also are the positions of U2AF subunits and 
ASF/SF2. Note ASF/SF2 is also in contact with p32 and the U1 snRNP (Fig.
1B2.3).
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Table 1C4 Viral proteins that are phosphorylated by CK2
Virus Viral protein Function
Boma disease P protein Transcriptional co-factor
Canine distemper P protein Transcriptional co-factor
Measles P protein Transcriptional co-factor
Vesicular stomatitis P protein Transcriptional co-factor
Respiratory syncytial P protein Transcriptional co-factor
Bovine papilloma El ATP dependent helicase
Hepatitis delta Small HDAg genome replication
EBV ZEBRA protein transcriptional activator
EBV EBNA-2 immortalisation of B-cells
Influenza PA polymerase polymerase
Polyoma VP1 major capsid protein
HSV VP22 viral replication
HSV VP16 transcriptional activator
HSV IE22 regulation of transcription
HSV R1 subunit ribonucleotide reductase
HSV Glycoprotein E blocking some host responses
VZV Glycoprotein I AP-1 recruitment to Golgi
VZV Gene 63 protein nuclear protein
HIV Vpu membrane protein
HIV Rev viral RNA processing
Human papilloma E7 oncoprotein
SV40 Large T oncoprotein
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phosphorylated. CK2 phosphorylation is also important in HIV-1 infection. HIV-1 
Rev activates CK2 and the activated CK2 phosphorylates several cellular and 
viral proteins in HIV-1 infected cells (Ohtsuki et al., 1998). Phosphorylation of 
Rev significantly reduces its binding to RRE, suggesting that CK2 may effect 
nuclear export of HIV-1 transcripts.
In addition to its ability to phosphorylate viral proteins, CK2 has been shown to 
nucleotidylate the HSV-1 IE protein ICP22 (Mitchell et al., 1997), IE63 is also 
nucleotidylated (Blaho et al., 1993) a modification which has been suggested to 
be carried out by CK2. Thus CK2 may play a general role in the 
processing/regulation of viral/cellular proteins involved in HSV-1 infection.
1C5 HSV-1 Thymidine kinase (vTK)
During synthesis of nucleotides for DNA synthesis cellular TK (cTK) uses Mg- 
ATP to monophosphorylate thymidine. This is a very specific reaction. HSV-1 
encodes its own thymidine kinase enzyme (vTK), which shows a much broader 
range of phosphorylation activities. It is a deoxypyrimidine kinase, able to 
phosphorylate a range of nucleoside analogues, it can carry out multiple 
phosphorylations and can use nucleoside triphosphates other than ATP as the 
phosphate source, (reviewed in Evans et al., 1998).
HSV TK is considered a luxury function as in normal cell culture in exponentially 
growing cells it is dispensable. However in serum starved resting cells, such as 
skin cells which HSV normally infects, it may be required, as the cell de novo 
pathway may not be active (Jamieson et al., 1974). In addition TK' HSV-1 viral 
mutants, are less virulent than the parental TK+virus (Field & Wildy, 1978). In 
mice, vTK is not required for DNA replication at the primary site o f infection, at 
least when that site is the cornea. In contrast, TK' mutants do not replicate in 
trigeminal ganglia (Tenser & Dunston, 1979), suggesting that vTK is required for 
secondary replication in the ganglia. Despite lack of replication, TK' mutants can 
establish latent infection (Coen et al., 1989). Reactivation from latency following 
superinfection with wt virus has been demonstrated, although TK' virus could not 
be reactivated from explanted ganglia. Southern blotting o f the reactivated virus, 
demonstrated in vivo complementation of the mutant virus with wt virus. In the
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same study, LATs were detected in only ~2-5 fold higher frequencies in wt 
infected ganglia than in TK- virus infected ganglia. Thus vTK is not required to 
establish a latent infection but is needed for reactivation (Coen et al., 1989).
1C6 Aims of this Project
IE63, is involved in an extraordinary range of regulatory feats and how it does this 
has been the subject o f many studies. The key to understanding the way a protein 
functions is often to discover those proteins it interacts with. If these have a 
known role in the host cell then much can be deduced about which pathways the 
viral protein is affecting. The most convincing explanation for the diverse 
functions of IE63 is that it interacts with and modifies the behaviour of essential 
regulatory proteins involved in the different processes it affects.
• The primary aim of this project therefore was to identify which viral and 
cellular proteins IE63 interacts with.
• Secondary to this was the uncovering of the ways in which these 
interactions could influence IE63 activity in infection.
The data presented will be used to argue that “IE63 is a multifunctional protein 
which regulates HSV-1 infection though multiple protein:protein interactions”.
1C7 Significance of interactions between IE63 and host cellular proteins
IE63 is a key protein in HSV-1 infection and so understanding of its action is 
important to the fundamental understanding o f HSV-1 biology. In addition, IE63 
has homologues in every member of the Herpesviridae so understanding its 
activities will have implications for the understanding of these other viruses. Any 
key viral protein, especially one so conserved, is a candidate for anti-viral therapy. 
Drugs designed to disrupt IE63 protein:protein or protein:nucleic acid interactions 
are an obvious potential offshoot of these kinds o f study. Finally, HSV-1 via IE63 
interferes with and utilises host cellular mechanisms for its own replication, 
therefore its study might be expected to shed considerable light on host cell 
processes.
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Chapter 2: Materials and Methods 
2A  Materials
2A1 Plasmids
The following plasmids were provided by the acknowledged investigator
pGEX-27: (Mears & Rice, 1996) Provided by S. Rice, Calgary University,
USA. Expresses the fusion protein GST-IE63.
pGEX-K: (Michelotti et al., 1996) Provided by K. Bomsztyk, University of
Washington, USA. Expresses the fusion protein GST-hnRNP K 
(also refered to as GST-K).
pGEX-145: (Seghezzi et al., 1998 ) Provided by R. Reed, Harvard University, 
USA. Expresses the fusion protein GST-SAP145.
Various plasmids expressing MBP/GST-CK2P and truncations and GST-
C K 2 a :  (Heriche et al., 1997; Leroy et al., 1999) Provided by O.
Filhol. INSERM, Grenoble, France.
pCMV-63: EcoRI/BamHI fragment containing IE63 and 400 C-
terminal base pairs (bp) was digested out of pEGFP63, and ligated 
into the EcoRI/BamHI sites in the multiple cloning site of 
pCMVIO (Stow et al., 1993).The plasmid therefore consists of the 
complete open reading frame of IE63 downstream of a CMV 
immediate early promoter, constructed by N. Reuthmeir, Institute 
of Virology, Glasgow. P. Lomonte provided pEGFP63 and 
pCMVIO.
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2A2 Enzymes
Restriction Enzymes were obtained from Boehringer Mannheim or New England 
Biolabs. T4 DNA ligase (lOU/pl) and calf intestinal phosphatase (lOOOOU/ml) 
were from Boehringer Mannheim. Lysozyme (lOmg/ml stock) came from Sigma 
and RNase ONE™ ribonuclease (lOU/pl) was obtained from Promega. CK2 
subunits were purified from Drosphilia ((X2P2 at 0.2mg/ml, a  at 3.6mg/ml, a ’2p2 at 
40pg/ml) and were a gift from O. Filhol.
2A3 Peptide substrate
The CK2 peptide substrate (Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu) was 
synthesised by Howard Marsden, MRC Virology Unit, Glasgow.
2A4 Bacteria and bacterial culture media 
2A4.1 Bacteria
The E.coli strain DH5a was used for maintenance and propagation of plasmid 
DNA. Protein expression from pGEX/MBP derived plasmids utilised E. coli strain 
BL21 (Studier et al., 1990). During optimisation of GST fusion protein expression 
use of the E. coli stain X a90 was investigated.
2A4.2 Bacterial culture media
All strains were grown in L-Broth (lOg NaCl, lOg Bactopeptone, 5g yeast extract 
in 11 water, pH 7.5) or at times in 2YT broth (5g NaCl, 16g Bactotryptone, lOg 
yeast extract in 11 water). Agar plates were made with 1.5% (w/v) agar in L-broth. 
Where necessary, media and LB agar plates were supplemented with antibiotic: 
50pg/ml kanomycin (for pET28c transformed cells) or lOOjug/ml ampicillin for all 
other plasmid containing bacteria.
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2A5 Cells and tissue culture media
All cell culture media were obtained from Gibco.
BHK-21 Cl 3 cells
A fibroblastic line derived from baby hamster kidney cells (MacPherson &
Stoker, 1962), BHK C13 cells were grown in Glasgow Modified Eagle's Medium 
(GMEM) supplemented with 10% new bom calf serum, 10% tryptose phosphate 
broth, 100 units/ml penicillin and lOOpg/ml streptomycin.
HeLa cells
An epithelial cell line derived from a human cervical carcinoma, HeLa cells were 
grown in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 2.5% 
foetal calf serum, 2.5% new bom calf semm and antibiotics as above.
Vero cells
Derived from African green monkey kidney, Vero cells were grown in GMEM 
supplemented with 10% foetal calf semm and antibiotics as above.
Vero 2-2 cells
Derived from African green monkey kidney, Vero cells were grown in GMEM 
supplemented with 10% foetal calf semm and antibiotics as above. They were 
then transfected with an IE63 expressing constmct encoding geneticin resistance 
and selected and grown in the presence of 200pg/ml G418.
2A5.4 Radioactive media
 ^c
When cells were labelled, the media used were [ S] 1-methionine medium (Eagles 
medium (Eagle, 1959) containing 20% the normal methionine level, 2% new bom
c 'i'y
calf semm and 30pCi/ml [ S] 1-methionine) or [ P]-orthophosphate medium 
(Eagles medium containing 20% the normal phosphate level, 2% new bom calf 
semm and 30pCi/ml [ P]-orthophosphate).
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2A6 Viruses
Viruses used were
HSV-1 strain i f
Wild type virus as described by (Brown et al., 1973). Referred to as wildtype (wt) 
virus for the rest o f this thesis.
HSV-1 27lacZ
An HSV-1 IE63 (ICP27) insertion mutant, resulting in inactivation o f the IE63 
gene, (Smith et al., 1992). A gift from R. M. Sandri-Goldin, University California, 
Irvine, California.
HSV-1 g E  (m l404)
HSV-1 Us7 insertion mutant resulting in disruption of the Us7 gene and which 
fails to make glycoprotein E (gE). (Johnson et a l ,  1988). Obtained from N. Stow, 
MRC Virology Unit, Glasgow.
HSV-1 TK1301
HSV-1 Thymidine kinase deletion mutant (Sanders et al., 1982), from D. Dargan, 
Institute of Virology, Glasgow.
2A7 Antisera and monoclonal antibodies
Antisera and monoclonal antibodies (Mabs) used during this investigation and 
their source are listed in Table 2A7.
2A8 Radiochemicals
All radiochemicals were purchased from Dupont at the following specific 
activities
6000Ci/mmol lOmCi/ml 
1175Ci/mmol lOmCi/ml 
8500Ci/mmol 5mCi/ml 
800Ci/mmol lOmCi/ml
y—[32p] ATP
[35 s] 1-methionine
[3 2p] -orthophosphate
a-[32P] ATP
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2A9 Common solutions
30% acrylamide mix
5x agarose gel loading buffer 
Bradfords reagent
Coomassie stain
Destain 
Geimsa stain
HEPES extract buffer 
PBS A
PBS complete 
PBS T
29% (w/v) acrylamide, l%(w/v) N,N’- 
methylene bis-acrylamide.
lxTAE, 1% SDS (w/v), 50% glycerol (v/v), 
1 mg/ml bromophenol blue.
0.01% (w/v) Coomassie Brilliant Blue, 
0.0003%(w/v) SDS, 4.75%(v/v) ethanol, 
8.5%(v/v) phosphoric acid.
0.02%(w/v) Coomassie Brilliant Blue 
50%(v/v) methanol, 43%(v/v) water, 
7%(v/v) acetic acid.
5%(v/v) methanol, 7%(v/v) acetic acid, 
88%(v/v) water.
1.5%(w/v) suspension o f Giemsa in 
glycerol, heated at 56°C for 2h and diluted 
with equal volume methanol.
50mM HEPES , 50mM NaCl, 0.1%(v/v) 
NP40, pH7.5.
170mM NaCl, 3.4mM KC1, lOmM 
Na2H P04, 1.8mM KH2P 0 4, pH7.2.
PBS A plus CaCl2.2H20  and MgCl2.6H20  
each at lg/1.
PBS A plus 0.05%(v/v) Tween 20.
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3x Protein gel loading buffer 150mM Tris HC1, 300mM dithiothreitol, 
6%(w/v) SDS, 0.3%(w/v) bromophenol 
blue, 30%(v/v) glycerol, pH 6.8.
Protein gel running buffer 0.05M Tris base, 0.05M glycine, 
0.1%(w/v)SDS
50xTAE 0.2M Tris base, 0.05M EDTA (pH 8.0), pH 
to 8.0 with acetic acid.
TE buffer lOmM Tris HC1, ImM EDTA, pH 8.0.
Towbin (blotting buffer) 25mM Tris base, 192mM glycine, 20%(v/v) 
methanol.
Transfer tank buffer PVDF 50mM Tris base, 50mM glycine, 20%(v/v) 
methanol, 0.01%(w/v) SDS.
Trypsin 0.25% (w/v) trypsin in Tris-saline containing 
phenol red, adjusted to pH 7.5 with NaHCOs
Versene 0.6mM EDTA in PBS A, 0.002% phenol red
Water Sterile deionised water obtained from a 
“Milli-Ro 60 plus” deioniser (Millipore, 
USA) and sterilised by autoclaving.
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2A10 Chemicals and reagents
All chemicals and reagents were purchased from BDH Chemicals UK or from 
Sigma Chemical Co. unless otherwise stated in this Section or in the methods.
Amersham: ECL Western blotting reagents, nitrocellulose membrane,
Rainbow molecular weight markers
Beecham Research: Ampicillin sodium B.P. (Penbritin®)
Bio-Rad: TEMED, ammonium persulphate, Coomassie brilliant blue
Dupont: En3hance
Fluka: Formaldehyde, formamide
Joseph Mills Ltd.: Ultra pure ethanol, methanol
Prolabo: Butanol, glacial acetic acid, glycerol, isopropanol
Pierce: Phosphocellulose units, spinZyme™ format
2A ll  Autoclaving and glassware sterilisation
Equipment and solutions were sterilised at 15psi for 20 min by staff in wash 
room, Institute of Virology, Glasgow. Glassware was sterilised by baking in an 
oven at 180°C for at least 12 h. Heat-labile solutions were sterilised by filtration 
though a Whatman syringe filter (diameter 0.2pm) into a sterile tube.
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2B Methods
2B1 Preparation and transformation of competent E.coli cells for plasmid 
growth and maintenance, and for protein expression.
Plasmids were grown and maintained in E.coli strain DH5a, and plasmids 
incorporating GST or MBP expression systems were transfected into E.coli strain 
BL21 or Xa90 immediately before protein expression. For all strains, the method 
of preparing competent E.coli and of transformation of plasmids into bacteria was 
the same.
A lm l overnight culture was inoculated into 100ml L-broth and grown for about 
3h at 37°C in a shaking incubator until the OD630 was approximately 0.4. The 
culture was then cooled on ice and cells pelleted by centrifugation at 5000rpm for 
1 Omin at 4°C in Sorvall RT 6000B refrigerated centrifuge. The cells were 
resuspended in 50ml cold 50mM CaCl2 and left on ice for 3Omin. Cells were then 
pelleted as before and resuspended in 10ml cold 50mM CaCl2, 15% glycerol.
200pi aliquots were snap frozen and stored at -70 C.
About lOng plasmid DNA were transformed into a 200pl aliquot o f competent 
E.coli which was thawed on ice. The DNA was added to the cells and the mixture 
incubated on ice for 30min prior to heat shock in a 42°C waterbath for 2min. 
800pl o f L-broth was added to the cells, which were shaken for 60min at 37°C 
before plating onto LB agar plates containing appropriate antibiotic (Section 
2A4). Plates were incubated overnight at 37°C.
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2B2 Cell Culture
2B2.1 Growth and maintenance of cells
Mammalian cells were passaged in sterile disposable 175cm2 plastic flasks in the 
appropriate media (Section 2A5) and were grown at 37°C in a humidified 
incubator under 5% C02- Confluent layers were harvested by washing the 
monolayer twice in 25ml trypsin: versin (1:4; supplied by Institute o f Virology 
Media Services) and resuspending in 10ml medium. For continual passage, BHK 
cells and HeLa cells were split in a 1:10 ratio every 4-5 days, Vero cells 1:6 every 
4-5 days and V2-2 cells 1:5 every 4-5 days.
2B2.2 Production of virus stocks
(i) Growth o f  virus
HSV-1 wt strain 17+ and viral mutants, TK' and gE", were all grown in this way. 
Ten roller bottles of almost confluent BHK21 C13 cells (approximately 3x10& 
cells/bottle) were infected at a multiplicity of infection (MOI) of 1 in 300 and 
grown in appropriate media (Section 2A5) at 31°C under 5% CO2 for 3-5 days.
When cells had rounded up and were starting to detach from the plastic, virus was 
harvested by shaking bottles till all the cells were in the medium and centrifuging 
at 2000rpm for 3Omin at 4°C in Sorvall RT 6000B refrigerated centrifuge. The 
supemate was then spun at 12000rpm for 2h (Sorvall GSA rotor). The resultant 
pellet consisted of cell released virus and was resuspended in 1 ml/bottle BHK 
medium, sonicated briefly to disrupt the pellet, aliquoted (10x1 ml) and snap 
frozen. To harvest cell associated virus, the pellet from the first centrifugation was 
resuspended in 5ml of BHK medium and sonicated thoroughly in a sonibath. Cell 
debris was pelleted by centrifugation at 2000rpm for lOmin (Sorvall RT 6000B 
refrigerated centrifuge), supernatant obtained from this spin contained cell 
associated virus. To increase the yield of virus, the cell pellet was re-suspended in 
a further 5ml of medium, sonicated and centrifuged again. Both supemates 
containing cell associated virus were combined, aliquoted (10x1 ml) and snap
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frozen. 271acZ virus was produced in the same way but grown in the IE63 
complementing cell line 2-2 (Sekulovich et al., 1988).
(ii) Sterility checks
An inoculum of each virus was streaked on a blood agar plate (to test for bacterial 
contamination), and a brain heart infusion agar plate (to test for fungal 
contamination), incubated at 37°C or room temp respectively for 1 week and 
inspected for any growth. Mycroplasma contamination although harder to detect 
was regarded as present if  blood agar plates discoloured.
(iii) Titration
Virus stocks were titrated on 60mm sterile dishes o f confluent BHK monolayers 
(~106 cells). 1:10 Serial dilutions of virus were made (10_M 0~8) and lOOpl of 
each plated out onto the monolayers. After lh  for absorption 5ml of BHK medium 
(Section 2A5) supplemented with methyl-cellulose to give a final concentration of 
1% methyl-cellulose was added to prevent progeny virus spreading through the 
medium. Dishes were incubated at 37°C for 2 days and cells were Giemsa stained. 
Plaques were counted under dissection microscope and the titre calculated as 
plaque forming units/ml (pfu/ml).
2B2.3 Viral infection of cells
Almost confluent monolayers were grown on 90mm plates and infected with 
various viruses or left uninfected. On some occasions, infected and uninfected 
cells were labelled with [35S] 1-methionine or [32P] orthophosphate. From these 
soluble protein extracts were made and used in various immunoprecipitation and 
pull down assays. With all viruses and in all cell types, infection was at a MOI of 
10 and unless otherwise stated infection was for 16h. 80% confluent cells were 
inoculated with virus in a small volume and, after lh  for absorption, more of an 
appropriate growth medium was added (Section 2A5). If  the cells were to be 
labelled, after lh  [ S] 1-methionine medium (150pCi) or [ P]-orthophosphate
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medium (150pCi) (Section 2A5) were added in place o f the usual growth 
medium. Cells for immunofluorescence were handled in a similar way but on a 
smaller scale and were infected when -60%  confluent. 13mm coverslips in Linbro 
plate wells were seeded at 0.5x10^ HeLa cells per well in 1ml o f normal HeLa 
medium and incubated overnight at 37°C prior to infection at a MOI of 10.
2B2.4 Transfection of cells
HeLa cells were transfected with pCMV-IE63 expression plasmid and used to 
seed coverslips for immunofluorescence or 50mm dishes to make soluble protein 
extracts. A 175cm 2 confluent flask of HeLa cells ( ~ l x l  0? cells) was treated with 
trypsin:versin (Section 2B 2.1) pelleted and resuspended in 10ml serum and 
antibiotic free DMEM. A lOOpl aliquot was taken and diluted lOx and counted. 
The cells were then pelleted again and resuspended in an appropriate volume, 
such that the concentration of the cells was 5x10^ per 750pl. For each 
electroporation, 5x10^ cells and 20pg of DNA were used. DNA was put in a 4mm 
cuvette and cells added, after incubation for lOmin on ice and flicking gently to 
resuspend settled cells, the cells were electrophorated at 400V (Hybaid cell shock 
electrophorator), incubated on ice again for lOmin and finally cells below the 
'foam' collected with a Pasteur pipette in 5ml complete HeLa medium.
Transfected cells were either plated onto 50mm dishes (5ml/dish) or were added 
to a 35mm dish with 3 coverslips (2.5ml/dish) and left for 24h, swirling every 
lOmin in the first hour and changing medium after 6h, before harvesting as for 
infected and noninfected cells (Section 2B2.5) or fixing for immunofluorescence 
(Section 2B8)
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2B2.5 Cell extract preparation
(i) Whole cell extracts
For immunoprecipitations and various pull down assays, soluble protein extracts 
were made of cells infected with various viruses or uninfected, these were
- i f  “2 9
sometimes labelled with [ S] 1-methionine or [ P]-orthophosphate (Section 
2B2.3 and 4). Cells were washed twice in cold PBS A and harvested in 10ml PBS 
A by scraping. Cells from 90mm dishes (~ 2x10? cells) were pelletted by 
centrifugation at lOOOrpm for 5min at 4°C (Sorvall RT 6000B refrigerated 
centrifuge) and resuspended in 800pl HEPES extract buffer (50mM HEPES , 
50mM NaCl, 0.1% NP40, pH7.5). The cells were lysed by sonication for 30-60sec 
in a soni-bath and debris pelletted by micro-centrifugation at 12000rpm for lOmin 
at 4°C. The soluble protein extract was stored at -70°C. In order to standardise the 
amount of protein added to immunoprecipitations or pull downs the total protein 
content of soluble protein extracts was determined by standard Bradford’s assay 
(Section 2B2.6) and if not already concentration was adjusted to 2mg/ml.
On one occasion cell extracts were treated with RNase A. 10U RNase ONE™ 
Ribonuclease (Promega) were added to cell extracts and after incubation at 37°C 
for 15 min the extracts were frozen and stored as above.
(ii) Nuclear extracts
For anti IE 175 co-immunoprecipitations a nuclear extract was prepared as 
described by Panagiotidis (1997). After infection for 6h, nuclear extract was made 
by resuspending harvested cells in five packed cell volumes o f buffer A (lOmM 
HEPES, 1.5mM MgCh, 0.5mM DTT, and protease inhibitor cocktail (in place of 
separate protease inhibitors used by Panagiotidis)) and allowed to stand for 
lOmin. The cells were pelleted for lOmin at 2000rpm (Sorvall RT 6000B 
refrigerated centrifuge) and resuspended in 2 packed cell volumes of buffer A. 
After 10 strokes in a glass Dounce homogeniser, cells were centrifuged as before, 
the supemate was taken as the cytoplasmic fraction and the pellet as nuclei. The
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nuclei pellet was resuspended in 3ml buffer C (20mM HEPES, 25% (v/v) 
glycerol, 0.42M NaCl, 1.5mM MgCl2, 0.2mM EDTA, 0.5mM PMSF, 0.5mM 
DTT and protease inhibitor cocktail), and Dounce homogenised. This suspension 
was stirred gently with a magnetic stirring bar for 3 Omin and centrifuged for 
30min (15000rpm, Sorvall SS34 rotor), the resultant supemate was dialysed 
against 50 volumes buffer D (20mM HEPES, 25% (v/v) glycerol, 0.1M NaCl, 
0.2mM EDTA, 0.5mM PMSF, 0.5mM DTT and protease inhibitor cocktail), and 
finally centrifuged for 20min (15000rpm Sorvall SS34 rotor). The precipitate was 
disregarded and supemate taken as nuclear extract.
2B2.6 Estimation of protein concentration
Estimation of protein concentration was performed using the method of Bradford 
(1976). lOpl of protein sample were diluted in 90pl dH20  and mixed with 1ml of 
Bradfords reagent. After lOmin at room temperature (RT) the absorbency of the 
solution was measured at 595nm, and converted to mg protein by comparison to a 
standard curve produced using known quantities of bovine semm albumin.
2B3 Co-immunoprecipitation experiments
To investigate protein:protein interactions, co-immunoprecipitations were carried 
out with several antisera. Conditions were optimised for each sera. An overview 
of this method is illustrated in Fig. 2B3.
Because of their high specificity, antibodies may be used to isolate specific 
antigens, and the proteins which interact with them from complex protein 
mixtures such as cell lysates. Identification o f the immunoprecipitated antigen and 
proteins which co-purify with the target antigen can be achieved by separation of 
the complex on an SDS-PAGE gel, followed by detection of radiolabelled 
proteins by autoradiography or non-labelled proteins by Western blotting.
Both polyclonal antisera and Mabs can be used for such co-immunoprecipitation 
experiments, however it is important to be aware o f certain limitations, for
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example an antibody may mask an interaction site or a protein:protein interaction 
may mask the antibody binding site. In this respect, polyclonal antisera are better 
but Mabs often give a cleaner result.
Mabs are non-precipitating as are most polyclonal antisera at low antigen 
concentrations employed, therefore a “sandwich” reagent is used to precipitate or 
isolate the antibody-antigen complex, and during this study Staphylococcus 
aureus protein A coupled to Sepharose was used. Mouse IgGi and IgG3 bind 
poorly to protein A, to overcome this when co-immunoprecipitating with Mabs 
sheep anti-mouse IgG was routinely added.
Salt and detergent concentrations in buffers used to immunoprecipitate and to 
wash will affect the ability of proteins to interact and so determine the stringency 
of the immunoprecipitation.
Co-immunoprecipitation has been used to study many protein interactions, a 
classic example within herpes viruses is the discovery of glycoprotein L (gL), in 
which an anti peptide serum revealed a second protein which co- 
immunoprecipitated with gL, subsequently by Western blotting this protein was 
shown to be glycoprotein H (gH). It was then shown that gH required gL to be 
antigenically recognised, and gL depends on gH for proper post-transcriptional 
processing (Hutchinson et al., 1992).
2B3.1 Co-immunoprecipitation using IE63 monoclonal antibody
Various cell extracts (~100pg) were mixed with 5pl HI 113 Mab (and lp l sheep 
anti mouse IgG) in 50pl buffer E (lOOmM Tris HC1, lOOmM NaCl, 2mM EDTA, 
2mM EGTA, 1% NP40, 0.5% Na deoxycholate, 0.5mM PMSF, pH 8) for 3h at 
4°C. 75 pi protein A-Sepharose (made up at 50% (w/v) and washed 2x in buffer E) 
was then added and mixing was for lh. After pelleting the beads and multiple 
washes in buffer E, 50pl protein gel loading buffer was added, samples placed in a 
boiling bath for 3 min and co-immunoprecipitating proteins separated by SDS- 
PAGE (Section 2B5.1). After separation gels were subject to Western blot 
analysis (Sections 2B5.2-4). During investigation of interacting proteins different
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buffers and IE63 antiserum were used (Appendix 1) but the overall method was as 
above. If a CK2 activity assay was to be carried out, protein gel loading buffer 
was not added and samples were processed as described (Section 2B6).
At one point in this thesis, IE63 co-immunoprecipitation is done under different 
conditions as described by Panagiotidis et al. (1997), this is the same method by 
which IE 175 co-immunoprecipitations were carried out (see below).
2B3.2 Co-immunoprecipitation using IE175/IE63 monoclonal serum
Using the method of Panagiotidis (1997), 5 pi of Mab, either HI 113 against IE63 
or 58S against IE 175, was mixed with 200pg nuclear extract and incubated at 4°C 
for 2h in a final volume of lOOpl binding buffer (lOmM Tris-HCl, 50mM NaCl, 
5% glycerol, ImM EDTA, 4mM dithiothreitol, 0.2mg/ml ovalbumin, (pH 7,9)). 
30pl protein A-Sepharose (made up as 50% (w/v) and washed 2x in binding 
buffer) was added and the incubation was continued for 2h at 4°C with constant 
mixing. The beads were washed 4x with 0.5ml binding buffer and resuspended in 
40pl protein loading buffer. After boiling for 3min, samples were separated by 
SDS-PAGE electrophoresis and analysed by Western blotting.
2B3.3 Co-immunoprecipitation using hnRNP K anti-serum
Beads for immunprecipitation were made up by mixing protein A-Sepharose 
beads (made up as 50% (w/v) and washed 2x in binding buffer) with anti hnRNP 
K or preimmune sera in binding buffer (5mM Tris-HCl, 250mM NaCl, ImM 
EDTA and 0.05% NP40, pH7.4) at 4°C for lh  ( lp l serum/lOpl beads). 
Immunoprecipitation was carried out by mixing the immune or preimmune beads 
with wt infected, 271acZ infected or mock infected (mi) BHK cell extracts 
(~200pg) for 2h in binding buffer at 4°C. After centrifugation and multiple 
washes, 30pl protein gel loading buffer was added to the beads, they were boiled 
and precipitated proteins were separated on a 10% SDS-PAGE gel and transferred 
to nitrocellulose membrane for Western blotting analysis. Again for CK2 activity
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Fig. 2B3 Co-immunoprecipitation
The appropriate antibody (Y) was incubated with radiolabelled cell extract (i). 
Antibody binds to its antigen (ag), also bound to the antigen are any proteins (a, b, 
z and x) which interact with it (ii). Protein A Sepharose was added, it binds to the 
antibody forming a complex of the antibody, antigen and interacting protein (iii). 
This was separated from the soluble cell extract by centrifugation (iv). After 
washing to remove non-specific binding proteins, the precipitate was boiled to 
denature the proteins and disrupt protein:protein interactions and proteins 
separated by SDS-PAGE electrophoresis (v). Labelled proteins were visualised by 
phosphoimaging and an estimation o f interacting protein size made by comparison 
with molecular weight markers simultaneously run on the gel.
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assays, protein gel loading buffer was not added and samples were processed as 
described (Section 2B6).
2B3.4 Co-immunoprecipitation using SAP145 antiserum
As for hnRNP K co-immunoprecipitation but using 5pi of anti-SAP 145 serum.
2B4 Fusion protein expression, purification and pull down assays
The Glutathione S-transferase (GST) gene fusion system can be used to identify 
new proteimprotein interactions, or to confirm and investigate those identified in 
other systems. The gene for the protein of interest is cloned into a pGEX plasmid 
in frame with the GST gene from the parasitic helminth Schistosoma japonicum. 
Fusion proteins are expressed in E.coli cells containing the recombinant pGEX 
plasmid. A protease deficient strain of E. coli, BL21 is used to minimise 
proteolytic degradation of the fusion protein. Protein expression from a pGEX 
plasmid is under the control of the tac promoter, which is induced using the 
lactose analogue isopropyl P-D-thiogalactoside (IPTG). Induced cultures are 
allowed to express GST fusion proteins for several hours, after which cells are 
harvested and lysed, cellular debris is cleared by centrifugation and fusion protein 
purified and immobilised by binding to Glutathione which is attached to 
Sepharose 4B (Smith & Johnson, 1988). After fusion proteins are bound to the 
matrix, it is washed with buffer to remove non-specifically bound bacterial 
proteins and mixed with cellular extracts. The beads serve as an affinity matrix 
allowing proteins which interact to bind to the immobilised target fusion protein. 
Bound proteins can be partially purified by a simple centrifugation step, hence the 
name “pull down” assay. Beads are washed again to remove non-specifically 
bound cellular proteins and proteins analysed by SDS polyacrylamide gel 
electrophoresis. An overview of this method can be seen in Fig. 2B4.
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During fusion protein expression several factors can be varied to maximise 
expression of a particular protein. Decreasing the temperature at which fusion 
proteins are expressed will decrease total yield but will also decrease the action of 
proteolytic enzymes which may degrade fusion proteins, it can also increase the 
solubility of the fusion protein, and alter its folding. Producing more fusion 
protein by increasing the IPTG concentration may increase the amount of product. 
Increasing the time of induction will increase how much fusion protein is 
expressed but will also increase the length of time proteases have to work in. As 
with co-immunoprecipitations, salt and detergent concentrations along with target 
and interacting protein concentration will effect which proteins are pulled down.
GST pull down assays have been successfully used by many workers, for example 
a similar approach to the one used here was used to identify an interaction 
between another immediate early HSV-1 protein IE110 and a novel 135kDa 
cellular protein (Meredith et al., 1994) and was also used to look at the sequence 
requirements for IE110 multimerisation and interaction with the 135kDa protein 
(Meredith et al., 1995).
Fusion protein pull downs are relatively easy to scale up after initial studies. GST 
has the advantage over other fusion systems of being comparatively small 
(compared to (3-galactosidase fusions) making it easier to express large proteins as 
fusions (optimum size for expression in bacteria being 60kDa) and being 
uncharged (compared to 6 His tags), meaning GST is less likely to interfere with 
the interactions of and folding of IE63. Pull downs were to be scaled up to the 
point where bands were visible on a Coomassie stained gel, when they would be 
cut out and sequenced using Laser Mass Map Spectroscopy.
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2B4.1 GST-IE63/hnRNP K/SAP 145
Expression of GST-IE63 was optimised, the results of which are included in this 
thesis (Appendix 2). What follows is the final protocol.
BL21 E.coli were transformed with plasmids expressing GST-hnRNP K, GST- 
SAP145, GST-IE63 or GST alone and grown on LB plates containing ampicillin 
(Section 2B1.5). Single colonies were picked and inoculated into 10ml LB broth 
containing ampicillin, the culture was grown overnight and next morning a 1:10 
dilution into 100ml was made. After further growth at 37°C and at an OD630 of 
0.4-0.6, fusion protein expression was induced by adding 0.2mM IPTG for 2h at 
37°C. Bacteria were then harvested, by centrifugation at 3000rpm for 10 min in 
Sorvall RT 6000B refrigerated centrifuge, resuspended in 5ml lysis buffer (PBS 
1% Triton X-100) and sonicated on ice using a soni-probe. Cell debris was 
separated from soluble proteins by centrifugation (15000rpm, 4°C, 20min, Sorvall 
SS34 rotor). Fusion proteins were purified from bacterial soluble protein lysates 
by binding to pre-swollen Glutathione-Sepharose 4B beads. Beads and supemate 
containing soluble protein lysate (5ml lysate/400pl beads), were mixed for lh  at 
4°C. After washing beads 3 times with PBS 1% Triton X-100 and once with PBS, 
beads with protein bound were mixed with ~100pg cell extract (Section 2B2.5) 
for lh  at 4°C in 5ml binding buffer (50mM Hepes, 50mM NaCl, 0.1% NP40 with 
the addition of protease inhibitor cocktail (Boehringer Mannheim), pH7.5). 
Approximately equal amounts of GST and GST-hnRNP K, GST-SAP145 or GST- 
IE63 were used as judged by Coomassie Blue staining of an SDS-PAGE gel of the 
fusion proteins bound onto Glutathione-Sepharose beads. Beads were washed 4x 
in binding buffer and bound proteins separated on SDS PAGE gel. Bound proteins 
were visualised using a phosphoimaging system (Section 2B5.4) and Western 
blotting (Section 2B5).
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Fig. 2B4 GST pull down assay
E. coli cells strain BL21 were transformed with GST-IE63 expressing plasmid and 
grown to an OD600 o f 0-4 (i). GST-IE63 expression was induced by the addition of 
IPTG (ii), after 2h, bacteria were harvested, resuspended in a small volume and 
split open by sonication (iii). GST-IE63 was purified from bacterial proteins by 
the addition o f Glutathione attached to Sepharose beads (iv). The pull down assay 
was performed by the addition o f [°S]-labelled cellular extracts to purified GST- 
IE63 bound onto beads. After washing, the proteins which interacted with GST- 
IE63 remained in a complex with the beads (v). The complex was boiled to 
denature the proteins and break proteimprotein interactions, and proteins 
separated by SDS-PAGE electrophoresis (vi). Labelled proteins were visualised 
by phosphoimaging and an estimation o f interacting protein size made by 
comparison with molecular weight markers simultaneously run on the gel.
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GST-IE63 fusion protein expressed and bound onto Glutathione beads as above, 
was also used to look at the interaction of IE63 with itself. In this case, after the 
cell extract had been mixed with fusion protein at 4°C for lh  and washing with 
binding buffer was complete, the beads were washed overnight in 50 pi of high 
stringency buffer (50mM Hepes, 1M NaCl, 0.1% NP40 with the addition of 
protease inhibitor cocktail, pH 7.5) to elute off bound proteins. The eluted 
proteins were then separated on SDS- PAGE gel and IE63 visualised using 
Western blotting.
A further experiment with GST-IE63 was to incubate the fusion protein on beads 
with purified CK2 subunits. 40pl beads with GST-IE63 bound were mixed with 
0.2pg CK2 a  subunit or 0.2pg CK2 a 2$2 complex. This was incubated at 4°C for 
lh  with constant mixing, washed 3x with binding buffer and CK2 activity or 
physical presence detected using CK2 peptide assay or Western blotting.
2B4.2 GST and MBP CK2
GST/MBP-CK2 fusion expressing constructs were transformed into BL21 E .co li. 
A fresh colony was picked and 10ml overnight cultures set up. Next day, a 1:10 
dilution into 100ml was made, cultures were grown to an OD of 0.4-0.6 and then 
induced for 3h with 0.3mM IPTG. The cells were harvested by centrifugation at 
3000rpm for lOmin (Sorvall RT 6000B refrigerated centrifuge) and resuspended 
in 5ml ice cold lysis buffer (lOmM phosphate, 30mM NaCl, 0.25% Tween 20, 
lOmM EDTA, lOmM EGTA, adjusted to pH7.0). After thermal shock (-70°C to 
+20°C) and a 3x 2min sonication using a soni-probe, the lysate was adjusted to 
0.5M NaCl and centrifuged to remove cell debris (15000rpm, 4°C, 20min, Sorvall 
SS34 rotor). The supernatant was then mixed with amylose resin (New England 
Biolabs) or Glutathione-Sepharose 4B beads, as appropriate, at 4°C for lh. After 
washing 3x with PBS the beads were mixed with cell extracts (~100pg) at 4°C for 
lh. Approximately equal amounts of each fusion protein were used as judged by
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Coomassie Blue staining of an SDS-PAGE gel of the fusion proteins bound onto 
beads. Finally beads were washed 2x with PBS to remove non-specific binding 
and 3x with 50pl PBS containing 1M NaCl to elute off bound proteins. Eluted 
proteins were separated by SDS-PAGE, transferred to nitrocellulose and analysed 
by Western blotting for IE63.
2B4.3 Affinity chromatography using rMp32 or rMGO Sepharose columns.
Affinity columns were produced by D. Matthews (Matthews & Russell, 1998) and 
used to identify proteins which interact with p32. lOOpl cell extract harvested 4h 
or 16h post infection was mixed with 40pl of p32- or glucose oxidase-Sepharose 
beads (rMp32/rMGO) at 4°C for 2h. After which beads were washed lOx with 
medium stringency washing buffer (PBS A; 200mM NaCl, 0.1% NP-40) and 
pelleted by micro-centrifugation (12000rpm for 1 min) before 3 5 pi protein gel 
loading buffer was added and samples boiled for 3min. Samples were loaded onto 
SDS PAGE for analysis by Coomassie staining or Western blotting. In some cases 
wash buffers o f higher stringency replaced the medium stringency washing buffer. 
(PBS A; 350mM NaCl or 500mM NaCl, 0.1% NP-40)
2B5 Western blot analysis of proteins and autoradiography
2B5.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE) of proteins
Proteins were resolved by electrophoresis though SDS polyacrylamide mini or 
larger gels (Laemmli, 1970) using Bio-Rad mini gel electrophoresis tanks or a 
large Bio Rad protean II xi cell.
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For 10ml 10% resolving gel
h 2o 4ml
30% acrylamide mix 3.3ml
1.5M Tris (pH 8.8) 2.5ml
10% SDS 0.1ml
10% APS 0.1ml
TEMED 0.004ml
8% resolving gel For 2ml stacking gel
4.6ml 1.4ml
2.7ml 0.33ml
2.5ml 0.25ml
0.1ml 0.02ml
0.1ml 0.02ml
0.006ml 0.002ml
For larger gels, amounts were increased to 50ml resolving gel and 10ml stacking 
gel but proportions of components remained the same.
Resolving gel mixes were poured into glass plate sandwiches, overlaid with 
butanol and allowed to set. The butanol was washed away with water, stacking gel 
mixture was overlaid and a comb inserted. Protein samples were mixed with 
protein gel loading buffer and placed in a boiling bath for 3min prior to loading. 
Along with samples, lOpl Rainbow marker was also loaded and run. Gels were 
run at 150mV till tracking dye reached the bottom. Gels were either stained with 
Coomassie Blue solution ( 50% methanol, 7% acetic acid, 43% water, 0.02% 
Coomassie blue stain) for 30min and destained in protein gel destain (5% 
methanol, 7% acetic acid, 88% water), or transferred to nitrocellulose for Western 
blotting and autoradiograph analysis. Gels which weren’t to be Western blotted 
but did contain radioactive proteins were, after staining and destaining, incubated 
in En^hance for 30min, briefly washed with water and vacuum dried prior to 
exposure to Kodak X-OMAT S film.
2B5.2 Electroblotting of proteins to nitrocellulose membrane
Proteins resolved on SDS-PAGE gels were transferred to nitrocellulose (Towbin 
et al., 1979) using a Bio-Rad transblot cell. A blotting sandwich was set up such 
that the gel was in contact with a sheet of nitro-celullose (Hybond-ECL 
Amersham) and both were sandwiched between Whatman 3mm paper of the 
appropriate size. This was in turn sandwiched between sponges provided by Bio- 
Rad and transfer carried out at 250mA for lh.
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2B5.3 Immunodetection of proteins
After transfer to nitrocellulose, the presence of specific proteins was detected 
using antisera. Incubation in PBS A 5% dried milk for lh  at RT, with one change 
of buffer after 30min, or 4°C overnight, blocked nitrocellulose membranes. They 
were then washed 3x lOmin at RT in PBS A 0.05% Tween (PBS-T), before 
incubation for lh  at RT on a shaker in 20ml of appropriately diluted primary 
antibody in PBS-T (Table 2A.7). Following this, blots were washed 3x lOmin at 
RT in PBS-T and protein A horseradish peroxidase conjugate or anti-mouse IgG 
whole molecule conjugate added in a 1/1000 dilution in PBS-T. After a 40min 
incubation at RT, again with shaking, blots were washed as previously and 
proteins were detected using the Amersham Enhanced Chemiluminescence (ECL) 
system. The two reagents were mixed in equal volumes and a total volume of 
10ml poured onto the filter, which was agitated for lmin. The blots were wrapped 
in cling film and exposed to Kodak X-OMAT S film.
2B5.4 Visualisation of [35S] and [32P] labelled proteins by phosphoimage 
analysis
i f  ^ 9
Proteins labelled with radioactive [ S] 1-methionine, [ P]-orthophosphate or a -
T9[ P] ATP were detected by conventional exposure to Kodak X-OMAT film at - 
70°C or by phosphoimaging. Phosphoimaging used a Bio-Rad Molecular Imager® 
FX and associated Bio-Rad Quantity One software. Images were prepared for 
printing using Adobe Photoshop software.
2B6 CK2 activity assays
2B6.1 Artificial peptide substrate assay for CK2 activity
The presence of CK2 protein was determined by its ability to phosphorylate an 
artificial peptide substrate. The final immunocomplexes were suspended in 30pl 
CKII reaction buffer (50mM Tris pH8.2,20mM MgCl2, lOpCi y -[32P] ATP per 
reaction, either with or without 0.1 mM peptide substrate Arg-Arg-Arg-Glu-Glu- 
Glu-Thr-Glu-Glu-Glu. Reactions were carried out in a waterbath at 25 °C for 
30mins. After brief centrifugation the supemate was applied to a SpinZyme™
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column (Pierce), which was then washed 3x with 75mM phosphoric acid. 
Phosphorylated peptide which bound to the column was detected by liquid 
scintillation counting in Beckman LS 5000 CE scintillation counter and results 
expressed as counts per minute (cpm). This method is illustrated in Fig. 2B6.1.
2B6.2 In vitro phosphorylation of co-immunprecipitated proteins
Phosphorylating ability of associated CK2 on other proteins present in the co- 
immunoprecipitated complex was examined using this in vitro phosphorylation 
assay. After usual washes, immunocomplexes which had been made using 
unlabelled cell extracts were washed with 50mM Tris pH 7.4. Complexes were 
then suspended in 20pl 50mM Tris pH 7.4 and to this 5pi radioactive solution 
(50mM Tris pH7.4, 20mM MgCh, lOpM ATP, 2.5pCi y—[32P] ATP per reaction) 
was added, the reactions were carried out for 15min at 25°C either in the presence 
or absence o f lOOpM DRB (5,6-dichloro-l-(3-D-ribofuranosylbenzimidazole). 
Immunoprecipitated proteins were separated by SDS-PAGE and transferred to 
nitrocellulose membrane. Phosphorylated proteins were visualised by 
phosphoimaging and immunoprecipitated proteins analysed by Western blotting 
for IE63 and hnRNP K.
2B6.3 Inhibition of CK2 phosphorylation
Phosphorylation could be inhibited and co-immunoprecipitated proteins analysed. 
Total cell extract (~100pg) was incubated with either lOOpM DRB, 10U CIP or 
phosphatase inhibitors (30mMp-nitrophenyl phosphate, lOmM NaF, O.lmM 
Na3VC>4, O.lmM Na2MoC>4 and lOmM (3-glycerophosphate) in lOOpl kinase 
buffer (50mM Tris pH 7.4, 20mM MgCl2, lOpM ATP) for 30min at 25°C, 5 pi of 
antibody was then added and the salt concentration increased to that used in the 
IE63 co-immunoprecipitation. Co-immunoprecipitation was then performed as 
usual and precipitated proteins analysed by Western blotting for IE63 and hnRNP 
K.
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Fig 2B6.1 CK2 Peptide assay
Co-immunoprecipitates (i) were incubated at 25°C for 30min in the presence of
39CK2 artificial peptide substrate and y-[ ^P]-ATP. Presence o f CK2 in the co-
39immunoprecipitate allows phosphorylation o f the peptide with y-[ “PJ-ATP (ii). 
The mixture was applied to a SpinZyme column (iii). Radioactive peptide was 
retained on the column. After washing the column was placed in a scintillation 
vial with scintillant and counted (iv). Counts per min (cpm) o f 32P reflected 
phosphorylation o f the peptide and therefore CK2 activity in the 
immunoprecipitate. Controls without peptide and with the addition o f CK2 
inhibitor DRB were also included.
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2B6.4 Nucleotidylation assay
Nucleotidylating ability of CK2 on co-immunopreciptated proteins was 
investigated. Anti-IE63 co-immunoprecipitated samples or whole cell extracts 
were added to 50pl mixes containing 50mM Tris-HCl, 5mM MgCh, (pH 7.5) 
30nM a - [ 32P] ATP and 150pM ATP. These were incubated at 30°C for lh  and 
reactions terminated by addition of EDTA to 25mM. Protein gel loading buffer 
was added to the reactions and boiling was for 5min. Proteins were separated by 
SDS-PAGE electrophoresis and analysed for nucleotidylation by exposure to X- 
OMAT film (Kodak) at -70°C for up to 1 week.
2B7 Preparation of samples for Laser Mass Map Spectroscopy (LMMS)
An unidentified protein band pulled down by the p32 Sepharose column was 
identified by Laser Mass Map Spectroscopy. Samples from p32 Sepharose 
column pull down were separated by SDS-PAGE and transferred to PVDF 
nitrocellulose membrane (Amersham). This is similar to transfer to nitrocellulose 
(Section 2B5.2) except that membrane was first soaked 15-30sec in methanol, 
then 5min in H2O, and finally in transfer buffer (50mM Tris base, 50mM glycine, 
20% methanol, 0.01% SDS) for at least 5min. After transfer PVDF membrane 
was rinsed in dH20  and dried overnight in a lyophilizer before staining for l-2min 
in sulphrodamine stain (50mg/L sulphrodamine (Kodak), 30% methanol, 0.2% 
acetic acid) and washing in water. Bands of interest were excised from the 
membrane. Sequencing grade trypsin was rehydrated using 50mM ammonium 
bicarbonate to 50ng/pl. Usually, 500pl of solution was made up and stored at - 
20°C for up to 1 month. 2-5pi of the trypsin was added to the excised bands and 
left on the bench overnight. 50% ethanol/50% formic acid was added to make up 
the sample volume to lOpl and to extract the trypsinised protein sample from the 
membrane. 0.5pl of the extracted sample was loaded onto a sample strip and, after 
this had air dried, matrix mix (lOmg/ml hydroxyannanic acid matrix, 50% 
acetonitrile, 0.1% TFA, 5pi insulin chains) was overlaid and again allowed to 
dry. The strip was finally loaded into a mass spectrometer for analysis. 
LASERMAT 2000 Mass Analyzer version 1.3 (Thermo Bio Analysis Ltd) 
software was used to interpret data produced. Simultaneously to this work a 
prepared sample was sent to Dr. G Kemp, St. Andrews University for LMMS.
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2B8 Immunofluorescence/ Confocal microscopy
The localisation of IE63 and p32 was studied with immunofluorescence and 
confocal microscopy was used to look at localisation o f SAP 145 and IE63. 
Infected, transfected or non infected cell monolayers on 13mm glass coverslips in 
24-well Nunc Linbro plates, were washed 3X with PBS A and fixed for lOmin at 
RT with 2% sucrose, 5% formaldehyde in PBS A. This solution was removed and 
cells washed 3x in PBS A. Cells were permeablised for lOmin at RT with 0.5% 
NP40, 10% sucrose in PBS A. Cells were again washed 3x PBS A. 20pl aliquots 
of the relevant primary antibody diluted to the appropriate concentration (Table 
2A7) in PBS A + 1% calf serum were then added to each cover slip for 60min at 
RT. Cells were again washed 3x in PBS and incubation with 20pl secondary 
antibody diluted 1:100 in PBS A carried out for 30 min at RT. For 
immunofluorescence, fluorescein isothiocyanate isomer I (FITC) and 
tetramethylrhodamine isothiocyanate (TRITC) conjugated secondary antibodies 
were used and for confocal microscopy cy3 conjugated antibody was used in 
place of TRITC. Finally cells were washed a further 3x in PBS A before a final 
wash in H2O; they were air dried on the bench and mounted on glass slides with 
mounting media, Glycerol in PBS (Sigma).
(i) Immunofluorescence
Cells were examined on a Nikon Microphot-SA microscope with appropriate 
filters. Images were captured with a digital Pixel CCD digital camera and 
prepared for printing by using Photoshop.
(ii) Confocal Microscopy
Cells were examined with a Zeiss LSM 510 confocal microscope system, with 2 
lasers giving excitation lines at 488nm (FITC) and 543nm (cy3) and a Zeiss 
Axioplan microscope using a 63x oil immersion objective lens, NA 1.4. Data 
were processed with LSM 510 software and then exported for preparation for 
printing using Photoshop. Roger Everett kindly assisted with the production of the 
confocal images presented in this thesis.
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Chapter 3: Identification of proteins which interact with 
IE63
The aim o f this project was to identify cellular and viral gene products which 
interact with the IE63 protein. There are many ways to investigate proteimprotein 
interactions, in the initial part of this study co-immunoprecipitations and GST- 
fusion protein pull down assays were used to reveal interacting proteins o f known 
size but o f unknown identity.
The profiles of interacting proteins produced by these two methods are presented 
in this chapter: the establishment and optimisation of co-immunoprecipitation and 
GST pull down experiments is described in Appendix 1.
While pursuing the identity of these proteins, a co-worker in our laboratory 
discovered, using the yeast two-hybrid screen, several potential interacting 
proteins (Bryant et al, 1999). The results of the yeast two-hybrid screen are 
shown in table 3.
Protein interacting with IE63 in the 
Yeast-2-hybrid screen
Number o f  clones showing sequence 
homology to this protein
hnRNP K 1
CK2(3 subunit 51
SAP 145 7
p32 6
A ly l 4
other proteins 7
sequences with no homology to any 
known protein in the data base
6
Table 3. Using a HeLa cell library, 2.3 x 106 individual clones were screened 
against an IE63 bait construct lacking only the N terminal 10 amino acids. 150 
positives were identified, but after false positve tests only 99 remained; a futher 
16 of these were not sequenced and one contained the empty vector, leaving 82 
clones.
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The latter part of this project was concerned with confirming and characterising 
the interactions suggested, and with examining the identities of two of the initially 
described protein bands not fished out by the two hybrid-screen (Results Chapters 
4 and 5).
3A Co-immunoprecipitation assays
3A1IE63 monoclonal antibody (HI 13) used to co-immunoprecipitate 
proteins from an f35Sl-methionine labelled extract of BHK cells infected with 
wt HSV-1
IE63 monoclonal antibody (Mab) HI 113 was used to co-immunoprecipitate [ S] 
radiolabelled proteins from wild type (wt), 271acZ and mock-infected (mi) BHK 
cell extracts (Sections 2B2.3 and 2B2.5). Proteins were separated by SDS-PAGE 
electrophoresis and visualised by phosphoimage analysis (Sections 2B5.1 and 
2B5.4). Samples were also Western blotted with IE63 Mab. Figure 3A1 panel I 
shows the [ S]-methionine labelled profile of the cell extracts used (lanes 1-3), 
viral proteins can be seen as unique bands in the wt extract, some inhibition of 
host protein synthesis can be observed as bands in mock infected extract which 
are absent in the wt extract. The extract made from 271acZ infected cells shows 
some viral proteins but not all, consistent with its defect being expressed during E 
and L phases. For example, the band at the top of the gel in wt extracts but not mi 
or 271acZ infected cell extracts most likely corresponds to the major capsid 
protein, where as the one below probably corresponds to gB. These infected cell 
extracts were prepared by labelling from the Oh post-infection, this ensured that 
both viral and cellular proteins were labelled, however a cleaner profile of viral 
proteins can be obtained by labelling 3-4h post-infection, under these conditions 
may more differences between mi, wt and 271acZ infected cell extracts are seen.
Lanes 4-6 show protein bands which co-immunoprecipitated with IE63 Mab; IE63 
is arrowed (lane 4). Bands corresponding to proteins o f approximately 180 kDa, 
150 kDa, 85 kDa, -70  kDa (doublet), 50 kDa, 44 kDa, 32 kDa (doublet) and 25 
kDa were seen to specifically co-purify with IE63 (lane 4), i.e. they were absent in 
lanes 5 and 6.
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Fig 3A1. Ten proteins of known size but unknown identity co- 
im m unoprecipitate with IE63
A co-immunoprecipitation assay was performed with IE63 Mab, HI 113, and 
wildtype (WT), 271acZ (27) and mock infected (MI) BHK cell extracts, the 
complex formed was separated on a 10% SDS PAGE gel, dried down and exposed 
to a phosphoimaging plate overnight.o c #
Panel I. [ S]-methionine labelled proteins co-immunoprecipitated from WT, 27 
and MI extracts. Whole cell extracts used are shown in lanes 1-3, the major capsid 
protein (MCP) and glycoprotein B (gB) are indicated. Radiolabelled co- 
immunoprecipitated proteins are shown in lanes 4-6. Bands corresponding to 
proteins interacting specifically with IE63 are arrowed.
Panel II. Western blot for IE63 using HI 113 Mab. Aliquots o f the above were run 
on another 10% SDS-PAGE gel, transferred to nitrocellulose and Western blotted 
for IE63.
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The Western blot in panel II shows IE63 being present in (lane 1) and 
immunoprecipitated from (lane 4) wt infected cell extract.
3B GST-IE63 pull down assays
3B1 Expression of GST-IE63 in BL21 E.coli.
Initial attempts to express GST-IE63 used a method described by Mears et. a l  
(1996) and are shown in Fig. 3B1 panel I lanes 1-4. There was no detectable full 
length GST-IE63 (~90 kDa), the major products being truncated forms of the 
fusion of around 40-50 kDa, smaller bands seen on the Coomassie gel were 
confirmed as IE63 truncations by the Western blot for IE63 (lane 1). As full 
length GST-IE63 was required, each of the variables in expression was altered in 
turn to increase the amount of full length product (Appendix 1). After 
optimisation, a workable amount o f full length product was detectable both by 
Western blotting and Coomassie staining (Fig. 3B1 lanes 5-7). The final 
optimised procedure is described in Section 2B4.1.
As bacterial expression and binding to Glutathione beads varied from experiment 
to experiment, aliquots of the bacterial extracts were mixed with Glutathione- 
Sepharose beads, washed and protein analysed on SDS-PAGE gels, to ensure 
equivalent amounts of various fusion proteins were used.
3B2 GST-IE63 used to pull down proteins from an [35Sl-methionine labelled 
extract of BHK cells infected with wt HSV-1
When the GST-IE63 fusion protein bound to Glutathione beads was mixed with 
radioactive wt infected extract, washed and separated by SDS-PAGE (Section 
2B4.1), the [ S]-methionine profile shown in Fig. 3B2 lane 1 was obtained. 
Arrowed bands of 175 kDa, 145 kDa, 85 kDa, 70 kDa, 63 kDa, 50 kDa, 46 kDa, 
44 kDa, 35 kDa, 32 kDa and -25 kDa interacting with GST-IE63 and not with the 
control protein GST alone (lane 2) were seen.
80
C hapter 3 Results
Identification o f  proteins which interact with IE63
INITIAL 
W. BLOT COOMASSIE
FINAL 
W. BLOT COOMASSIE
kDa
97
69
46
30
CO CO CO COCO CO CO CD
uj UJ UJ LLJ
F- I— F- F- I— F- 1—
CO CO co CO co CO co CO
0 0 0 0 0 0 0 0
I
full length_ 
GST-IE63"
1 2 5 6 7 8
Fig. 3B1 Fusion proteins expressed from  pGEX and pGEX27
Western blot for IE63 using HI 113 Mab (lanes 1, 2, 5 and 6) and Coomassie 
stained gel (lanes 3, 4, 7 and 8) o f  initially expressed GST-IE63 (lanes 1 and 3) 
and GST alone (lanes 2 and 4) bound onto Glutathione beads, and after 
optimisation, o f finally expressed GST-IE63 (lanes 5 and 6) and GST alone (lanes 
6 and 8) bound onto Glutathione beads. GST-IE63 expression and purification 
was initially carried out as described by Mears and Rice (1996), optimised 
expression and purification conditions are outlined in Appendix 1.
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The large amount of GST protein present in lane 2 obscured the identification of 
similar molecular weight proteins which were brought down non-specifically by 
GST-IE63 and conclusions about the binding of the 25 kDa, 32 kDa, 35 kDa 
should therefore be treated with caution.
The use of whole cell extracts ensured, as far as possible, that the interactions 
detected between IE63 and particular proteins were not artifacts which arose as a 
result o f over-representation of particular cellular proteins.
o c
When the [ S] profile in Fig. 3B2 was compared to the immunoprecipitated 
profile (Fig. 3A1). They were very similar. It was hoped that the GST pull down 
assay could be scaled up more easily than the co-immunoprecipitation, and the 
interacting proteins identified by protein Laser Mass Map Spectroscopy. The 
immunoprecipitation would then provide conformation of the interactions. In fact, 
neither method was used to identify interacting proteins and both were used in the 
conformation of interactions found in the yeast-2-hybrid system.
3C Self interaction of IE63.
In certain cases a dominant negative phenotype arises when one wt and one 
mutant subunit interact to form a heterodimer, for example with HSV-1 ICP 4 or 
HIV Rev (Hope et al., 1992, Shepard et al., 1990). In the same way, mutations in 
the activation domain of IE63 produce a trans dominant negative phenotype 
during infection and in transfection experiments (Smith et al., 1991). As in Fig. 
3B2, a radiolabelled band of 63kDa was pulled out of infected cell extracts by 
GST-IE63 and not by GST alone, it was thought that this may be IE63 interacting 
with GST-IE63 and that IE63 may form multimers. Thus the pull down proteins 
were separated by SDS-PAGE electrophoresis, transferred to nitrocellulose and 
Western blotted for IE63, however, due to the large amount o f truncated GST- 
IE63 protein it was impossible to see if an extra band was present at 63 kDa with 
infected cell extract (data not shown). To solve this, after the usual low salt wash 
to remove non-specifically binding proteins, the beads were washed with a high 
salt wash overnight (Section 2B4.1). The eluted proteins were then separated by 
SDS-PAGE and Western blotted for IE63. Eluted proteins from GST-IE63 and
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Fig. 3B2. Eleven proteins of known size but unknown identity are specifically 
pulled down by GST-IE63
35[ S]-methionine radiolabelled proteins pulled down by GST-IE63 (lane 1) and 
GST alone (lane 2) from wildtype (WT) infected BHK cell extracts. GST-IE63 
and GST alone were expressed using final conditions and bound onto Glutathione 
beads, after washing with PBS beads were incubated with ~100pg cell extract for 
lh. After further washes, pulled down proteins were separated on a 10% SDS- 
PAGE gel. Bands corresponding to proteins interacting specifically with GST- 
IE63 are arrowed (lane 1).
+ WT extract 
GST-IE63 GST
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GST were compared and a band corresponding to IE63 was seen eluted from 
GST-IE63 (Fig. 3C lane 5); the other bands specific to lanes 5 and 6 are 
contaminating GST-IE63 truncations washed off the beads. IE63 is therefore 
capable of interacting with itself, this is also shown by Zhi et al., (1999).
High molecular weight multimers were not seen on SDS-PAGE gels as these are 
denaturing gels, and prior to loading the samples were boiled for at least 5 min in 
protein gel loading buffer, which disrupts any protein:protein interactions. Use of 
non-denaturing gels of infected extract Western blotted for IE63 may allow 
visualisation of multimers and enable the number of IE63 molecules associating 
to be determined.
The interaction detected was between GST-IE63 and IE63 from infected cell 
extract, thus there is no chance that multimerisation was due to GST-GST 
interactions: GST itself has been reported to exist as a dimer in solution (Warholm 
et al., 1983) which has confused the issue of studying multimerisation using GST 
fusion proteins.
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Fig. 3C IE63 interacts with itself in GST fusion protein binding assays
Western blot for IE63 using HI 113 Mab. Fusion proteins bound onto Glutathione 
beads were incubated with lOOpg protein from a BHK cell extract, after low 
stringency washing, specifically bound proteins were eluted with a high salt wash 
and separated on a 10% SDS-PAGE gel, transferred to nitrocellulose and Western 
blotted for IE63. Cell extracts used (lanes 1 and 2), proteins eluted from, wildtype 
infected (WT) extract bound onto GST (lane 3), mock infected extract (MI) bound 
onto GST (lane 4), WT extract bound onto GST-IE63 (lane 5) and MI extract 
bound onto GST-IE63 (lane 6).
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Chapter 4: Interaction of IE63 with hnRNP K and CK2
The previous Chapter discussed the initial characterisation o f proteins o f known 
size but of unknown identity which interact with IE63. Concurrent with this work, 
a yeast two-hybrid screen was underway the results of which suggested four 
cellular proteins might interact with IE63 in vivo. This Chapter presents work 
which shows that two of the proteins detected, hnRNP K and CK2, interact with 
IE63 in virus infected cells. Experiments aimed at uncovering the implication of 
these interactions to infection are described.
hnRNP K was a most interesting candidate for interaction with IE63 because this 
protein is implicated in many of the same processes as IE63, for example, in 
mRNA shuttling from the nucleus to the cytoplasm, processing of pre-mRNA and 
regulation o f gene transcription.
IE63 is known to be phosphorylated and to alter the phosphorylation of other viral 
proteins, but itself has never been shown to have phosphorylating ability; for this 
reason the association with a kinase, while interesting, was not unexpected (see 
Introduction Section and Discussion Section).
4AIE63 and hnRNP molecules
4A1 Interaction of IE63 with hnRNP K 
4A1.1 Using the GST pull down assay
A GST pull down experiment using GST-hnRNP K and ~100pg wt infected 
extract (Section 2B4.1) followed by Western blotting with IE63 Mab, showed that 
IE63 and GST-hnRNP K interact, whereas GST and IE63 do not (Fig 4A1.1 Panel 
II compare lanes 3 & 4). Fusion proteins used were visualised by Coomassie
‘JC
staining (Panel I). [ S]-methionine labelled wt extract was used and labelled 
proteins pulled down by GST-hnRNP K (lane 2) or GST alone (lane 1) were 
detected by phosphoimage analysis (Panel III). A band of 63 kDa corresponding 
in size to IE63 was seen along with bands of ~170kDa, 70kDa, 46kDa, and
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Fig. 4A1.1 Interaction of IE63 with hnRNP K in the GST fusion protein 
binding assay
Wild type infected (WT) or mock infected (MI) BHK cell extracts were incubated 
with GST or GST-hnRNP K proteins.
Panel I GST-hnRNP K (lane 1) and GST (lane 2) proteins used were run on a 
10% SDS-PAGE gel and visualised by Coomassie staining.
Panel II After incubation with extracts, proteins pulled down were, along with 
aliquots o f the extracts used, separated by SDS-PAGE electrophoresis, transferred 
to nitrocellulose and Western blotted for IE63 using HI 113 Mab. MI (lane 1) and 
WT extracts (lane 2), proteins from WT extract bound to GST (lane 3) and to 
GST-hnRNP K (lane 4). The smaller bands in lanes 2 and 4 represent degradation 
products o f IE63.
Panel III. [ S]-methionine labelled profile o f proteins pulled out o f radiolabelled 
WT extract by GST (lane 1) or GST-hnRNP K (lane 2), Proteins were separated 
on 10% SDS-PAGE gel, dried down and exposed to a phosphoimaging plate 
overnight.
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32kDa. As hnRNP K is capable of forming oligomers (Bomsztyk et al., 1997), the 
70kDa band (Panel III, lane 2) is likely to be GST-hnRNP K interacting with 
hnRNP K from the extract, or could correspond to the other 70kDa band seen in 
IE63 co-immunoprecipitations (Fig. 3A1). The 170kDa protein band (Panel III, 
lane 2) may be the same band taken to be 175kDa (or even 150 kDa) in IE63 co- 
immunoprecipitations/GST-IE63 pull downs (Fig. 3A1/3B2) and the 46kDa and 
32 kDa bands may be the 50kDa or 44 kDa and 32kDa bands seen in these 
previous Figs.
4A1.2 Using Co-immunoprecipitation
Evidence for an interaction between IE63 and hnRNP K in vivo came from 
Western blotting of the IE63 co-immunoprecipitation experiments (Section 3 A2) 
with hnRNP K antiserum. Fig 4A 1.2 Panel I confirms that IE63 was precipitated 
by IE63 Mab from wt extract (lane 1). The same samples were Western blotted 
for hnRNP K (Panel II), hnRNP K was clearly co-immunoprecipitated by the 
IE63 Mab from wt extract, and was absent in co-immunoprecipitations from 
271acZ or mi extracts (lanes 2 and 3). Thus it is a fair conclusion that one of the 
bands o f the 70kDa doublet seen in Fig 3A1 corresponds to hnRNP K.
hnRNP K antiserum was then used to immunoprecipitate hnRNP K (Section 
2B3.3) from wt, 271acZ and mi extracts. Fig. 4A1.2 Panel III shows that hnRNP K 
antiserum precipitated hnRNP K from all three extracts (lanes 1-3) while the pre- 
immune serum did not (lane 4). The same samples were Western blotted for IE63 
(Panel IV) and IE63 was seen to be co-immunoprecipitated with hnRNP K only 
from the wt extract (lane 1). As a control, IE63 was not precipitated by the pre- 
immune serum (lane 4).
To determine if  any other viral proteins were required for the interaction between 
IE63 and hnRNP K, co-immunoprecipitations were repeated with hnRNP K 
antiserum and extracts from wt infected, pCMV-63 transfected or mi cells. 
Transfected and wt infected extracts gave the same result namely, IE63 was co- 
immunoprecipitated with hnRNP K (Panel VI lanes 3 and 4). hnRNP K was 
immunoprecipitated with anti-hnRNP K serum from mi, wt or transfected extracts
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Fig.4A1.2 Co-im m unoprecipitation of IE63 and hnRNP K confirms the 
interaction between IE63 and hnRNP K
Wild type infected (WT), 271acZ infected (27), pCMV-63 transfected (Trans) or 
mock infected (MI) BHK cell extracts were co-immunoprecipitated with IE63 
Mab or hnRNP K antiserum. The precipitated proteins were separated by SDS- 
PAGE gel electrophoresis, transferred to nitrocellulose membranes and analysed 
by Western blotting using hnRNP K or IE63 antibodies.
Panel I. Co-immunoprecipitation by IE63 Mab, blotted for IE63.
Panel II. Co-immunoprecipitation by IE63 Mab, blotted for hnRNP K.
Panel III. Co-immunoprecipitation by hnRNP K antiserum, blotted for hnRNP K. 
Panel IV. Co-immunoprecipitation by hnRNP K antiserum, blotted for IE63. 
Panel V. Co-immunoprecipitation by hnRNP K antiserum, blotted for hnRNP K. 
Panel VI. Co-immunoprecipitation by hnRNP K antiserum, blotted for IE63. 
Panel VII. Extracts used Western blotted for IE63.
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(Panel V lanes 2-4) Again, controls with preimmune sera were used and did not 
precipitate hnRNP K or IE63 (Panel V lane 1 and Panel VI lane 1). Panel VII 
shows the mi, wt and transfected extracts Western blotted for IE63.
4A2 Using hnRNP K antiserum, the form of hnRNP K immunoprecipitated 
by hnRNP K antiserum was slower migrating than the form which co- 
immunoprecipitated with IE63 using IE63 monoclonal antibody
When the two co-immunoprecipitations, as performed above (4A1.2), were run on 
the same gel, and Western blotted for hnRNP K (Fig 4A2 Panel I), the form of 
hnRNP K co-immunoprecipitating with IE63 Mab (lane 1) migrated faster than 
the form immunoprecipitated by hnRNP K antiserum (lane 4). This was also seen 
in the [ S]-methionine labelled profile of the same gel (Panel II), where hnRNP K 
and IE63 bands were closer together when IE63 Mab was used (Panel II lane 1) 
than when hnRNP K antiserum was used (Panel II lane 4).
4A3 hnRNP Ai and hnRNP Ci/Ci proteins do not interact with IE63
hnRNP proteins involved in pre-mRNA processing (Dreyfuss et al., 1993) can, 
under certain conditions, be co-purified by co-immunoprecipitation (Pinol-Roma 
et al., 1988). Because of this and as hnRNP Ai and hnRNP C 1/C2 are 34kDa and 
41/43kDa respectively (Pinol-Roma et al., 1988), similar in size to bands 
observed in co-immunoprecipitations with IE63 Mab (Fig 3A1), Western blots of 
the IE63 co-immunoprecipitations were performed. Both were negative (Fig 4A3 
Panel I). Western blotting o f the same reaction for IE63 (Panel II) confirmed that 
IE63 had been precipitated.
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Fig. 4A2 The form of hnRNP K im m unoprecipitated by hnRNP K antiserum  
is slower m igrating than the form of hnRNP K co-im m unoprecipitated with 
IE63 by IE63 Mab
Co-immunoprecipitations from [35S]-methionine labelled wild type (WT) BHK 
cell extracts with IE63 Mab and hnRNP K antiserum were run on the same SDS 
PAGE gel, transferred to nitrocellulose and Western blotted for hnRNP K. The 
same piece o f nitrocellulose was then exposed to a phosphoimaging plate 
overnight.
Panel I. Co-immunoprecipitations by IE63 Mab and hnRNP K antiserum,
Western blotted for hnRNP K.
Panel II. [35S]-methionine labelled profile o f the Western blot shown in panel I. 
arrowed bands correspond to IE63 (63) and hnRNP K (K).
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Fig.4A3 IE63 does not interact with hnRNPs A l or C1/C2
Western blots for hnRNP Al (Panel I), hnRNP C1/C2 (Panel II) and IE63 (Panel 
III) o f wild type (WT) (lane 1) and mock infected (MI) (lane 2) BHK cell extracts, 
and o f anti IE63 co-immunoprecipitates from these extracts (lanes 3 and 4). Co- 
immunoprecipitated proteins were separated on 10% SDS-PAGE gel, transferred 
to nitrocellulose and Western blotted with Mabs against hnRNP A l, hnRNP 
C1/C2 and IE63.
4B IE63 and CK2
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4B1IE63 interacts with CK2
CK2 is a heterotetramer consisting of two catalytic subunits (a  or a ’) and two 
copies o f the regulatory p subunit, a  and a ’ are 35 kDa - 44 kDa and the p 
subunit is 24 kDa - 29 kDa (Dahmus, 1981, Hathaway & Traugh, 1979). The 
[ S]-methionine labelled profile of interacting proteins identified in Fig. 3A1 
contained bands o f 44kDa and 25kDa which were possibly CK2. However 
Western blotting of this IE63 co-immunoprecipitation for either the a  or p 
subunits of CK was negative (data not shown).
As detection of enzyme activity is a much more sensitive way to detect the 
presence of CK2, an assay for this activity was developed (Section 2B6.1). CK2 
activity was co-immunoprecipitated from wt infected and pCMV-63 transfected 
extracts using IE63 Mab (Fig 4B1 Panel I lanes 5 and 8), and using hnRNP K 
antiserum (Panel II lanes 6 and 10). No CK2 activity was present, with either 
antibody, in the absence of artificial peptide substrate or in immunoprecipitates 
from mi or 271acZ infected extracts or in the presence o f the specific CK2 
inhibitor 5,6-dichloro-l-p-D-ribofuranosylbenzimidazole (DRB; Zandomeni & 
Weinman, 1984). Detection of considerable CK2 activity implies that the negative 
result in Western blotting was due to the known low sensitivity of CK2 antisera, 
and that CK2 and IE63 do indeed interact in wt infected cell extracts.
4B2 Mapping the sites of interaction between CK2 and IE63
As the CK2p subunit was identified by the yeast two-hybrid screen, GST and 
MBP fusions of full length and truncated versions of CK2 p were used to map the 
regions of CK2 p required for interaction with IE63 (Section 2B4.2). MBP and 
GST fusions behave similarly, the reason for using both was the availability of 
constructs.
Fig. 4B2 Panel I shows the aa present in and the amounts of each fusion protein 
used in mapping (Section 2B4.2), visualised by Coomassie staining. An
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Fig. 4B1 CK2 activity is present  in immunoprecipi tates  of wild type infected
or IE63 transfected cells generated by IE63 Mab  or  hnRNP K ant iserum
Panel I. CK2 activities present in co-immunoprecipitates generated by IE63 Mab 
from wild type (wt) infected, 271acZ infected (27), pCMV-63 transfected (trans), 
or mock infected (mi) BHK cell extracts. Assays were performed in the absence 
(lanes 1-4) or presence (lanes 5-9) of the CK2 peptide substrate and in the 
presence o f the CK2 inhibitor DRB (lane 9).
Panel II. CK2 activities present in co-immunoprecipitates generated by anti- 
hnRNP K or pre-immune serum of wt, 27, trans, and mi cell extracts. Assays were 
performed in the absence (lanes 1-5) or presence (lanes 5-10) o f the CK2 peptide 
substrate.
3?
CK2 activity is proportional to counts per minute (cpm) o f y-[ “P]-ATP 
incorporated into the peptide substrate.
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Fig 4B2. The CK2P regions involved in the interact ion with IE63
GST and MBP fusion proteins o f CK2p and different truncations were expressed, 
purified on columns and mixed with HSV-1 wild type infected cell extracts. 
Bound proteins were eluted, separated by SDS-PAGE and Western blotted using 
1E63 Mab. Numbers following p indicate aa residues present in the truncation. 
Panel I. Coomassie stained gel of GST and MBP CK fusion proteins used. 
Proteins bound to beads were run on a 10% SDS-PAGE gel and visualised by 
Coomassie staining.
Panel II. Western blot o f eluted proteins for IE63.
Panel III. Diagram showing regions o f CK2p involved in interaction with IE63.
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approximately equal amount of each fusion protein was added to wt infected cell 
extracts and bound proteins eluted off with high salt buffer. Eluted proteins were 
separated by SDS-PAGE and Western blotted for IE63. Only fusion proteins MBP 
p aa 2-182, and MBP p aa 1-215 bound to IE63 (Fig 4B2 Panel II lanes 4 and 5). 
The CK2p region necessary for IE63 interaction was therefore within aa 150-182 
(Panel III), a region which overlaps with the portion required for interaction 
between p and a / a ’ subunits (Krehan & Pyerin, 1999). Other regions between aa 
1 and aa 150 may be involved in the interaction but they are not sufficient for it. 
More complete mapping with CK2 N-terminal truncations and point mutations in 
aa 150-182 would be of value.
Interestingly, full length GST CK2 a  fusion protein although added in the same 
amount as the p fusions (Panel I lane 1), pulled down far more IE63 than the P 
fusions did.
4B3 The CK2 a  subunit can interact with IE63
Because the CK2p region mapped for interaction with IE63 overlapped with the 
region required for the interaction with CK2 a  and as the GST-CK2 a  fusion 
protein pulled down much more IE63 than any of the P proteins, further 
investigation into CK2 subunit interaction was carried out.
The artificial peptide assay was used to detect the presence o f CK2 a  binding to 
GST-IE63 either in the presence or absence of CK2 p subunit (Section 2B4.1 and 
2B6.1). CK2 activity was, as expected, detected when GST-IE63 was mixed with 
wt or mi extracts (Fig 4B3 Panel I lanes 1 and 2), but not with GST alone (lanes 3 
and 4). GST-IE63 mixed with purified a  gave little CK2 activity (lane 5) whereas 
GST-IE63 plus purified 012P2 holoenzyme was very active (lane 6). GST with 
either a  or CX2P2 holoenzyme was inactive (lanes 7 and 8). As further controls, all 
reactions were repeated in the absence of the peptide substrate (lanes 9-16). In 
addition extracts and purified enzyme added were checked for enzymatic activity 
(lanes 17-20). These data therefore suggest that the interaction between IE63 and 
CK2 is via the p subunit of CK2.
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The interaction with a  subunit was also examined using Western blotting. GST- 
IE63 pull downs after incubation with purified CK2 subunits (a  and 012(32 (P alone 
was not avalible)) were separated on an SDS-PAGE gel, and Western blotted for 
CK2 a  and P subunits. To detect the CK2 subunits with the low sensitivity CK2 
antisera, a large amount of purified enzyme (0.2ug) was used. Fig 4B3 Panel II 
lane 2 indicates that GST-IE63 can indeed interact with a  subunit of CK2, GST 
alone did not pull down the a  subunit (lane 3). GST-IE63 pulled down both a  and 
p subunits when incubated with holoenzyme (lane 4), GST alone pulled down 
neither (lane 5). From these data an interaction is suggested between IE63 and the 
a  subunit o f CK2.
4C CK2 activity in the IE63/CK2/hnRNP K complex
4C1 CK2 can phosphorvlate hnRNP K and IE63
As IE63 and hnRNP K were found in a complex with CK2, the ability of CK2 to 
phosphorylate each of these proteins in vitro was investigated. CK2 activity 
assays (2B6.2) were set up in the presence or absence o f the CK2 specific 
inhibitor DRB, phosphorylated proteins were separated by SDS-PAGE and 
detected by phosphoimaging. Using co-immunoprecipitates from wt, 271acZ or mi 
cell extracts obtained with hnRNP K antiserum, addition of DRB made no 
difference to the phosphorylation of hnRNP K in vitro but considerably reduced 
the phosphorylation of IE63 (Fig 4C1 Panel I compare lanes 1 and 5). By contrast, 
using immunoprecipitates from wt infected cell extracts obtained with IE63 Mab, 
the in vitro phosphorylation of both hnRNP K and IE63 bands was consistently 
reduced by DRB treatment (Fig. 4C1 Panel III compare lanes 1 and 2). Western 
blots showed that similar amounts of IE63 and hnRNP K were present in reactions 
with or without DRB (panels II and IV).
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Fig. 4C1. CK2 phosphorylates IE63 and a subfraction of hnRNP K in vitro
Co-immunoprecipitates from wild type (WT), 271acZ (27) and mock infected (MI) 
BHK cell extracts generated by hnRNP K antiserum, IE63 Mab or pre-immune
T9serum, were incubated in kinase buffer with y-[ P]-ATP , with or without the 
CK2 inhibitor DRB and then separated on an SDS-PAGE gel. Proteins were 
visualised by phosphoimaging or by Western blotting for IE63 or hnRNP K.
Panel I. Phosphoimage o f phosphorylation with y-[32P]-ATP of IE63 and hnRNP 
K after co-immunoprecipitation with hnRNP K antiserum, in the presence (lanes 
5-8) or absence (lanes 1-4) o f DRB.
Panel II. Western blot o f anti-hnRNP K co-immunoprecipitation (panel I) for 
IE63 and hnRNP K.
T9Panel III. Phosphoimage of phosphorylation with y-[ PJ-ATP of IE63 and 
hnRNP K after co-immunoprecipitation with IE63 Mab, in the presence (lane 2) or 
absence (lane 1) of DRB.
Panel IV. Western blot for IE63 o f IE63 Mab co-immunoprecipitation (panel III).
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4C2 Phosphorylation of IE63 is required for, or at least increases, its 
interaction with hnRNP K
To examine the relevance of IE63 and hnRNP K phosphorylation, cell extracts 
were dephosphorylated with calf intestinal phosphatase (CIP), phosphorylation 
was preserved by the addition of phosphatse inhibitors (PI), or cycling phosphate 
addition by CK2 was inhibited by the addition of DRB (Section 2B6.3). Extracts 
were then co-immunoprecipitated with IE63 Mab, separated by SDS-PAGE gel 
electrophoresis and Western blotted for hnRNP K and IE63.
Addition of CIP increased the migration of both IE63 and hnRNP K bands 
(Fig.4C2 lane 3), compared to untreated proteins (lane 1), presumably due to 
phosphate groups removal, indicating that both proteins are phosphorylated. Two 
predominant bands were seen representing dephosphorylated hnRNP K and 
dephosphorylated IE63 but dephosphorylation of IE63 was not complete, as 
indicated by the smeared band. So either phosphorylation makes no difference to 
their interaction or enough phosphorylated IE63 was left to co-immunoprecipitate 
some hnRNP K. Given that, compared to untreated extracts, more IE63 was 
immunoprecipitated from CIP treated extracts while a similar amount of hnRNP 
K was co-immunoprecipitated, there was relatively less hnRNP K interacting with 
IE63. This adds weight to phosphorylation of IE63 being important for the 
interaction. The phosphorylation of hnRNP K is less likely to be important, as 
dephosphorylated hnRNP K was efficiently co-immunoprecipitated following CIP 
treatment.
The presence of phosphatase inhibitors prevented any removal o f phosphate 
groups (lane 5) and IE63 was seen migrating similarly to the untreated sample. 
When hnRNP K co-immunoprecipitated with IE63 Mab from PI treated extract 
was examined (lane 5) there was considerably more of it than from untreated 
extracts (lane 1), despite there being a similar amount o f IE63 precipitated. Thus 
we can conclude that phosphorylated IE63 has a greater affinity (or is required?) 
for interaction with hnRNP K. In lane 5, an even more slowly migrating hnRNP K 
band was seen co-precipitating with IE63 (marked *).
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Fig 4C2. Phosphorylation by CK2 of IE63 but not hnRNP K is required for 
the interaction between IE63 and hnRNP K
Prior to and during co-immunoprecipitation with IE63 Mab, wild type (WT) and 
mock infected (MI) BHK cell extracts were treated with calf intestinal 
phosphatase (CIP) (lanes 3 and 4), phosphatase inhibitors (PI) (lanes 5 and 6), the 
CK2 specific inhibitor DRB (lanes 7 and 8), or left untreated (lanes 1 and 2). Co- 
immunoprecipitated proteins were separated by SDS-PAGE electrophoresis, 
transferred to nitrocellulose and Western blotted for IE63 and hnRNP K.
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Treatment with DRB showed that less hnRNP K was co-precipitated than from 
untreated extract despite more IE63 being present (lane 7) as a smear which 
presumably was a reflection of a mix of dephosphorylated IE63 species. In other 
words, DRB did not completely inhibit CK2 phosphorylation. From the DRB- 
treated data (lanes 7 and 8), it is hard to know whether the phosphorylated 
proteins have a greater affinity for each other than unphosphorylated ones, or 
whether phosphorylation of IE63 is required but there was enough residual 
phosphorylated protein for some co-immunoprecipitation to occur.
Taken together the results of CIP, PI and DRB treatment suggest that the 
phosphorylation o f IE63 by CK2 is required for (or at least increases the affinity 
of) the interaction between IE63 and hnRNP K, however the phosphorylation of 
hnRNP K has little effect on its interaction with IE63.
4C3 Phosphorylation of other proteins in the IE63 complex.
Fig. 4C3 shows all the immunoprecipitated proteins pulled out from wt extract 
using IE63 Mab after an in vitro phosphorylation assay. Comparison with the 
same reaction treated with DRB revealed CK2 phosphorylation of substrates other 
than IE63 and hnRNP K. The smallest band corresponds in size to one o f the 
bands of the 32kDa doublet seen in a [ S]-methionine labelled profile and was 
clearly phosphorylated by CK2. The next largest band may be the 44kDa or 
50kDa band, if  it is the 44kDa band then CK2a (the most likely identity of this 
band) is autophosphorylated: both CK2a and p have autophosphorylation sites 
(Dobrowolska e ta l ., 1999). Interestingly despite most autophosphorylation of 
CK2 occurring on the p subunit (Issinger, 1993, Litchfield et al., 1991), here the 
putative CK2 p band at 25kDa was not autophosphorylated. IE63, hnRNP K and 
the upper most band also appeared to be phosphorylated by CK2.
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Fig. 4C3. Other proteins in the complex are phosphorylated by CK2
Phosphoimage o f phosphorylation with y-[32P]-ATP of IE63 and co- 
immunoprecipitating proteins. Co-immunoprecipitates o f wild type (WT) (lanes 1 
and 3) and mock infected (MI) BHK cell extracts (lane 2) generated by anti-IE63, 
were incubated in kinase buffer with y-[32P]-ATP, with (lane 3) or without the 
CK2 inhibitor DRB (lanes 1 and 2) and then separated on an SDS-PAGE gel. 
Proteins were visualised by phosphoimaging after exposure to phosphoimaging 
plate overnight.
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4C4 IE63 is not nucleotidvlated by CK2
IE63 is nucleotidylated (Blaho et al., 1993) a modification which has been 
suggested to be carried out by CK2. The products of a GST-IE63 pull down assay 
were incubated with a-[ P]-ATP (Section 2B6.4) and nucleotidylation was 
detected by incorporation of [ P] as seen by phosphoimaging o f proteins 
separated by SDS-PAGE. Results (Fig. 4D2) showed firstly that nucleotidylating 
activity was not pulled down by GST-IE63 from wt infected (lane 3), or mi 
extracts (lane 4) and that purified a ’2P2 (lane 7) or (X2P2 (lane 8) could not 
nucleotidylate GST-IE63.
Nucleotidylation of many cellular and at least 2 viral proteins was seen when
9^whole cell extracts had a-[ PJ-ATP added. The viral bands correspond in size to 
IE 175 and to either IE68 or IE63, all of which have been reported to be 
nucleotidylated.
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Fig. 4C4. CK2 does not nucleotidylate GST-IE63
After GST pull down assay was carried out with wild type (WT) and mock 
infected (MI) BHK cell extracts or with purified CK2 a 2 $ 2  and (X2P2. Glutathione 
beads with GST/GST-IE63 and interacting proteins were incubated with a -[32P]- 
ATP, run on a 10% SDS-PAGE gel, dried down and exposed to X-OMAT film 
for 48h. Nucleotidylation is seen as a 32P labelled band as shown by activity 
present within WT and MI extracts used in pull downs (lanes 1 and 2) -  see text 
for details.
Nucleotidylation o f GST-IE63 and/or interacting proteins by interacting proteins 
pulled out from WT extract (lane 3) and MI extract (lane 4) by GST-IE63. 
Nucleotidylation of GST and/or interacting proteins by interacting proteins pulled 
out from WT extract (lane 5) and MI extract (lane 6) by GST.
Nucleotidylation o f GST-IE63 by interacting CK2 holoenzyme, 012^2 (lane 7) or 
a 2p2 (lane 8), and o f GST by 012^2 (lane 9) or (X2P2 (lane 10).
IE68/63HM
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Chapter 5: Interaction of IE63 with p32, SAP145 and 
other viral proteins
Two other potential IE63 interacting proteins suggested by the yeast 2-hybrid 
screen were Spliceosome Associated Protein 145 (SAP 145) and another protein 
involved in splicing, p32. This chapter confirms interactions involving IE63 with 
both SAP 145 and p32, and examines the identity o f other bands seen in the 
original co-immunoprecipitation profile (Fig. 3A1).
IE63s involvement in splicing inhibition made SAP 145 and p32 good candidates 
for interaction, indeed p32 was such a good candidate that work had begun on its 
interaction with IE63 before results o f the yeast 2-hybrid assay were known.
5A Interaction of IE63 and p32
5A1IE63 and p32 interact to form a complex with hnRNP K and CK2 
5A1.1 Using a p32 Sepharose column
A Sepharose column with p32 attached (rMp32) (Section 2B4.3) was used to 
look at the interaction between p32 and IE63. p32 is highly charged thus as a 
control glucose oxidase, a protein with a similar pi, was attached to the same type 
of column (rMGO) and used in parallel. After incubating rMp32 with cell 
extracts, Coomassie stained bands corresponding to proteins of ~63kDa, and 
44kDa were seen to interact specifically with p32 (Fig. 5 A 1.1 panel I lane 6). 
Other bands seen on the gel were either not specific to rMp32 being used 
(compare lanes 1-3 with lanes 4-6) or the presence of IE63 (compare lanes 4 and 5 
with lane 6). Interestingly a band of ~50kDa was pulled out specifically by rMp32 
(compare lane 4 and 5 with lanes 1 and 2) but only from mi and 271acZ infected 
cell extracts (compare lanes 4 and 5 with lane 6).
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Fig 5A1.1 p32 attached to a Sepharose column binds IE63
A Sepharose column with p32 attached (rMp32) was mixed with cell extracts and 
the proteins interacting with it separated by SDS-PAGE electrophoresis, Proteins 
were visualised by Coomassie staining or Western blotting for IE63, hnRNP K 
and p32 of the gels, or by performing a CK2 peptide assay on the complex 
formed.
Panel I: Coomassie stained gel o f proteins interacting with rMp32 when mixed 
with mock (MI) (lane 4), 271acZ (lane 5) or wild type (WT) (lane 6) infected 
extracts, also proteins interacting with glucose oxidase attached to Sepharose 
(rMGO) when mixed with MI (lane 1), 271acZ (lane 2) or WT (lane 3) infected 
extracts.
Panel II: Western blot o f the above gel for IE63 (TOP), hnRNP K (MIDDLE)
and p32 (BOTTOM).
panel III and IV on next page
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Fig 5A1.1 p32 attached to a Sepharose column binds IE63 cont.
Panel III: CK2 activity as measured by phosphorylation of an artificial peptide. 
Counts per minute (cpm) are proportional to activity found in pull downs with 
rMGO from WT extract (lane 5), and with rMp32 from WT (lanes 1 and 2), 
271acZ (lane 3), and MI (lane 4) extracts, CK2 assays were performed in the 
presence (lanes 2-5) or absence (lane 1) o f artificial peptide.
Panel IV: Western blot for IE63 of rMp32 pull down with pCMV63 transfected 
(Trans) (lane 4), MI (lane 5) and WT (lane 6) cell extracts. Extracts used (lanes 1-
3).
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Western blotting of the same column eluates for IE63 indicated that the 63kDa 
band was IE63 (Fig. 5A1.1 panel II lane 6), while blotting for hnRNP K revealed 
that although p32 and hnRNP K did not interact in the absence o f IE63 (lane 4 and 
5), in wt infected extracts they did (lane 6).
Performing a CK2 peptide assay on interacting proteins pulled out on the p32 
column demonstrated that CK2 was also present in the complex (Fig. 5A1.1 panel 
III lane 2) and that CK2 and p32 were not associated in the absence o f IE63 (lanes 
3 and 4). Controls without peptide (lanel) and using rMGO in a pull down with 
wt extract (lane 5) were used and were negative.
Use of IE63 transfected extracts (Fig.5Al.l Panel IV lane 4) showed that IE63 
alone could interact with p32 and that no other viral proteins were required.
5A1.2 Using immunoprecipitation
Further confirmation of the interaction between p32 and IE63 came from co- 
immunoprecipitation experiments. p32 antiserum was used to Western blot an 
anti-IE63 co-immunoprecipite generated as the original co-immunoprecipitation 
was (Section 2B3.1). IE63 precipitated itself from the wt infected extract 
(Fig.5A1.2 panel I lane 1) and p32 was co-immunoprecipitated with it (Panel II 
lane 1). As a control for cross reactivity of the IE63 Mab with p32, p32 did not 
precipitate from mi extract (Panel II lane 2). Thus it seems likely that one of the 
bands seen as a doublet at 32kDa in Fig.3A2 corresponds to p32.
5A2 IE63 causes redistribution of p32
p32 is usually seen to have a predominantly mitochondrial/cytoplasmic 
distribution (Muta et al., 1997). Immunofluoresence was used to visualise IE63 
(green) and p32 (red); infected and uninfected cells could therefore be recognised 
by the presence or absence o f green stain, while the distribution o f p32 in 
uninfected and infected cells could be compared by looking at the red staining. In 
HSV-1 infected cells, p32 appeared to be redistributed to form between one and 
three large foci in the perinuclear region of the cell, the nucleus was also diffusely
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Fig. 5A1.2 IE63 and p32 co-immunoprecipitate
Co-immunoprecipitations with IE63 Mab separated on a 10% SDS-PAGE gel and 
Western blotted for p32 and IE63.
Panel I: Western blot for IE63 performed on anti-IE63 co-immunoprecipitates 
from wild type (WT) (lane 1) and mock infected (MI) (lane 2) extracts. Extracts 
used (lanes 3 and 4).
Panel II: Western blot for p32 performed on anti-IE63 co-immunoprecipitates 
from WT (lane 1) and MI (lane 2) extracts. Extracts used (lanes 3 and 4).
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stained and no p32 was seen in the cytoplasm (Fig. 5B2.2 Panel I). However 
HSV-1 glycoprotein E (gE) is capable of binding to the IgG molecules which 
make up rabbit antibodies, such as the p32 one used here, and has been described 
as a low affinity Fc receptor (Bell et al., 1990, Dubin et al., 1990, Johnson et al., 
1988). Staining for gE (green) and p32 (red) (Panel II), revealed exact co­
localisation between them due to a cross reaction between the rabbit IgG in p32 
serum and gE from HSV-1 infection. Use of cells infected with gE' virus (Panel 
III) and IE63 transfected cells (Panel IV) overcame the problem and revealed that 
IE63 alone was sufficient to cause redistribution of p32. The distribution o f p32 
was mitochondrial/cytoplasmic in uninfected/untransfected cells and was 
excluded from the nucleus. In gE' cells and pCMV-63 transfected cells, this was 
altered to a diffusely nuclear pattern, although some cytoplasmic staining was still 
visible.
5A3 CK2 can phosphorvlate p32
The ability of CK2 to phosphorylate proteins which co-immunoprecipitate with 
IE63 is discussed in Section 4D1 and demonstrated that a band of 32kDa was 
phosphorylated by an activity which was inhibited by the specific CK2 inhibitor 
DRB (Fig. 4D1). Examination of the amino acid sequence o f p32 (Fig. 5A3) 
revealed that it contained 5 consensus sequences for CK2 phosphorylation. 
Phosphorylation of p32 by CK2 is therefore not unexpected and the 32kDa band 
seen to be phosphorylated by CK2 is most likely to be p32, although the 
phosphorylated protein could correspond to either of the bands in the 32kDa 
doublet.
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Fig. 5A2 IE63 causes p32 to redistribute in cells
Immunofluoresence was performed as described in section 2B8
on wild type (wt) infected, gE negative virus infected, pCMV63 transfected
and mock infected HeLa cells.
Panel I: wt infected cells in the same field stained using IE63 (A) 
and p32 (B) antisera as primary antibodies and TRITC and FITC 
as secondary antibodies.
Panel II: wt infected cells in the same field stained using gE (A) 
and p32 (B) antisera as primary antibodies and TRITC and FITC 
as secondary antibodies.
Panels III and IV on next page.
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Fig. 5A2 IE63 causes p32 to redistribute in cells (CONT.)
Panel III: gE- infected HeLa cells, in the same field,
6h post-infection, stained using p32 (A) and IE63 (B) antisera 
as primary antibodies and TRITC and FITC as secondary antibodies. 
Panel IV: pCMV63 transfected HeLa cells, in the same field, 
stained using p32 (A) and IE63 (B) antisera as primary antibodies 
and TRITC and FITC as secondary antibodies
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Fig. 5A3 CK2 phosphorylat ion sites on p32
Consensus sequences for CK2 phosphorylation are shaded, amino acids predicted 
to be phosphorylated are shown in bold. Sites were considered as potential 
phosphorylation sites if a S/T residue was N terminal to a D or E residue (<4 aa 
away). Adapted from data in Deb & Datta (1996).
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5B Interaction of IE63 with SAP145
5B1IE63 and SAP145 interact 
5B1.1 Using the GST pull down assay
GST pull down experiments using GST-SAP145 or GST-IE63 fusion proteins and 
~100pg wt/mi extract, followed by Western blotting for IE63 or SAP 145, showed 
that GST-SAP145 could pull IE63 down from infected cell extract (Fig 5B1.1 
Panel I lane 5, marked with a star) and that GST-IE63 could pull SAP 145 down 
from mi or infected cell extracts (Panel II lanes 3 and 4). As GST-IE63 pulled 
SAP 145 out of mi and wt infected extracts, this indicates that no other viral 
proteins are involved in the interaction; the slight decrease in intensity o f SAP 145 
from mi extracts was not a consistent observation. GST alone did not pull down 
IE63 (Panel I lane 3) or SAP 145 (Panel II lanes 1 and 2). A Coomassie stained gel 
o f the GST fusion proteins used is shown in Panel III.
5B1.2 Using co-immunoprecipitation
Further evidence for the interaction between SAP 145 and IE63 came from 
Western blotting of anti SAP 145 co-immunoprecipitates with IE63 antibody. Fig. 
5B1.2 (lane 1) shows that SAP 145 antiserum precipitated itself from wt extract, 
and that IE63 was co-immunoprecipitated with it. The pre-immune serum did not 
precipitate either protein (lane 2). Attempts to Western blot the original anti IE63 
co-immunoprecipitation with SAP 145 antibodies proved negative.
5B2 hnRNP K and SAP145 can co-immunoprecipitate but only in the 
presence of IE63
It was important to determine whether there was a direct SAP145-IE63 interaction 
or an indirect one occurring though hnRNP K. Equally it was important to know if 
the hnRNP K-IE63 interaction was direct or via SAP 145. To study this, the 
interaction between SAP 145 and hnRNP K was investigated. Using hnRNP K
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Fig. 5B1.1 GST-IE63 interacts with SAP145 and GST-SAP145 interacts with 
IE63
Fusion proteins were expressed bound onto beads and mixed with wild type (WT) 
and mock (MI) infected cell extracts. Proteins interacting were separated by SDS- 
PAGE electrophoresis and Western blotted for IE63 or SAP 145.
Panel I: Western Blot for IE63, proteins pulled out o f WT and MI extracts by 
GST (lanes 3 and 4), out o f WT and MI extracts by GST-SAP145 (G ST-145) 
(lanes 5and 6), and extracts used (lanes 1 and 2).
Panel II: Western blot for SAP 145, proteins pulled out o f WT and MI extracts by 
GST (lanes 1 and 2), and out o f WT and MI extracts by GST-IE63 (GST-63) 
(lanes 3 and 4).
Panel III: Coomassie stained gel o f fusion proteins used.
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Fig. 5B1.2 SAP 145 and IE63 co-immunoprecipitate
Western blots for SAP 145 and IE63. After co-immunoprecipitation from wild 
type infected cell extracts (WT) using SAP 145 antiserum (a  145) (lane 1) and pre- 
immune serum (PI) (lane 2), co-immunoprecipitated proteins were separated by 
SDS-PAGE, transferred to nitrocellulose and Western blotted for SAP 145 (TOP) 
and IE63 (BOTTOM).
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antiserum, hnRNP K was precipitated from wt, 271acZ and mi extracts (Fig. 5B2, 
lanes 2-4), whereas SAP 145 was only co-immunoprecipitated from wt infected 
extract (lane 2). Pre-immune serum precipitated neither hnRNP K or SAP 145.
SAP 145 and hnRNP K can therefore not interact in the absence of IE63.
5B3 SAP145 and CK2 interact but only in the presence of IE63
Anti SAP 145 co-immunoprecipitates from wt, 271acZ, and mi extracts and a co- 
immunoprecipitate o f wt extract with pre-immune serum, were assayed for the 
presence of CK2 activity using the peptide substrate assay. Activity was found 
only in co-immunoprecipitates from wt extracts (Fig. 5B3 lane 2). It follows then 
that SAP 145 and CK2 cannot usually interact. However in infected cell extracts 
they can interact indirectly via IE63. A control of an anti-SAP 145 co- 
immunoprecipitate assayed for CK2 in the absence o f peptide substrate showed 
low activity.
5B4 SAP145 and p32 don’t interact even in the presence of IE63.
The p32 column was used to examine whether SAP 145 could interact indirectly 
with IE63 via p32. Extracts used Western blotted for IE63 and SAP 145 are shown 
(Fig. 5B4 lanes 1-3). Proteins binding to the p32 column, were also Western 
blotted for IE63 and SAP 145. IE63 from wt extract was seen to bind to p32 (lane 
4), but SAP 145 in mi (lane 5), 271acZ (lane 6) or wt infected (lane 4) extracts was 
not. Therefore while IE63 and SAP 145 interacted, this did not occur when IE63 
was bound to p32.
5B5 IE63 and SAP145 co-localise in cells
HSV-1 infection causes a redistribution of the cellular splicing snRNPs from a 
widespread diffuse speckled pattern to a highly punctate organisation in the 
nucleus (Martin et al., 1987). IE63 is both necessary and sufficient to cause this 
effect, and at later times post infection IE63 co-localises with the redistributed 
snRNPs (Phelan et al., 1993; Sandri-Goldin et a l , 1995). SAP 145 is a component 
of the U2 snRNP complex (Gozani et al., 1994), and would be expected to be
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Fig. 5B2 hnRNP K and SAP145 only interact in wild type infected extract
Western blots for SAP 145 and hnRNP K. After co-immunoprecipitation using 
hnRNP k antiserum and wild type (WT) (lane 2), 271acZ (lane 3) or mock infected 
(MI) (lane 4) extracts and pre-immune serum (PI) with WT extract (lane 1), co- 
immunoprecipitated proteins were separated by SDS-PAGE, transferred to 
nitrocellulose and Western blotted for SAP 145 (BOTTOM) and hnRNP K (TOP).
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Fig. 5B3 CK2 and SAP145 only interact  in the presence of IE63
CK2 activity in anti-SAP 145 co-immunoprecipitates. Anti SAP 145 co- 
iminunoprecipitations were performed followed by a CK2 peptide assay. CK2 
activity was determined by scintillation counting. Counts per minute (cpm) being 
proportional to enzyme activity. Assays were performed without peptide on co- 
immunoprecipitates from wild type extract (wt) (lane 1) or with peptide on co- 
immunoprecipitates from wt (lane 2), mock infected (mi) (lane 4), and 271acZ 
infected (lane 5) extracts, or with peptide on a co-immunoprecipitate from wt 
extract using pre-immune serum (pi) (lane 3).
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Fig. 5B4 SAP145 and p32 do not interact even in the presence of IE63
A Sepharose column with p32 attached (rMp32) was mixed with cell extracts and 
the proteins interacting with it separated by SDS-PAGE electrophoresis, IE63 and 
SAP 145 were visualised by Western blotting. Extracts used (lanes 1-3), proteins 
interacting with rMp32 from wild type infected (WT) (lane 4), mock infected 
(MI) (lane 5) and 271acZ infected (lane 6) extracts.
Chapter 5 Results
Interaction w ith p32, SA P 145 and other viral proteins
located with snRNPs. For this reason, the cellular location of SAP 145 in infected 
and uninfected cells was inspected.
HeLa cells were infected with wt virus or transfected with the IE63 expressing 
plasmid and the localisation of IE63 and SAP 145 determined. Cells were stained 
for IE63 (green) and SAP 145 (red); infected cells and uninfected cells can then be 
distinguished by the presence or absence of green stain, and SAP 145 location 
examined by looking at red stain. The distibution of SAP 145 does not appear to 
differ between infected and uninfected cells, although it may be a little more 
punctate (Fig.5B5, Panel I).
Use of the confocal microscope allowed IE63 and SAP 145 co-localisation to be 
seen in the same image, (Fig.5B5 Panels I and II). Results in IE63 transfected 
cells (Fig.5B5 panel III), show that no other viral factors are required for this co­
localisation. Immunofluoresent staining for SAP 145 (red) and SC35 (green) in wt 
infected cells demonstrated that they co-localise Panel IV.
5C Interaction of IE63 with other HSV-1 proteins
5C1 Interaction of IE63 with viral TK
5C1.1 The identity of a 44kDa band seen in Coomassie stained rMp32 
pulldown assays.
In Fig. 5A1.1 lane 6, a densely stained band o f ~44kDa was seen to be specifically 
interacting with rMp32 in the presence of IE63. As CK2 activity was shown to be 
present in the complex, one explanation was that this band was CK2a or a ’ 
subunit, however its abundance was inconsistent with CK2 only being present in 
very small amounts, and the amount o f CK2 activity present bound to the column 
(Fig 5B 1.1) was no greater than that co-immunoprecipitated by hnRNP K 
antiserum where the band was not visible by Coomassie staining. Results of 
rMp32 pull downs with samples at different times post infection (Fig.5Cl.l), 
suggested that the 44kDa band was viral or at least required another viral
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Fig. 5B5 IE63 causes the redistribution o f and co-localises w ith SAP145
HeLa cells were infected with wild type virus or transfected with pCMV63, fixed and stained for 
IE63 and SAP 145 then analysed by confocal microscopy. The same field is shown in each case. 
Panel I: HSV-1 infected and uninfected cells stained for SAP145 (A), IE63 (B) and merged (C). 
Panel II: HSV-1 infected cells stained for SAP 145 (A), IE63 (B) and merged (C).
Panel III: pCMV-63 transfected cells stained for SAP 145 (A), IE63 (B) and merged (C).
Panels IV: HSV-1 infected cells stained for SAP145 (A) and SC35 (B).
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Fig 5C1.1 The 44kDa band increases in intensity between 4h and 24h post­
infection
Coomassie stained gel o f proteins interacting with a Sepharose column with p32 
attached (rMp32) when mixed with wt (WT) extract harvested at 4h (lane 1) or 
24h (lane 2) post-infection.
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component for interaction with IE63. The band increased in intensity between 4h 
and 24h post infection (compare lanes 1 and 2).
As the protein was relatively abundant, an attempt was made to determine its 
identity by Laser Mass Map Spectroscopy. Simultaneously to trying to sequence 
the protein myself, a sample was set to St. Andrews for analysis on their machine. 
Sequence data obtained by Dr. G. Kemp in St. Andrews identified the band as 
HSV-1 TK (Kemp, unpublished data).
5C1.2 Confirmation of identity of 44kDa band as viral TK.
Confirmation came in 3 ways. Firstly the 44kDa band disappeared when TK1301 
(a TK negative virus) infected extract was used in rMp32 pull downs as 
performed in Section 5A1 (Fig. 5C1.2 Panel I compare lanes 3 and 4).
Secondly TK was shown to interact with p32 by Western blotting, with anti TK 
serum. Analysis o f proteins from wt extract which were bound to rMp32 or 
rMpGO columns, showed that p32 pulled down TK (Panel II lane 2), while TK 
was not seen to interact with glucose oxidase (lane 1).
Lastly anti IE63 co-immunoprecipitates were Western blotted for TK. IE63 Mab 
immunoprecipitated IE63 from wt infected extract (Panel III lane 1 lower), TK 
was co-immunoprecipitated with IE63 (lane 1 upper), mouse ascites fluid did not 
precipitate IE63 or TK from wt infected extracts (lane 3).
5C2 Interaction with IE175
5C2.1 Examination for an interaction between IE63 and IE175 using co- 
immunoprecipitation
Panagiotidis et al (1997) have claimed that IE63 and IE 175 physically and 
functionally interact. This interaction seemed a good positive control for my 
study.
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Fig 5A1.1 p32 attached to a Sepharose column binds IE63
A Sepharose column with p32 attached (rMp32) was mixed with cell extracts and 
the proteins interacting with it separated by SDS-PAGE electrophoresis, Proteins 
were visualised by Coomassie staining or Western blotting for IE63, hnRNP K 
and p32 o f the gels, or by performing a CK2 peptide assay on the complex 
formed.
Panel I: Coomassie stained gel o f proteins interacting with rMp32 when mixed 
with mock (MI) (lane 4), 271acZ (lane 5) or wild type (WT) (lane 6) infected 
extracts, also proteins interacting with glucose oxidase attached to Sepharose 
(rMGO) when mixed with MI (lane 1), 271acZ (lane 2) or WT (lane 3) infected 
extracts.
Panel II: Western blot o f the above gel for IE63 (TOP), hnRNP K (MIDDLE)
and p32 (BOTTOM).
panel III and IV on next page
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Prior to these experiments, it had been reported that the electrophoretic mobility 
of IE 175 was altered in the absence of IE63, however it was not clear if  IE63 was 
directly or indirectly involved in this post-translational modification (Rice & 
Knipe, 1988; Su, 1989; McMahan, 1990). Interaction was also suggested from co­
transfection experiments which indicated that IE63 and IE 175 can alter each 
other’s intracellular localisation (Zhu & Schaffer, 1995).
Co-immunoprecipitations, as described in Section 2B3.1, were performed with 
HSV-1 wt and mi whole cell extracts (Section 2B2.5i). The precipitated proteins 
were separated by SDS-PAGE and Western blotted for IE63 or IE 175 (Fig. 
5C2.1a). IE63 Mab precipitated IE63 (Panel I, lane 3) however IE 175 was not 
detected (Panel II, lane 3).
Co-immunoprecipitations were then repeated using the conditions o f Panagiotidis 
(1997), (Section 2B3.2) with HSV-1 wt or mi nuclear extracts (Section 2B2.5ii). 
As a control, mouse ascites fluid was incubated with wt nuclear extract in the 
same way as the Mab was. After separation on an SDS-PAGE gel and Western 
blotting, IE63 Mab had precipitated IE63 (Fig 5C2.1b Panel I, lane 3), but IE175 
was not detected (Panel II, lane 3). Ascites fluid did not precipitate IE63 or IE 175 
(Panels I and II, lane 1).
IE175 Mab (58S) (Ackerman et al., 1984) was used to co-immunoprecipitate 
IE63. The conditions published by Panagiotis were followed (Section 2B3.2) 
using HSV-1 wt nuclear extract, incubated with 58S Mab or mouse ascites fluid. 
Proteins were separated by SDS-PAGE gel electrophoresis and Western blotted 
for IE175, IE63 and IE110. IE175 Mab co-immunoprecipitated IE175 (Fig 5C2.1c 
Panel I, lane 1), but did not precipitate IE63 (Panel II, lane 1). Western blotting 
for IE110, another immediate early gene of HSV-1 involved in regulation of viral 
gene transcription, confirmed that IE 175 and IE110 interact (Yao & Schaffer,
1994) (Panel III, lane 1), and served as a positive control for an IE 175 co- 
immunoprecipitation.
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Fig 5C2.1a Using standard  anti-63 co-immunoprecipitation conditions IE63 
and IE175 do not interact
HI 113 monoclonal antibody (Mab) was used in co-immunoprecipitation 
experiments under conditions in section 2B3.1, the immuno-complex precipitated 
was separated on 10% SDS-PAGE gel, transferred to nitrocellulose and Western 
blotted for IE63 orIE175
Panel I. Western blot for IE63 using HI 113 Mab. Wildtype (WT) and mock 
infected (MI) BHK cell extracts used (lanes 1 and 2), proteins immunoprecipitated 
from WT extract (lane 3) and MI extract (lane 4) with IE63 Mab.
Panel II. Western blot for IE 175 using a mix o f 58S, H640, and 10176 Mabs. WT 
(lane 1) and MI cell extracts used (lane 2), proteins immunoprecipitated from WT 
extract (lane 3) and MI extract (lane 4) with IE63 Mab.
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Fig 5C2.1b Using method of Panagiotidis for anti-63 co-immunoprecipitation 
IE63 and IE175 do not interact
IE63 HI 113 monoclonal antibody (Mab) was used in co-immunoprecipitation 
experiments under conditions described by Panagiotidis (1997), the immuno- 
complex precipitated was separated on 10% SDS-PAGE gel, transferred to 
nitrocellulose and Western blotted for IE63 or IE 175.
Panel I. Western blot for IE63 using HI 113 Mab. Wildtype (WT) (lane 5) and 
mock infected (MI) BHK nuclear extracts used (lane 4), proteins 
immunoprecipitated from WT extract (lane 3) and MI extract (lane 2) with IE63 
Mab, proteins immunoprecipitated from WT cell extract with mouse ascites fluid 
(MA) (lane 1).
Panel II. Western blot for IE 175 using a mix o f 58S, H640, and 10176 Mabs. WT 
(lane 5) and MI nuclear extracts used (lane 4), proteins immunoprecipitated from 
WT extract (lane 3) and MI extract (lane 2) with IE63 Mab, proteins 
immunoprecipitated from WT cell extract with MA (lane 1).
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Fi<z 5C2.1c Using method of Panagiotidis for anti-175 immunoprecipitation 
IE63 and IE175 do not interact
58S monoclonal antibody (Mab) was used in co-immunoprecipitation experiments 
under conditions described by Panagiotidis (1997), the immuno-complex 
precipitated was separated on 10% SDS-PAGE gel, transferred to nitrocellulose 
and Western blotted for IE63, IE175, or IE 110.
Panel I. Western blot for IE 175 using a mix o f 58S, H640, and 10176 Mabs. 
Wildtype (WT) (lane 4) and mock infected (MI) BHK nuclear extracts used (lane 
3), proteins immunoprecipitated from WT extract with IE 175 Mab (lane 1) and 
proteins immunoprecipitated from WT cell extract with mouse ascites fluid (MA) 
(lane 2).
Panel II. Western blot for IE63 using HI 113 Mab. WT (lane 4) and MI nuclear 
extracts used (lane 3), proteins immunoprecipitated from WT extract with IE 175 
Mab (lane 1) and proteins immunoprecipitated from WT cell extract by MA (lane 
2).
Panel III. Western blot for IE 110 using 11060 Mab. WT (lane 4) and MI nuclear 
extracts used (lane 3), proteins immunoprecipitated from WT extract with IE 175 
Mab (lane 1) and proteins immunoprecipitated from WT cell extract with MA 
(lane 2).
Panel IV. Over exposed Western blot for IE63 using HI 113 Mab. WT (lane 5) 
and MI nuclear extracts used (lane 4), proteins immunoprecipitated from WT 
extract with IE 175 Mab (lane 1), proteins immunoprecipitated from WT cell 
extract by MA (lane 2) and proteins immunoprecipitated from MI extract with 
IE175 Mab (lane 3).
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Severe over exposure o f IE63 Western blots following IE175 co- 
immunoprecipitations on occasions showed a faint IE63 band when extracts of wt 
infected cells were incubated with IE 175 Mab or with mouse ascites fluid (Panel 
IV lanes 1 and 2).
5C2.2 Examination for an interaction between IE63 and IE175 using GST- 
IE63 pull down assay
GST-IE63 and GST alone were incubated with HSV-1 wt infected extract for lh  
at 4°C, Glutathione beads were washed, and interacting proteins separated by 
SDS-PAGE electrophoresis. IE175 was detected by Western blotting using IE175 
Mab (10176) in the wt extract used (Fig 5C2.2 lane 2) but was not pulled down by 
GST-IE63 (lane 3).
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Fig 5C2.2 IE63 and IE175 do not interact in a GST fusion protein pull down
assay
Western blot for IE 175 using a mix o f  58S, H640, and 10176 monoclonal 
antibodies. GST-63 and GST fusion proteins were bound onto Glutathione beads 
incubated with ~ lOOpg BHK cell extract and washed, pulled down proteins were 
separated on a 10% SDS-PAGE gel, transferred to nitrocellulose and Western 
blotted for IE 175. Wildtype (WT) and mock infected (MI) extracts used (lanes 1 
and 2), Proteins pulled down by GST-63 mixed with WT extract (lane 3) and MI 
extract (lane 4) and GST incubated with WT extract (lane 5).
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Chapter 6: Discussion
IE63 is a key regulatory protein in HSV-1 lytic infection (see Section 1B8-13) 
which has been demonstrated to inhibit host cell mRNA splicing (Hardwicke & 
Sandri-Goldin, 1994, Hardy & Sandri-Goldin, 1994), redistribute splicing factors 
(Martin et al., 1987, Phelan et al., 1993, Sandri-Goldin et al., 1995), increase 
polyadenylation efficiency at viral poly (A) sites (McLauchlan et al., 1989; 
McGregor et al., 1996), transport viral transcripts to the cytoplasm and prevent 
transport of cellular transcripts (Hibbard & Sandri-Goldin, 1995, Phelan et al., 
1996). In addition, IE63 may regulate transcription directly (Rice & Knipe, 1988; 
Jang & Latchman, 1992; Pangiotidis et al., 1997) and is necessary for viral 
replication complex formation (Curtin & Knipe, 1993). However, no convincing 
evidence has been presented to explain the mechanism by which IE63 participates 
in such a wide variety of processes. Work presented in this thesis reveals several 
protein:protein interactions between IE63 and host cell and viral proteins, 
indicating that IE63 is a multifunctional protein capable of participating in 
different processes through interaction with a number o f partner proteins.
A separate discussion of certain experimental techniques used can be found in 
Appendix 1.
6A1 The interaction of IE63 with hnRNP K and CK2 
6A1.1 IE63 interacts with hnRNP K and CK2
Chapter 4 presents data which confirms the interaction between IE63 and hnRNP 
K (Fig. 4A 1.1-2), and between IE63 and CK2 (Fig.4Bl). All 3 proteins were 
shown to co-immunoprecipitate in a complex held together by IE63 and which 
contains other unknown proteins; no other viral proteins were required for hnRNP 
K, CK2 and IE63 to associate (Fig. 4B1). A 70 kDa band and the 44 kDa and 25 
kDa bands seen in the original co-immunoprecipitation (Fig. 3A1) and in the 
GST-IE63 pull down (Fig. 3B2) presumably correspond to hnRNP K and to CK2 
a  and p subunits. The interaction with hnRNP K is specific and was not found 
with other hnRNP proteins (Fig. 4A1.3).
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6A1.2 CK2 phosphorylates IE63 and hnRNP K co-immunoprecipitated by 
IE63 Mab.
CK2 was seen to phosphorylate, and not to nucleotidylate (Fig. 4D2), IE63 and 
hnRNP K (Fig. 4C1 and 4D1) and phosphorylation may be important for 
proteinrprotein interaction in the IE63 complex (see below).
DRB always inhibited phosphorylation of IE63 and hnRNP K pulled down by 
IE63 Mab but the extent of this varied a little (compare Fig. 4C1 to Fig. 4D1), 
perhaps due to DRB instability between assays. Treatment with DRB never 
completely inhibited phosphorylation of IE63, implying that other kinases can 
phosphorylate IE63. Confirmation o f phosphorylation by other kinases comes 
from Zhi and Sandri-Goldin (1999), and potential phosphorylation sites for 
several different kinases on IE63 can be seen in Fig. IB 12b.
Other co-immunoprecipitating proteins were phosphorylated by CK2 (Fig.4Dl), 
but without positive identification o f these bands this knowledge is o f limited use.
6A1.3 Different forms of hnRNP K were seen co-immunoprecipitated with 
anti-IE63 and anti hnRNP K sera
The form of hnRNP K precipitated by hnRNP K antiserum was slower migrating 
(Fig.4A2) and not phosphorylated in vitro by CK2 (Fig.4Cl) compared to the 
hnRNP K form co-immunoprecipitated by IE63 Mab. May be if  IE63 
predominantly interacts with a CK2 phosphorylated form of hnRNP K, and the 
hnRNP K antiserum used predominantly immunoprecipitates its non- 
phosphorylated form (due to specific recognition o f the non phosphorylated form 
or this form being the major form represented in the cell), then as both forms can 
interact with IE63, the difference in migration seen here would be observed.
The difference in hnRNP K form precipitated may not only reflect 
phosphorylation, primary transcripts of hnRNP K are alternatively spliced to 
generate four variants and changes in the relative proportions of variants are 
associated with alterations in cell proliferation (Dejgaard et al., 1994).While the 
antibody used in this study was directed against a peptide present in all four
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isoforms, it is possible that the discrimination seen was between different 
isoforms of hnRNP K which were differentially phosphorylated by CK2.
6A1.4 Phosphorylation of IE63 is important for the interaction between IE63 
and hnRNP K
Phosphorylation of hnRNP K by CK2 was not required for hnRNP K:IE63 
interaction. Both CK2 phosphorylated and CK2 unphosphorylated forms of 
hnRNP K were co-immunoprecipitated with IE63 Mab (Figs. 4C1), and 
dephosphorylated hnRNP K was co-immunoprecipitated by IE63 Mab from CIP 
treated extracts (Fig. 4C2). However as treatment of extracts with phosphatase 
inhibitors increased the amount of hnRNP K co-immunoprecipitating with 
phosphorylated IE63, and treatment with CIP and DRB decreased the amount of 
hnRNP K co-immunoprecipitating with dephosphorylated IE63, the 
phosphorylation of IE63, may play a role in IE63:hnRNP K interaction. As 
dephosphorylation was not complete it is difficult to determine between 
phosphorylation increasing the affinity of interaction and an absolute requirement 
with enough residual phosphorylated form to pull down some hnRNP K.
When extracts were treated with PI and subject to IE63 immunoprecipitation an 
even more slowly migrating form of hnRNP K was seen (Fig. 4C2 *). Which may 
correspond to the form precipitated by hnRNP K antiserum (Fig. 4A2).
Phosphorylation o f hnRNP K by other kinases is RNA or DNA dependent and 
interleukin 1 responsive. Oxidative stress increases Tyr phosphorylation of 
hnRNP K and this increase has been shown to increase hnRNP K association with 
some of its molecular partners - Lck, Vav and PKC6 (Schullery et al., 1999) and 
Bomsztyk (Personal Communication). As hnRNP K is not normally 
phosphorylated by CK2 (Van Seuningen et al., 1995a), the relevance of its 
phosphorylation in the presence of IE63 is o f great interest. In the same way as 
oxidative stress increases phosphorylation on hnRNP K altering its molecular 
partners, during HSV-1 infection CK2 phosphorylation may affect hnRNP K 
interactions with other proteins. So far with respect to CK2 phosphorylation only
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the interaction between hnRNP K and IE63 has been examined (Fig.4C2) but it is 
consistent with this model.
6A1.5 The CK2 subunit which interacts with IE63
Examination of the CK2 subunit which interacts with IE63 yielded contradictory 
data (Fig. 4B3). Use of the peptide assay suggested that the interaction o f CK2 
with IE63 was via the p subunit while Western blotting pointed to an interaction 
with the CK2 a  subunit. The peptide substrate binds to the p subunit o f CK2 
where it is held for the a  subunit to phosphorylate. Thus the peptide substrate 
assay will not show CK2 activity catalysed by the a  subunit unless CK2P is also 
present and this assay cannot determine if IE63 interacts with a  or p, as even if 
IE63 interacts with purified a  subunit, no CK2 activity will be detected as the 
peptide cannot be bound and phosphorylated. On balance, interaction with CK2 is 
considered to be via the a  subunit. However as purified p subunit was not 
available (it is very unstable without the a  subunit) it is not possible to rule out 
that IE63 can interact directly with both subunits. The presence of a 44 kDa and a 
25 kDa band and of CK2 activity (as detected by the peptide assay) in the original 
co-immunoprecipitation (Fig. 3A2) suggests that which ever subunit directly 
interacts, both are present in the IE63 complex.
6A2 Relevance of the interaction of IE63 with hnRNP K 
6A2.1 IE63 and hnRNP K are similar
IE63 and hnRNP K have structural and functional similarities. Both have acidic 
N-termini required for function, possesses methylated RGG boxes, contain 
repeated KH domains and have C-terminal regions which facilitate protein:protein 
interactions (Sections IB 12 and 1C1). Functionally, both affect transcriptional 
and post-transcriptional processes, are capable of self interaction, shuttle from the 
nucleus to the cytoplasm and are present in multi-protein complexes (Sections 
1B9-1B10 and 1C1).
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These similarities suggest that IE63 and hnRNP K may access common cellular 
pathways. IE63 could prevent hnRNP K from accessing these pathways thereby 
inhibiting competition or subvert its activities directing them for use in viral rather 
than cellular gene expression. Alternatively many of the functions ascribed to 
IE63 may be due to its interaction with hnRNP K which could play a key role in 
HSV-1 infection.
It has been suggested that hnRNP K can act as a molecular docking platform (see 
Section 1C 1.1) allowing cross talk between transcription, mRNA processing and 
signalling. Thus, hnRNP K interaction with IE63 in infected cells suggests 
exciting possibilities for an IE63 regulation o f these processes.
6A2.2 Transcriptional effects
IE63:hnRNP K interaction may account for the ability of IE63 to activate and 
repress gene expression (Panagiotidis et al., 1997, Rice & Knipe, 1988). hnRNP 
K interacts with TBP and can activate CT-mediated transcription o f c-myc 
(Michelotti et al., 1996); an interaction with IE63 could redirect hnRNP K to 
transactivate viral genes. In support o f this, tandem copies o f a C+T-rich DNA 
sequence, similar to known hnRNP K DNA binding sites, are present in an HSV-1 
genome location which has been proposed to act as a transcriptional regulator of 
viral IE genes (Quinn et al., 1998).
IE63 binding to hnRNP K could also relieve the hnRNP K suppression o f gene 
activity, similar to the way in which expression o f hepatitis C virus core protein 
relieves hnRNP K suppression o f the cellular TK promoter (Tsieh et al., 1998).
6A2.3 Shuttling effects and RNA export
IE63 may shuttle by more than one route (Section IB 1.4), while the N-terminal 
NES permits access to one of these routes (Sandri-Goldin, 1998), other routes are 
not so clear. Shuttling could be via a second C-terminal NES (Fig. IB 12b), 
through a novel NES or via interaction with a cellular shuttling protein. As 
hnRNP K can shuttle from the nucleus to the cytoplasm, interaction with IE63
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may allow IE63 to piggy back on hnRNP K thereby exporting viral transcripts. 
Alternatively, the interaction may inhibit hnRNP K shuttling allowing IE63 to 
access the hnRNP K shuttling pathway. The presence o f the highly conserved 
SADET sequence (fig. IB 12b), a sequence with high homology to part o f the 
KNS domain o f hnRNP K (Fig. 6A2.3), in the IE63 homologues o f all 
alphaherpesviruses (Appendix 2) suggests that IE63 could hijack the hnRNP K 
specific export/import pathway.
Both IE63 (Ingram et al., 1996) and hnRNP K (Matunis et al., 1992) bind RNA 
directly. It is not known if hnRNP K binds to viral mRNA although HSV-1 RNA 
is rich in G+C (-70% ) and hnRNP K has a binding preference for poly (rC) RNA.
It has been suggested that the KH domains o f IE63 specifically bind late viral 
transcripts and facilitate their export (Soliman, T., personal communication), 
maybe IE63 binding to hnRNP K provides a way to selectively export these 
RNAs.
Fig. 6A2.3 Sequence alignment of hnRNP K and IE63
hnR N P K 32  3 YD|RGRPGDRYDGMVGF^HBW DSAIDTW SPSEW OMAY 3 6 1  
I E 6 3  3 3 8  AMRDCVLRQENFIEALASADETLAWCKMCIHHNLPLRPQ 37  6
Sequence alignment showing homology between the minimally defined KNS 
region o f hnRNP K and a region in IE63. Residues shared between proteins are 
shaded and residues conserved throughout the herpesviridae IE63 homolgues are 
shown in bold (see Appendix 2).
6A2.4 Translational effects
As HSV-1 infection proceeds, synthesis o f viral proteins is selectively turned off, 
as is that o f most host proteins. IE mRNAs persist in the cytoplasm late in 
infection when IE protein synthesis is almost completely inhibited, so 
translational control o f viral gene expression has been suggested (Honess & 
Roizman, 1974; Weinheimer & McKnight, 1987; Elshiekh et al., 1991; Laurent et 
al., 1998). This level o f control would occur as part o f the second stage o f host 
shut o ff separate from the effect by VHS protein (see Section 1 A6.2). Non­
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translated mature viral mRNAs have been found to be sequestered in complexes 
containing the 40S ribosomal subunit (Laurent et al., 1998), thus initiation of 
translation appears to be blocked after the binding of 40S ribosomal subunits but 
before association with the 60S subunit; 80S ribosome assembly is therefore 
blocked. During HSV infection, the ribosomal subunits and some other host cell 
proteins involved in translation, including elongation factor la  (efla), are more 
highly phosphorylated than in uninfected cells (Chou et al., 1995, Masse et al., 
1990a, Masse et al., 1990b).
In several systems, hnRNP K can be seen to inhibit translation o f mature mRNAs 
by blocking 80S ribosome assembly (Collier et al., 1998, Ostareck et al., 1997), 
and hnRNP K has been shown to interact with efla. Interaction o f hnRNP K with 
IE63 and CK2 may therefore play a role in HSV-1 driven inhibition of translation.
6B1 The interaction of IE63 with p32 (also involving CK2 and hnRNP K) 
6B1.1 IE63 interacts with p32, CK2 and hnRNP K
IE63 was seen to interact with p32 (Fig.5Al. 1) and hnRNP K and CK2 were also 
present in the complex. Further, the use o f extracts transfected with IE63 showed 
that no other viral proteins were involved in the interaction. The original anti IE63 
co-immunoprecipitation and GST-IE63 pull down profiles (Figs.3A2 and 3B2) 
showed 2 bands of approximately 33 kDa -35 kDa and Western blotting showed 
that p32 was co-immunoprecipitated with IE63 (Fig. 5A1.2). It seems reasonable 
to assume that one of the 33 kDa -35 kDa bands corresponds to p32, the identity 
o f the other band is discussed below.
There were proteins which interacted with p32 in uninfected cells which did not 
interact in infected cells. This could reflect their down-regulation following 
infection or, more interestingly, they could be displaced by IE63 to moderate p32 
activity. Without knowledge of their identity further conclusions are difficult to 
reach. The most prominent band is ~50kDa, none of the cellular proteins known to 
interact with p32 are this size.
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6B1.2 p32 is phosphorylated and redistributed in the presence of IE63
IE63 expression caused a redistribution of p32 (Fig.5A2), and p32 (or a protein of 
similar size) was phosphorylated by co-immunoprecipitating CK2 (Fig.4Dl). As 
p32 and CK2 were only associated with each other in infected cells, p32 would 
not be expected to be phosphorylated by CK2 in uninfected cells, although this 
was not directly examined. Inhibition of phosphorylation by DRB of the ~33 kDa 
band was almost complete so phosphorylation by other kinases either does not 
occur or occurs to a very small extent.
A doublet o f bands was seen at 33 kDa -35 kDa (Fig. 3A2), one of these 
presumably is p32, one band of the doublet was phosphorylated (Fig. 4D1), 
(whether these are the same protein band has not been resolved). The known 
association o f p32 and ASF/SF2 suggests that the second band which co- 
immunoprecipitated with IE63 at 33 kDa -35 kDa was ASF/SF2, however 
Western blotting for ASF/SF2 was unable to confirm or reject this possibility. 
ASF/SF2 has 3 potential CK2 phosphorylation sites (Fig. 6B1.2).
Fig. 6B1.2 Potential CK2 phosphorylation sites on ASF/SF2
MSGGGVIRGPAGNNDCRIYVGNLPPDIRTKDIEDVFYKYGAIRDIDLKNRR 
GGPPFAFVEFEDPRDAEDAVYGRDGYDYDGYRLRVEFPRSGRGTGRGGG 
GGGGGGAPRGRYGPPSRRSENRVWSGLPPSGSWQDLKDHMREAGDVC 
Y AD VYRDGT G W E F  VRKEDMT Y A VRKLDNTKFRSHEGET A YIR VKVDG 
PRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPRHSRSRSRT
Sites were considered as potential phosphorylation sites if  a S/T residue was N 
terminal to a D or E residue (<4 aa away). Residues which may be phosphorylated 
are boxed. Consensus sites shaded.
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6B1.3 Is p32 a sticky protein ?
Previous studies using the yeast 2 hybrid system have shown that p32 interacts 
with several proteins and, coupled its high charge, it is considered to be a “sticky” 
protein which is pulled out non-specifically in assays. However (i) the 
demonstration of an interaction in different assay systems, the use o f a similarly 
highly charged “sticky” protein (glucose oxidase) as a control in the pull down 
assay; (ii) the obvious redistribution o f p32 in infected cells and (iii) the recent 
demonstration that p32 can regulate splicing (Peterson-Mahrt et al., 1999), a 
function which IE63 clearly disrupts (Sandri-Goldin & Mendoza, 1992; 
Hardwicke & Sandri-Goldin, 1994; Hardy & Sandri-Goldin, 1994; Sandri-Goldin 
et al., 1995), all point to this interaction being a specific and functionally 
important one.
6B2 Relevance of the interaction of IE63 with p32 
6B2.1 Splicing effects
The biological functions o f p32 have proved to be controversial. Originally 
identified as a component of the ASF/SF2 splicing factor (Krainer et al., 1990b), 
subsequent work shows that the p33 subunit alone contains all the functional 
properties of a splicing factor (Mayeda et al., 1992), however p32 inhibits 
ASF/SF2 from acting as a splicing repressor or splicing enhancer protein 
(Peterson-Mahrt et al., 1999). The IE63/p32 interaction may therefore be the 
mechanism by which IE63 inhibits splicing.
The cellular location of p32 has caused confusion in the debate on p32 function; 
p32 has been reported to be predominantly (exclusively) mitochondrial ( Muta et 
al., 1997; Matthews & Russell, 1998), cytoplasmic (Luo et al., 1994; Simos & 
Georgatos, 1994; Tange et al., 1996; Wang et al., 1997) and nuclear (Luo et al., 
1994; Simos & Georgatos, 1994; Tange et ah, 1996; Wang, 1997; Matthews,
1998). Using immunofluoresence with a standard fixation method, p32 was seen 
staining with a predominantly cytoplasmic distribution (Fig. 5A2). However with
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HSV-1 infection and when IE63 was expressed alone, this distribution was 
dramatically altered and p32 was seen in the nucleus.
Although IE63 causes a redistribution of p32, there was little co-localisation of 
p32 and IE63 unlike previous observations for IE63 and other splicing proteins 
(Phelan et al., 1993). Once transported to the nucleus and having disrupted 
splicing, p32 may perform another function.
Generally, p32 may have a predominantly cytoplasmic/mitochondrial distribution 
with a small amount being present in the nucleus, and this distribution may permit 
ASF/SF2 to function in splicing. However under specific conditions, for instance 
viral infection, p32 could redistribute to the nucleus and disrupt splicing activity 
by interacting with ASF/SF2. A similar redistribution from cytoplasm to the 
nucleus is observed in adenovirus infected cells, where p32 has been suggested to 
play a role in adenovirus splicing regulation (Matthews & Russell, 1998).
Redistribution under particular circumstances could account for the differences in 
p32 activity found between in vitro and in vivo studies. In vitro results provide 
evidence that p32 has the capacity to regulate splicing (Peterson-Mahrt et al.,
1999), but an in vivo example of splicing regulation is proving more difficult to 
find, indeed in vivo experiments in yeast show p32 to be important in maintaining 
oxidative phosphorylation (Muta et al., 1997).
Disruption of splicing via p32 following HSV-1 infection would be consistent 
with the HIV-1 Rev:p32 interaction, in which exogenously added p32 relieves the 
inhibition of splicing in vitro exerted by the basic domain of Rev. Rev bound to 
RRE and interacting with p32 associated with ASF/SF2 at the splice site, would 
stabilise the interaction of U1 snRNP with the 5’ splice site so inhibiting assembly 
of functional spliceosomes (Fig. IB 14.1, Tange et al., 1996). IE63 could act 
similarly in bound to HSV-1 pre-mRNA, by binding p32 altering its 
phosphorylation and that of ASF/SF2, so stabilising the pre-spliceosome complex.
Another HSV protein identified as interacting with p32 is the product o f ORF P 
(Bruni & Roizman, 1996). ORF P protein co-localises with the splicing factor
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SC35 (Bruni & Roizman, 1996) consistent with p32 acting as a splicing factor, 
however the concurrent presence of p32 was not examined. Expression of ORF P 
is required for the decreased accumulation of ICPO and ICP22, two of the four 
HSV genes to yield spliced mRNAs (Randall & Roizman, 1997). Although not 
directly related to IE63 function this adds weight to the role o f p32 as a splicing 
regulatory factor in HSV-1 infected cells.
6B2.2 Shuttling effects and RNA export
It has been suggested that IE63 utilises the same pathway for export as HIV-1 Rev 
(Mears & Rice, 1998, Sandri-Goldin, 1998). ASF/SF2 is one o f a subset of SR 
proteins which shuttle from the nucleus to the cytoplasm; phosphorylation of 
these proteins is important for shuttling (Caceres et al., 1998) and the Rev- 
ASF/SF2-p32 interaction has been implicated in HIV-1 mRNA transport 
(Gilmartin et al., 1992; Yu et al., 1995a; Tange et al., 1996). Similarly, IE63 
could interact with ASF/SF2 and p32 to promote export of viral mRNAs into the 
cytoplasm, either by interacting with the spliceosome, stabilising and allowing 
unspliced mRNAs to be exported, or by the complex directly interacting with the 
export machinery.
6B2.3 mRNA movement to the NPC
A cellular partner o f p32, the lamin B receptor (LBR) (Nikolakaki et al., 1996), is 
part of a subassembly of nuclear envelope proteins. During HSV-1 infection the 
snRNPs and the non-snRNP protein SC35 redistribute within the nucleus 
(Fig.lB9.1) (Martin et al., 1987; Sandri-Goldin et al., 1995) and migrate to the 
nuclear periphery (Phelan et al., 1993; Sandri-Goldin et al., 1995). IE63 is 
necessary and sufficient for this effect and co-localises with the redistributed 
snRNPs at later times post infection (Phelan et al., 1993; Sandri-Goldin et al.,
1995). Copies of the motif (RS) through which most splicing factors interact (Wu 
& Maniatis, 1993) are present in the LBR, and the interaction of p32 with the 
LBR complex has lead to the suggestion that LBR acts as a transient docking site 
for nuclear speckles in the nuclear envelope before mRNA export takes place 
(Nikolakaki et al., 1996). The p32/IE63 interaction may go some way to explain
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the movement of the redistributed snRNPs to the nuclear periphery during the 
course o f infection. Whether movement of speckles, docking at nuclear membrane 
and transport through the pore are linked has not been investigated. Maybe p32 
plays a role in linking splicing regulation to export o f viral mRNA.
6B2.4 Transcription effects
p32 has been identified as a transcriptional activator (Yu et al., 1995b) and 
implicated in transcriptional regulation o f viral gene expression both in HIV-1 
(Yu et al., 1995a) and in EBV infection (Wang et al., 1997). The potential role for 
p32 with IE63 in HSV-1 and host gene transcriptional regulation should not be 
ignored.
6B2.5 Relevance of interaction of p32 with IE63 and CK2
In uninfected cells, p32 inhibits splicing in two ways, by inhibiting ASF/SF2 
binding to RNA and hence its function in the initiation o f pre-spliceosome 
formation and by blocking ASF/SF2 phosphorylation (Peterson-Mahrt et al., 
1999). Not only does p32 affect ASF/SF2 phosphorylation but it can itself be 
phosphorylated: p32 protein contains five consensus sites for CK2 
phosphorylation which makes phosphorylation o f p32 by CK2 a possibility 
(Section 6B1.2).
Cascades of phosphorylation and dephosphorylation have been suggested to direct 
the sequential binding and release of pre-mRNA binding proteins during the 
splicing reaction, and many proteins involved in splicing are known to be 
phosphorylated (Section 1B7, Cao et al., 1997; Xiao & Manley, 1997; Kanopka et 
al., 1998). The reorganisation of SR proteins from interchromatin granules to 
active splice sites has been proposed to be regulated by cycles of phosphorylation 
and dephosphorylation (Misteli & Spector, 1997).
Petersen-Mahrt et al., 1999, report that p32 not only interacts with ASF/SF2 but 
also with other SR proteins and in one case this disrupts SR protein function. IE63 
alters the phosphorylation of a splicing factor found in the pre-spliceosome
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complex (Fig. 1B2.3), the 70 kDa component of U1 snRNP, which was more 
highly phosphorylated during wt infection than during 27 Lac-Z infection (Sandri- 
Goldin & Hibbard, 1996). Although opposite to ASF/SF2 where inhibition of 
phosphorylation disrupts function, this points to changes in phosphorylation of 
splicing factors brought about by IE63/p32 as important to the shut off o f host 
pre-mRNA processing. It was not possible to detect a direct interaction between 
IE63 and U1 70 kDa (data not shown), however the interaction of p32 and IE63 
could bring CK2 into contact with U1 70 kDa to alter its phosphorylation and 
thereby inhibit splicing.
Inhibition of splicing activity may be sufficient to cause redistribution of splicing 
factors as seen in HSV-1 infection, an effect shown to be due to IE63 (Phelan et 
al., 1993). Here there may also be role for IE63/p32 induced changes in 
phosphorylation (direct or via a cascade).
The identity o f the other band at 33 kDa -35 kDa (Fig.3A2) and whether the 
phosphorylated band in Fig. 4D1 is p32 or another protein needs to be resolved, 
but this does not alter the idea that IE63 associates simultaneously with splicing 
factors and a kinase creating a potential for activity of the splicing factors to be 
altered via phosphorylation.
6C1 The interaction of IE63 with SAP145 (also involving hnRNP K and CK2)
6C1.1 IE63 interacts with SAP145, hnRNP K and CK2, but this excludes 
interaction with p32
The interaction between IE63 and SAP 145 was determined by both co- 
immunoprecipitation (Fig. 5B1.2) and GST pull down assays (Fig. 5B1.1), adding 
weight to its significance. However as Western blotting of the anti IE63 co- 
immunoprecipitate for SAP 145 proved to be negative, the prominent band at the 
top of the original [35S] profile (Fig. 3A2) is unlikely to be SAP145; the negative 
blot could reflect weak interaction between the two proteins or the low sensitivity 
of the SAP 145 antibody.
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hnRNP K and CK2 were also found in the complex (Figs. 5B2 and 5B3), but were 
not associated with SAP 145 in the absence o f IE63. Interestingly, the interactions 
o f SAP 145 with IE63, and of p32 with IE63 appear to be mutually exclusive (Fig. 
5B4). This may explain the negative SAP 145 Western blot o f the anti-IE63 co- 
immunoprecipitate as if only a small sub population of IE63 was interacting with 
SAP145, or the conditions chosen for immunoprecipitation favoured the p32 
interaction, combined with a weak antibody, SAP 145 may not be detected.
SAP 145 and p32 don’t normally interact in uninfected cells so interaction with 
IE63 does not disrupt their normal function.
6C1.2 SAP145 and IE63 co-localise in infected cells and SAP145 is not 
phosphorylated by CK2
Further to their interaction, SAP145 and IE63 co-localise (Fig. 5B5). SAP145 and 
SC35 also co-localise, consistent with co-localisation o f SC35 and IE63. Fig. 4D1 
does not show a phosphorylated band of this molecular weight, so it is unlikely 
that SAP 145 is phosphorylated in infected cells. Phosphorylation in uninfected 
cells has not been examined.
6C2 Relevance of the interaction of IE63 with SAP145 
6C2.1 Splicing effects
The defined role for SAP145 in splicing (Section 1C3, Champion-Amaud &
Reed, 1996) aids speculation about the function o f its interaction with IE63.
SAP 145 is involved in U2 snRNP binding to the BPS and commitment to 
splicing; presumably IE63 interaction with SAP 145 regulates this activity to block 
cellular pre-mRNA splicing. IE63 may block splicing by preventing the binding 
of SAP 145 to the spliceosome complex, or by binding to SAP 145 in the 
assembled splicing complex. Interaction with other splicing factors has been 
reported (Sandri-Goldin, 1998), although this work lacked controls and the 
immunoprecipitated profile contained a large number o f non-specifically 
interacting proteins. Which interactions are direct with IE63 and which are as a 
result o f splicing factors interacting with each other has not been determined.
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The co-localisation of IE63 with splicing factors e.g. SC35 has been known for 
some time, as SAP 145 is found associated with many splicing factors this 
interaction between IE63 and SAP 145 which follows the pattern of other reported 
co-localisations (Phelan et al., 1993) may well explain the previous findings.
Interaction of SAP 145 with IE63 may primarily cause redistribution of splicing 
factors or may inhibit splicing and as a consequence splicing factors are 
redistributed.
6C3 Relevance of the lack of interaction of IE63 with SAP145 and p32 
6C3.1 Splicing effects or splicing and RNA export effects
Fig. 1C3 shows the relative positions of SAP145 and ASF/SF2 at the 3’ splice 
site; during splicing it has been proposed that p32 can modulate ASF/SF2 activity 
(Peterson-Mahrt et al., 1999), this places p32 and SAP 145 in close proximity and 
both interact with IE63 although these interactions appear to be mutually 
exclusive. Perhaps they occur at different times post-infection, redistribution of 
p32 occurs from early in infection whereas the co-localisation of IE63 and 
SAP 145 is more apparent later. Or maybe the interactions involve separate sub­
populations of IE63 and either both sub-populations block splicing at separate 
points or one blocks splicing while the other has a different role, for instance 
affecting export o f RNA. IE63 mediated redistribution o f splicing factors and 
inhibition of splicing can be separated from each other (Sandri-Goldin et al., 
1995) perhaps these two activities reflect SAP 145 and p32 acting separately.
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6D1 Interaction of IE63 with Viral Thymidine kinasefvTK)
6D1.1 IE63 and vTK were both present in a complex of proteins
The presence o f vTK in the complex of interacting proteins was determined (Fig 
5C2.2), however no attempt was made to determine if vTK was interacting 
directly with IE63 or indirectly via the other proteins which interact with IE63. 
This investigation was hindered by an inability to express vTK from virus in the 
absence of IE63. As IE63 is essential for vTK expression a viral mutant with this 
phenotype is not possible.
6D1.2 Relevance of association with vTK
Irrespective o f whether the interaction is direct or indirect, vTK was detected in a 
complex with IE63 and this interaction may affect the functions of IE63. The 
enzyme vTK is involved in DNA metabolism in infected cells and in reactivation 
from latency (Section 1C5). IE63 affects the localisation of the single stranded 
binding protein U l29, a component o f the viral DNA replication complex and 
promotes replication complex formation (Section IB 13, Curtin & Knipe, 1993), 
whether this is linked to an association with vTK is not known. Maybe IE63 
serves as a site o f nucleation for components of the DNA replication complex so 
promoting replication foci formation and providing a possible route for regulation 
of DNA replication linked to RNA processing and/or visa versa.
6D2 The Interaction of IE63 with IE175
6D2.1 IE63 and IE175 do not co-immunoprecipitate
Pangiotidis et al. (1997), reported that IE63 and IE 175 interact, however under the 
immunoprecipitation conditions used here IE63 and IE 175 did not interact (Fig. 
5C1.1). Neither, in my hands, did they interact under the conditions he used for 
co-immunoprecipitations with IE63 or IE175 Mabs (Fig. 5C1.2).
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Small differences between the experiments which showed an interaction and those 
presented here were:
(i) The strain o f virus used, wt HS V -1 strain KOS1.13G vs. Glasgow strain 
17+.
(ii) In the buffers used to make nuclear extract, the individual protease 
inhibitors were replaced by a protease inhibitor cocktail from Boehringer 
Mannheim
(iii) Gamma-Bind Plus Sepharose (Pharmacia) was replaced with protein A 
Sepharose (Sigma)
(iv) Co-immunoprecipitation used the same Mabs either HI 113 for IE63 or 
58S for IE175 but Western blotting for IE175 was performed with just 58S and 
H640 instead of a mixture of 58S, H640, and 10176 Mabs.
Strain differences between 17+ and KOS have been noted, for example gC from 
KOS exhibits much less C3b binding than gC from most HSV-1 strains (Friedman 
et al., 1986), but at the level of IE gene expression or function there are no known 
differences. However the relative expression levels of IE63 and IE 175 may differ, 
perhaps contributing to a difference in sensitivity o f the assay, especially if the 
IE63-IE175 interaction is weak.
As all extracts were stored at -70°C and kept on ice while work was carried out 
the difference in protease inhibitors is unlikely to be significant.
Addition of an extra Mab (10176) for Western blotting was included as attempts 
with 58S and H640 give a weak response even with total infected cell extract. The 
new mix detected the same forms of IE 175 (and did so with a greater sensitivity 
than 58S + H640 did), so this is unlikely to account for the difference in result.
The role of the Gamma-Bind Plus Sepharose or Protein A Sepharose was to bind 
to the antibody, which then binds its antigen (Fig. 2B2), to which the co- 
precipitating protein(s) attaches. As both forms of Sepharose successfully pull out 
the antigen, either IE63 or IE 175 depending on the antibody used, it is unlikely 
that either reagent would have an effect on the co-precipitating proteins.
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Panagiotis et al. (1997), included a control with no antibody, in which neither 
IE63 or IE 175 were precipitated so an interaction between Gamma-Bind Plus 
Sepharose and IE 175 or IE63 can be ruled out. However, a control using an 
ascites fluid to detect whether IE63/IE175 reacts with unrelated mouse antibodies 
was not included. Here a co-immunoprecipitation with ascites fluid was included 
and after severe over exposure of the IE63 Western blot (Fig.5C1.3) a weak non- 
specific interaction between IE63 and the ascites fluid was seen.
The difference therefore may be that a stronger (maybe due to differences in strain 
affecting the abundance of each protein and/or the strength of their interaction ?) 
non-specific interaction, between the mouse ascites fluid and IE63 was detected, 
and that by excluding the ascites control this was seen as a specific result.
Interestingly, here only the slowest migrating form of IE 175 (Fig. 5C1.3) was 
precipitated by the IE 175 Mab 58S, while Panagiotis et al. (1997), with the same 
antibody detected at least 3 major forms; these faster migrating forms may interact 
with IE63. Why only the most slowly migrating form was pulled out could reflect 
a difference in the abundance o f IE 175 isoforms between different HSV-1 strains, 
although there is little evidence for this.
This result shows that with many protein interactions a condition can be found 
under which the two proteins will interact, however only if this interaction is 
significantly stronger than the proper controls can it be regarded as “real”.
6D2.2 IE63 and IE175 do not interact in a GST pull down assay
IE63 and IE 175 did not interact in a GST-IE63 pull down assay, although they did 
in the Panagiotis study. The difference between the GST-IE63 pull down Western 
blotted for IE 175 reported here (Fig 5C2) and the other study, was that here whole 
cell extract was used in place of in vitro transcribed/translated IE 175. Adding 
artificially high levels of in vitro synthesised IE 175 may cause it to be over 
represented and a positive interaction with GST-IE63, as compared to a negative 
result when whole extract was used, is likely to be non-specific.
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Further support for IE63 and IE 175 not interacting comes from the absence of any 
published evidence confirming the interaction.
These data do not detract from the fact that IE63 and IE 175 are functionally 
associated and together may play a role in transcription (Su & Knipe, 1989). The 
interaction of IE63 with CK2 may account for the change in IE 175 migration on 
SDS-PAGE in the presence of IE63; changes in phosphorylation may alter the 
transcriptional activity of IE 175 (see Section 1A5.2 and IB 10).
6D2.3 IE175 and IE110 do co-immunoprecipitate
Both IE110 and IE 175 alone can activate/repress transcription but they have also 
been reported to act together to regulate gene expression at a transcriptional level 
(Everett, 1984, O'Hare & Hayward, 1985). When transfected and analysed by 
immunofluoresence, IE110 localises in punctate structures which correlate with 
pre-existing cellular structures (ND10 domains), co-transfection o f IE110 with 
IE 175 causes a portion o f IE 175 to co-localise with IE110 in these structures 
(Mullen et al., 1995).
The IE175:IE110 interaction (Fig. 5C1.3) was included primarily as a positive 
control. However a literature search revealed only one other such report (Yao & 
Schaffer, 1994), in which far-Westem blotting and GST-IE110 affinity 
chromatography were used. So the result presented represents the first 
documented evidence that IE110 and IE 175 can be co-immunoprecipitated from 
HSV-1 infected cells.
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6E IE63 as a multifunctional protein.
It is apparent that certain proteins are involved in both transcription and at least 
one stage of post transcriptional processing e.g. WT1, Y-box proteins, and hnRNP 
K (Section 1B6.3 and 1C1). These proteins are likely to function in different ways 
at different sites of processing and in the co-ordination o f gene expression. They 
perform multiple roles by having distinct functional domains, and by interacting 
with multiple protein partners. From the protein:protein interactions demonstrated 
here, the distinct domain structure o f IE63 and from its multiple activities it is 
clear that IE63 is another multifunctional protein.
Multiple interactions by IE63 may be facilitated by its ability to oligomerise (Fig. 
3C), enabling the formation of large complexes o f proteins. Moreover, the 
particular patterns of protein:protein interaction may be dynamic, changing at 
different intracellular locations or time points post-infection to facilitate the 
different functions of IE63. As seen here, the protein interactions may be 
exclusive o f each other and involve different sub-populations of IE63. How 
protein :protein interactions are selectively regulated in response to location or 
progression of infection is unclear. Maybe the phosphorylation o f IE63 or its 
partners, and/or the ability of IE63 to bind viral RNA, play a part, as with hnRNP 
K (Denisenko et al., 1996; Schullery et al., 1999) influencing the selection of 
partner proteins and conferring responsiveness to the stage o f viral gene 
expression reached. Or IE63 could travel with the viral mRNA as it is directed 
from one cell location to another, affecting for instance the splicing or export 
machinery by modifying the appropriate factor. Direction from one event to the 
other may also be driven by IE63, if  for instance it binds to a component o f the 
nuclear matrix, or if  one of its partners, most likely hnRNP K, determines 
movement.
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6F Future work
These interactions suggest several ways by which IE63 could disrupt and direct
RNA processing to increase viral gene expression. Future experiments will
include
• Identifying which interaction is responsible for which IE63 activity by 
analysing the phenotype of IE63 viral mutants which do not interact with one 
or more of the proteins identified here.
• Inhibition of IE63 CK2 phosphorylation and/or CK2 phosphorylation of 
interacting proteins with chemical inhibitors or with proteins mutant in CK2 
phosphorylation sites, followed by analysis o f the effect on the interaction and 
on the process o f infection.
• Determination o f the hnRNP K isoform interacting with IE63, and what this 
form does in uninfected cells and infected cells. A way forward here is the 
comparison of the migration of a mixture of known hnRNP K variants with the 
migration of the co-immunoprecipitated form.
• Co-localisation studies of hnRNP K and IE63
• Use of IE63 in transcription assays determine effects on hnRNP K ’s 
transcriptional ability (or of p32’s), analogous to the derepression of 
transcriptional activity exerted by the Hep C core protein.
• Investigation of the step at which splicing is halted, would help reveal the role 
of SAP 145 in splicing inhibition, and can be determined by analysis of 
splicing complexes found in vitro.
• Determination o f whether IE63 effects p32 interaction with its normal cellular 
partner protein ASF/SF2, through Western blotting and immunoprecipitation
• Mutation o f other potential shuttling sequences in IE63, and use of mutants 
which don’t interact with hnRNP K, analysed in the heterokaryon assay, will 
help elucidate other shuttling pathways IE63 may use to export viral mRNA.
• CK2 is known to phosphorylate many HSV-1 proteins it may be of interest to 
determine, as Rev does in HIV-1 infected cells, if  interaction with IE63 
increases CK2 activity.
• Identification o f the other bands seen in the original IE63 co- 
immunoprecipitation and GST-IE63 pull down, and o f the bands seen
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interacting with p32 in uninfected cells which no longer do so during infection. 
May be done using Laser Mass Map Spectroscopy.
• Use of yeast-2-hybrid assay, and transient transfection o f vTK to see if  this 
protein interacts directly with IE63 or indirectly via a cellular factor.
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Investigation into and Discussion of Methods Used
A l.l Co-immunoprecipitations
Details of theory of co-immunoprecipitations and the experimental conditions 
which can be varied are found in Materials and Methods.
Al.1.1 The use of various anti-IE63 antibodies available.
Unfortunately the other antibodies available namely a rabbit peptide anti-serum 
against the first 16 aa of IE63 and a rabbit polyclonal antiserum raised against a 
bacterially expressed recombinant IE63 molecule, although able to detect IE63 in 
Western blots did not act to immunoprecipitate IE63 from cell extracts at any of 
the concentrations tried (Fig. Al.1.1).
The heavy chain of the immunoprecipitating antibody and IE63 migrated around 
the same point on the SDS-PAGE gel, however, visualisation o f the heavy chain 
(due to cross reactivity o f immunoprecipitating antibody with secondary antibody 
or protein A used in Western blotting) provided a convenient control to show that 
similar amounts of antibody were added to each reaction.
Al.1.2 The interaction of proteins from different cell types with IE63.
In the first Results Section, a profile of BHK infected cell proteins which interact 
with IE63 was established (Fig. 3A1). To investigate if  these interactions were 
similar in different cell types the experiment was repeated using radiolabelled cell 
extracts of HSV-1 infected HeLa or Vero cell lines. These were run on SDS- 
PAGE gels and compared to the profile produced from BHK cell extracts. The 
pattern of immunoprecipitating bands was broadly the same in all cell types (Fig. 
Al.1.2, corresponding bands are labelled), however the intensity o f the bands did 
vary from experiment to experiment and in this particular case the exposure of the 
Hela cell immunoprecipitation had to be greatly enhanced in order to detect any
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Fig Al.1.1 Only monoclonal antibody HI 113 immunoprecipitates IE63
Western blot for IE63, using HI 113 Mab. Co-immunoprecipitations from 
wildtype (WT) and mock infected (MI) BHK extracts using rabbit anti-peptide 
IE63 serum (peptide - lanes 1-4), IE63 Mab (HI 113 - lanes 5 & 6), and the rabbit 
polyclonal antiserum raised against bacterially expressed IE63 (recombinant - 
lanes 7-10), were run on a 10% SDS-PAGE gel, transferred to nitrocellulose and 
Western blotted for IE63. As indicated 5pl or 20pl o f each anti-sera was used to 
immunoprecipitate.
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Fig Al.1.2 The pattern  of IE63 interacting proteins does not change in 
different cell lines
Panel I. [ l5S]-methionine labelled proteins co-immunoprecipitated from various 
cell line extracts. [ l5S]-methionine labelled proteins were co-immunoprecipitated, 
with IE63 Mab HI 113, from wildtype (WT) and mock infected (MI) BHK (B- 
lanes 1 and 2), Vero (V-lanes 3 and 4) and HeLa (H-lanes 5and 6) cell extracts. 
Protein complexes formed were separated on a 10% SDS PAGE gel, dried down 
and exposed to a phosphoimaging plate overnight.
Panel II. Western blot for IE63 using HI 113 Mab. Aliquots o f the above samples 
were run on another 10% SDS-PAGE gel, transferred to nitrocellulose and 
Western blotted for IE63 (lanes 4-9). Whole cell extracts are included (lanes 1-3).
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interacting bands. In the Vero, extract the bands above IE63 were more blurred 
than with BHK or HeLa extracts, this is likely to be a reflection of the relative 
amounts of proteins. The Western blot in Panel II confirms that in this case the 
infected Hela cells produced less IE63 than Vero or BHK cells, HeLa cells are 
thought to be less permissive as far as virus yield is concerned (~10 fold) but are 
routinely used by many labs to study virus proteins. Repetition of the co- 
immunoprecipitations gave profiles with somewhat different relative intensities, 
but always the same pattern of bands, further the immunoprecipitated bands 
within a particular profile showed the same relative intensity compared to each 
other.
Panel II also shows a band migrating slightly slower than IE63 in BHK and Vero 
cells (lanes 1 and 2), this looks specific and may be more phosphorylated forms of 
IE63. These forms were observed on occasion. They are consistent with the 
previous observation that two forms of IE63 can be separated by SDS-PAGE, but 
that more often one is seen (Ackerman et al., 1984, Pereira et al., 1977).
BHK cells were chosen for the rest of the study, they are routinely used in 
Glasgow to examine HSV-1 protein interactions and as they were routinely 
passaged in our lab, were easy to obtain. The exception was in 
immunofluorescence where the morphology of HeLa cells makes them more 
suitable for study.
Al.1.3 The stringency of interaction between IE63 and its co- 
immunoprecipitating proteins
The initial profile of protein bands which interact with IE63, was determined by 
immunoprecipitation with a buffer containing lOOmM NaCl, a salt concentration 
close to the physiological salt concentration of ~90mM. The strength of each of 
these interactions was of interest and so co-immunoprecipitations were repeated 
substituting the lOOmM buffer with washes of increasing salt concentration, the
o  c
resultant [ S] profile of bands was then inspected (Fig. A l . 1.3 panel I bands 
labelled a to h). Bands representing specific interactions were most apparent at 
lOOmM but at higher salt concentrations certain bands remained obvious. The 32 
kDa doublet (a) showed the strongest interaction with IE63, it was still clearly
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Fig. Al.1.3 Stringency of interactions between IE63 and unknown protein 
bands
Panel I. [ S]-methionine labelled proteins co-immunoprecipitated from extracts 
and washed with increasing concentrations o f NaCI. The co-immunoprecipitated 
proteins were separated on a 10% SDS-PAGE gel, dried down and exposed to a 
phosphoimaging plate overnight. Co-immunoprecipitation experiments were 
performed on wildtype (WT) and mock infected (MI) extracts using HI 113 Mab 
with final wash conditions changed from lOOmM (lanes 7 and 8) to 50mM (lanes 
9 and 10), 150mM (lanes 5 and 6), 300mM (lanes 3 and 4) or 500mM (lanes 1 and 
2) NaCI. Whole cell extracts used are shown in lanes 11 and 12.
Panel II. Western blot for IE63 using HI 113 Mab. Aliquots o f the above samples 
were run on another 10% SDS-PAGE gel, transferred to nitrocellulose and 
Western blotted for IE63 using HI 113 Mab.
Appendix 1
visible after a 500mM salt wash, the first band above IE63 ~70kDa (b) is also just 
discernible. The band above this one (c, also ~70kDa) remained associated up to 
300mM. The bands of 85kDa (d) and 44kDa (e) were only visible at or below 
150mM NaCI and the high molecular weight bands (f and g, 180kDa and 150kDa 
respectively) and the 25kDa band (h) disappear even at 150mM salt. In this gel, 
the 50kDa band cannot be distinguished.
The Western blot in Panel II shows the amounts of IE63 precipitated, as the salt 
concentration increases less IE63 is precipitated so care must be taken in the 
interpretation of these results. Loading more of the co-immunoprecipitates 
washed at high salt concentration to equalise the amount of IE63 present, would 
have solved this discrepancy. Nevertheless there is a clear difference in the 
affinity of interaction between IE63 and each of the other interacting proteins.
A1.2 GST-IE63 fusion protein expression
Details of theory of GST fusion protein assays and experimental conditions which 
can be varied are found in Materials and Methods.
Al.2.1 Initial GST-63 fusion protein expression.
Expression of GST-IE63 initially obtained can be seen in Fig.3Bl lanes 1 and 3. 
This was improved to the levels seen in lanes 5 and 7.
The effects of temperature, IPTG concentration, method of lysis, time of 
induction, as well as the ratio of beads to lysate were investigated, to ensure that 
the maximum amount of full length GST-63 was expressed, that all expressed 
protein was binding to beads and that the beads were saturated. Use of another 
protease deficient E.coli strain (XA90) and different culture medium (2YT broth) 
were also investigated, neither increased yield and the results o f these are not 
shown.
Lack of fusion protein binding to the beads might be because the protein was not 
expressed, because it was insoluble, because it was degraded or because it did not 
bind to the Glutathione beads. Thus samples were taken at different stages and run
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along side the Glutathione bound proteins (Fig. Al.2.1). A very small amount of 
full length GST-IE63 (lanes 3 and 5 indicated by *) was detected in a sample of 
induced bacterial culture and in the soluble fraction of bacterial cell extract, but 
most o f the induced protein appeared to be degraded and of the small amount 
expressed none bound to the Glutathione beads (lane 6).
Al.2.2 The effect of temperature
Fig. A l.2.2 shows that at 37°C some full length GST-63 is expressed and can be 
seen in the soluble fraction of the lysate (marked with a *, compare lanes 1 and 3). 
However none of this full length fusion binds to the Glutathione beads (lane 4). 
Repeating the experiment at 31°C or 26 °C decreased the yield. Thus protein 
expression continued to be at 37°C.
Al.2.3 Effect of IPTG concentration
Increasing the IPTG concentration from 0.1 mM to 0.2mM slightly increased the 
production of fusion protein but not to the point where, even by Western blotting 
and probing for IE63 (Fig. Al.2.3) full length GST-IE63 could be detected 
binding to Glutathione beads. Increasing the IPTG concentration above 0.2mM 
does not increase expression and may even have a deleterious effect. Thus 0.2mM 
IPTG was then used.
Al.2.4 The effects of lysozyme or sonication for splitting open bacterial cells
Instead of using lysozyme as in (Mears & Rice (1996), after harvesting, bacteria 
were resuspended in PBS and sonicated, described more fully in Section 2B4.1. 
However no difference between the proteins present in the soluble fractions or 
insoluble fractions of the two differently produced lysates was observed (Fig. 
A l.2.4 compare lanes 4 and 12 and lanes 6 and 14). In contrast to this binding to 
the beads was more efficient after sonication, now a full length GST-IE63 fusion 
protein was detected and seen by Coomassie staining (lane 8 marked *).
Perhaps GST-IE63 is in different conformation after sonication allowing it to 
bind. Or the increased processing time (~2h) involved in lysozyme treatment
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Fig. Al.2.1 A little full length GST-IE63 is expressed but does not bind 
G lutathione beads
Coomassie stained 10% SDS-PAGE gel o f samples o f bacterial culture taken 
before induction (lane 2), after induction with IPTG (lane 3), and o f insoluble 
fraction (lane 4) and soluble fraction (lane 5) o f the bacterial lysate produced. 
Proteins from the soluble fraction which bound to Glutathione beads are shown in 
lane 6, full length GST-IE63 indicated by *. After growing a bacterial culture, 
transformed with pGEX-27, to an OD600 o f 0.4, a sample was taken before the 
culture was induced with IPTG. After induction a sample was taken and then the 
bacteria were harvested, resuspended in a small volume and lysed with lysozyme. 
Soluble and insoluble proteins were separated from this lysate by centrifugation 
and after samples were removed the soluble fraction was incubated with 
Glutathione beads. Again a sample was taken and all fractions were separated by 
SDS-PAGE electrophoresis.
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Fig. Al.2.2 M aximum expression of GST-IE63 occurs at 37°C
Coomassie stained 10% SDS-PAGE gel o f the soluble protein fraction o f  bacterial 
cell lysate (s) and Glutathione bound proteins pulled out o f this lysate (b).
Cultures containing GST alone expressing plasmid were induced with IPTG at 
37°C (lanes 1 and 2), Cultures containing GST-IE63 expressing plasmids were 
induced with IPTG at 37°C (lanes 3 and 4), 31°C (lanes 5 and 6) and 26°C (lanes 
7 and 8). Full length GST-IE63 is marked *.
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Fig. Al.2.3 Optim um  IPTG concentration for GST-IE63 expression is 0.2mM
Western blot for IE63, using HI 113 Mab showing GST-IE63 binding to 
Glutathione beads after incubation with soluble protein lysates produced from 
cultures induced with 0.1 mM (lane 1), 0.2mM (lane 2), 0.4mM (lane 3), 0.6mM 
(lane 4) and 0.8mM IPTG, lane 6 shows GST protein, which had been induced 
with 0.1 mM IPTG, bound to Glutathione beads. Proteins bound to Glutathione 
beads after incubation with soluble protein lysate and washing, were separated on 
10% SDS-PAGE gel, transferred to nitrocellulose and Western blotted for IE63.
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Fig. Al.2.4 Splitting open bacteria by sonication ra ther than using lysozyme
produces full length GST-IE63 which binds to Glutathione beads.
Coomassie stained 10% SDS-PAGE gel o f  proteins in samples taken before 
induction o f culture (UN), after induction o f culture with 0.2mM IPTG (IN), o f  
soluble protein lysate (Sol) extracted from cultures, and o f proteins from the 
soluble fraction which bound to Glutathione beads (Binds). Bacteria from induced 
culture were lysed open by sonication (lanes 1-8) (Section 2B4.1) or using 
lysozyme (Mears & Rice, 1996 - lanes 9-16). In each case expression o f GST- 
IE63 (63) is compared with expression o f  GST (G). Full length GST-IE63 is 
indicated by *.
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allows enhanced proteolytic digestion. The large number of proteins on the 
Coomassie stained gel may have obscured a slight increase in full length GST- 
IE63 in the soluble fraction after sonication. Western blotting this gel for IE63 
may resolve this. Sonication was used to split open the bacterial cells in optimised 
method.
Al.2.5 Effect of different induction times on GST-IE63 expression
Increasing the time of expression from 1.5h to 2h significantly increased the 
amount of GST-IE63 binding to Glutathione, however further increasing this to 3h 
had no further effect (marked * Fig. Al.2.5 compare lanes 6, 9 and 12). GST-IE63 
protein induction was therefore carried out for 2h.
Al.2.6 Optimising ratio of beads to lysate
Having optimised expression to a degree, as there was still only a limited amount 
of full length GST-IE63 being produced, it was important to ensure that (i) all the 
GST-IE63 being expressed was being extracted from the lysate and (ii) that the 
Glutathione beads were saturated with GST-IE63.
Fig. A l.2.6 shows the effect of increasing the volume of beads added to 5ml of 
sonicated lysate. An increase from 200pl to 400pl pulled more GST-IE63 out of 
the lysate (lanes 2 and 3) however a further increase to 800pl (lane 4) made no 
difference. When the volume of bacterial lysate was increased to 10ml or 15ml 
(lanes 5 and 6) with 400pl beads no further fusion protein was bound.
The optimal ratio of beads to lysate was therefore 400pl beads to 5ml lysate.
Al.2.7 Final expression
At the end of this optimisation, the conditions determined and used for the 
remainder of the work were as described in Section 2B4.1. Only a small 
proportion (~ 5%) of the bound fusion protein was full length but this was a 
greater amount than before and it was hoped that it was enough to pull down 
interacting proteins. Specific truncated products were observed (Fig. 3B2) these
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F il*. A l.2.5 Induction of GST-IE63 expression with IPTG is maximal after 2h
Coomassie stained 10% SDS-PAGE gel. Samples o f  IPTG induced culture 
containing GST expressing plasmid (IN) (lane 1), soluble protein lysate produced 
from this culture (S) (lane 2) and proteins from the lysate bound to Glutathione 
beads (B) (lane 3), were separated on a 10% SDS-PAGE gel and stained along 
side samples o f IPTG induced expression culture containing GST-IE63 expression 
plasmid, induced (IN) for lh  (lane 13), 1.5h (lane 10), 2h (lane 7), and 3h (lane 4), 
soluble protein fraction (S) o f the lysate o f these cultures (lanes 14, 11,8 and 5 
respectively) and proteins bound to Glutathione beads (B) (lanes 15, 12 ,9, and 6 
respectively). Full length GST-IE63 marked *. Cultures were grown to an OD 600 
0.4, induced with 0.2mM IPTG, harvested, resuspended in 5ml PBS and 
sonicated, cell debris was cleared and soluble protein lysate incubated with 
Glutathione beads.
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Fte. A l.2.6 Saturation of beads with GST-IE63
Coomassie stained 10% SDS-PAGE gel. 5ml soluble protein lysate extracted from 
IPTG induced GST-IE63 expressing cultures was incubated with increasing 
volumes o f Glutathione beads, lOOpl beads (lane 1), 200pl beads (lane 2), 400pl 
beads (lane 3), 800pl beads (lane 4). 10ml (lane 5) and 15ml soluble GST-IE63 
lysate (lane 6) were incubated with 400pl beads and 5ml GST soluble lysate was 
incubated with lOOpl Glutathione beads. Proteins which bound to beads after 3 
washes in PBS were separated by SDS-PAGE electrophoresis.
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correspond to the N-terminal portion of IE63 between aa 1 and ~aa 90-180, and 
are similar to the truncations reported by Mears & Rice (1996).
A1.3 Discussion of experimental techniques used 
Al.3.1 Use of co-immunoprecipitation experiments: advantages and 
disadvantages
Co-immunoprecipitation experiments produce a good profile of proteins which 
interact with IE63 (Fig. 3A2) and suggest that IE63 interacts with multiple protein 
partners. Repeating the experiment in different cell types reveals that these 
interactions are universal (Fig. Al.1.2). Data from co-immunoprecipitations 
washed with increasing concentrations of salt, point to different strengths of 
interaction with different partners of IE63 (Fig. Al.1.3).
Co-immunoprecipitation from whole cell extracts is a good technique to get a 
representation of what is happening in vivo, interactions are detected in the midst 
o f competing components, both antigen and interacting protein are found at same 
relative concentration as is found in the cell, complexes in their natural state are 
precipitated and proteins are post-transcriptionally modified correctly, so 
interactions dependent on this will be detected. However the protein bands were 
not visible even on a silver stained gel so identification by Laser Mass Map 
Spectroscopy or mico-sequencing was not possible. Because of the complicated 
nature of antibody antigen interactions it was not easy to scale up co- 
immunoprecipitations .
A second disadvantage of co-immunoprecipitations is that direct and indirect 
interactions cannot be distinguished, it should be noted that in this thesis, only the 
known interacting proteins and their interaction with each other and IE63 are 
examined, in this respect, for these proteins to be associated IE63 is required. For 
all the interactions, use of an IE63 expressing plasmid shows that no other viral 
protein is required, however an as yet unidentified cellular protein may be 
intermediary between IE63 and one or more of the interacting proteins reported 
here.
vi
Appendix 1
Al.3.2 Use of fusion protein pull down assays: advantages and disadvantages.
GST fusion proteins will be discussed but the same is true for MBP and Sepharose 
systems used.
It appears to be difficult to express a large amount of GST-IE63 particularly when 
compared to the amount of GST produced under the same conditions.
GST-IE63 is -90  kDa well above the optimum size for bacterial protein 
expression of -6 0  kDa, so premature termination o f transcription or translation 
may be occurring, however plenty of other large fusion proteins are produced and 
this is unlikely to be the primary reason for truncated GST-IE63 products.
The addition of a carrier e.g. GST to a foreign protein expressed in E. coli is 
reported to stabilise expression of the fusion protein (Lee et al., 1984), sometimes, 
however the expressed protein is degraded but the carrier is not. Moreover fusion 
proteins are sometimes cleaved in vivo at the fusion joint between the carrier and 
the expressed foreign protein. The appearance o f GST-IE63 truncated fusions of 
consistent sizes suggesed there are sites within IE63 which are particularly prone 
to proteolytic degradation, this may be due to aberrant folding when attached to 
GST. Use of sonication increased the amount of full length GST-IE63 binding to 
beads, whether this was because sonication releases GST-IE63 in a different 
conformation to lysozyme treatment so leaving different sites exposed or allowing 
more binding to beads, or whether the increased time it takes for lysozyme 
treatment means that more degradationed could occur is not known.
IE63 is an essential viral protein with multiple functions during infection, it could 
well be toxic to bacterial cells. It was observed that as they begin to express IE63 
they also start to die, and expression will never be as high as for a non-toxic 
protein. In comparing the density of a culture expressing GST and GST-IE63 the 
toxic affect of IE63 could be seen; at the same time after induction the GST 
culture was thicker than the GST-IE63 culture when prior to induction they were 
growing similarly.
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Despite this problem a number of proteins can be seen to interact with GST-IE63 
(Fig. 3B1), and these were of a similar size to those identified by co- 
immunoprecipitation. Because of the predominance of truncated products, 
proteins interacting with the N-terminal of IE63 may be have been over 
represented, however the presence of some full length IE63 in this non- 
quantitative assay should be enough to pull out some of all the interacting 
proteins.
GST fusion protein expression is a powerful tool for looking at protein:protein 
interactions, unlike co-immunoprecipitation, it can be scaled up to isolate proteins 
of unknown identity and the fusion protein can be mutated relatively easily in the 
pGEX vector but results must be carefully considered as this system is very much 
in vitro; the amounts of the fusion protein added are not physiological and the 
form in which the recombinant protein is found may differ from how it is in vivo. 
Folding may be altered by the presence o f GST, masking or revealing potential 
sites of interaction, processing will be different in proteins expressed in E.coli to 
those expressed in mammalian cells, for example phosphorylation will be 
different. Any of these things many lead to false conclusions about the presence or 
absence of an interaction.
Although not used in this study purification of the fusion protein in vitro has an 
advantage, by mixing two purified proteins (as different types o f fusion protein 
e.g. GST and MBP, or as a fusion protein and in vitro transcribed translated 
product) direct and indirect interactions can be distinguished.
Al.3.3 Other methods used to detect/study protein:protein interactions
Because every system has advantages and disadvantages, evidence of any 
protein:protein interaction must be found using more than one, examples o f other 
procedures used to identify the protein interactions reported here, are the yeast-2- 
hybrid system and immunofluorescence. The yeast-2-hybrid data was completed 
by another worker, it is a sensitive way to screen for potential interacting proteins, 
giving an investigator some possibilities to confirm or discredit in the other types 
of assays. In addition it provides the cDNA clone of any proteins identified, and 
can be used to test the interaction between 2 known proteins for which the cDNA
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clones are available. The yeast -2-hybrid system is limited by the stability of the 
proteins in yeast cells, the need for post-translational modifications which do not 
occur in yeast, the site of interaction not being occluded by the fusion protein or 
the protein itself being capable of transactivation.
Immunofluoresence is not a way to detect protein:protein interactions however it 
is a good way to see if reported interactions have a physiological significance, co- 
localisaton provides evidence that the two proteins are associated in cells, it also 
allows intracellular location of proteins and in the case of viral infection the 
position of two proteins with time post-infection can be visualised.
Appendix 2
APPENDIX 2 : AMINO ACID CONSERVATION OF 
IE63 (ICP27)
Proceeding from the N to C termini, the aiphaherpesviruses consist of:
An acidic region, a basic region, a linker, and a C terminal conserved domain.
Acidic and basic residues are in colour for all but the conserved domains. The charged regions are, 
as expected, highly hydrophilic.
Aiphaherpesviruses
H S V -1  M ATDIDM LI; LGL L S D S D L D E D P P E . PA SRRDC L E S D S S G  C S S S  iEDM EDPH GEDGPEPILDAARPAVRPSRP 5 DPG 
H S V -2  M A TD ID M LID LG LD LSD SELEED A LER D EEG R R D D PESD SSG EC SSSD ED M ED PC G D G G A EA I. D AAIPKG PPARPEDAG  
E H V -1  M ALSSVSSCEPM EDEM SIM GSDTEDNFTGGDTCA
E H V -4  M A LSSV SSCEPM DD EM SIM G SD TD DTL. GGSCVE
B H V -1  M A D PE IA T L ST A SE SD D L SL F G SD R E
PRV
VZV M A SA SIP T D
MDV M SVDAFSRE S DDMMSLL D Y D F IE G S S  S DENAEVTEMETSAK
H S V -1  VPSTQTPRPTERQGPNDPQPAPHSVW SRLGARRPSCSPEQHGGKVARLQPPPTKAQPARGGRRGRRRGRGRGGPGAADGL
H S V -2  TP ASTPRPAARRGADDPPPATTGVW SRLGTRRSASPREPHGGKVARIQPPSTKAPHPRGGRRGRRRGRGRYGPGGADST
E H V -1  EA TRG LVN KSAFVPTQTVG TVSALRNW GDPPKSVW SFSASPQRAQ PSNPKSERPAFGH GRRNRRRPFRRNNW KQ QQRG
E H V -4  AAQSAVVNKRAF MS ST G TM STIR N V V SEV PK SLV V SFA A SPK N PK PQ N TTS RSA FPH G R K N R RR PFRR N NW K .. QRA
B H V -1  EDD A PSLAPALRSW GQVRKRKLEG AE DEPMPAEPPGI GAASGDGGPAEAPPARRARVRPRRPRRRPRRRQPAGEQRSR
PRV M ED SG N SSG SEA SRSG SEER R PV R: RLGSRPPERRPVRARLGAIRRRRGGRGGRAARQALRQRRRQQQQQQRQQQHQR
VZV P D V S T IC  DFM NLLPDEPSDDFALEVTDW ANDEAIGSTPGEDSTTSRTVYVERTADTAYNPRYSKRRHGRRESYHHNRPK
MDV TA NN K N EV LFA PPC TQ ELLT ER PSPD SK N SQ G D D D SN SIY G N V IR D A Q H SA SR Y A TR C LD N A IPR K R LR LA N LTV D SA C I
H S V -1  S PRRRAPRTNRNPGGPRPGAGWT GPGAPHG AWRGS QP PPGGQ RTRGVRQAPPPLM TLAIAPPPA PRAPAPERKA
H S V -2  PKPRRRVSRNAHNQGGRHPASART GPGATHGEARRGG: QL V SG GPRPRGTRQAPPPLM ALSLTPPH A GRAPVPi- RKA
E H V -1  WEKPEPENVPARQSAGSWPKRSSLPVHMRLGQRGGDSSSADSGHGGAGPSDRWRFKTRTQSVARVHRNRRRGNANHGSNT
E H V -4  W KQSQ AAPANQGSRNWPKRSSMPVHMRLGHRSGDFQSA AGHCTAGPSGGWRFKTRTHSASRVYHNRQRGNTNKSGNA
B H V -1  G PAA K R FA A LATSSHGG GGAAARSIGSSLRLARSLAFAAQ RATAERVTAVFAGARLDLMRPVQNGGFRAAGV....................
PRV RRQEADRPDGGPD A PPD R LSESA RA A VSA TH A  RVG ATRVNELFASA RH LLSRPVFND G FR A AG S............................................
VZV T L W V L P  SNHHGGR V TG Y A RIER G H R R SSR SYN TQ SSRK H R FR SLSN R RR R PTTPPAM TTG ER N  ,Q T H FE SY R L R FS
MDV SQTKRPHGTGNRKQYHRRNFPM SPTSQEKIHLRLHNRLGSRS KQQRSLNY RRLQEGHHRRRFYS :R R IY  QNHSHHRT
H S V -1  PAA T I  . A T T R L V L R S IS E R A A V  R IS : SFGRSAQVMH PFG G Q PFPA A N ............................... SPWAPVLAGQGG. PFDAETR
H S V -2  P S A  T I  PA V R A V L R SIS  RAAV R IS  SFGRSALVMQ PFGGM PFPAAN............................... SPW APVLATQAG. GFDAETR
E H V -1  PGRSAG. R L N A A A A SSIA  VCR R VTSSRIG iM FH G A RFTLTTPV K N G G FRA  N S .................. SPW A PV LG FG SD . QFNPEAR
E H V -4  S SS R S G D R L N A A A A N A IA P V S K R V T SS R IS  MFHGARE'TLTSPVKNGGFRA H S .................. SPW SPV L N F G L E . QFNPEGR
B H V -1   SPWAAVLDFGAE . QFVPEGR
PRV  SPWAAVLEFGAE . QFTPDGR
VZV KR ARRr.RIRK; Y I P V  .R IT G R A I V V STA G A SV TI SVRHL E T I K LV V RY A TIQ EG D SW ASG G CFPG I..................KQ
MDV HDIRVPLEK YRVSRQH DLPVH EELN' IL Q R E K H R L A S IS N t C D F R V S SK .................................. NRW AAVLTFSSNAESTLCGP
H S V - 1  RVSWETLVAHGPSLYRTFA GNPR AASTAKAMRDCVLRQENFIEALASADETLAWCKMCIHHNLPL RPQ DPIIGTTAAVLD
H S V - 2  RVSWETLVAHGPSLYRTFAANPR AASTAKAMRDCVLRQENLIEALASADETLAWCKMCIHHNLPLRPQDPIIGTAAAVLE
E H V - 1  RITWDTLVEHGVNLYKLFEVRSHAAEAARSLRDAVMRGENLLEALASADETLSWCKMIVTKNLPMRTRDPIISSSVALLD
E H V - 4  RITWDTLVTHG ENLY KLFEVR SHA AEA A RSLR DLVM R GEN LLEA LA SA D ETISW C KM IITKN LPM R TR D PIIH SSIALLE
B H V - 1  RVTWETLM FHGRDLYRMFEVRPHAAQAARALRDLVLRSANLVDALASADECLTWCKFIATKNLRLRTKDPIVATAGAVLE
PRV RVTWETLMFHGADLHRLFEVRPHATEAARVLREMVLLNEGLTESLASADETLTWVKLILTKGLTLRTLDPIVATAGAVLQ
VZV N TSW PELM LY GHELYR TFESY KM D SRIA RA LR ERV IRG ESLIEA LESAD ELLTW IKM LAA KN LPIY TNN PIV ATSKSLLE
MDV Q ITW E Y L LHAGPELRNTFEIRPRISLQASAAREAVLRGESFIAALG SAEETLSW LKLH AVLKIiR LVNH DPIFKTAGAVLD
H S V - 1  NLATRLRPFLQCYLKAR.
H S V - 2  NLATRLRPFLQCYLKAR.
E H V - 1  N LR LK L EPFM R C Y LSS S .
E H V - 4  N LR L K L E PFM R C Y L SS S .
B H V - 1  N LRLK LAPFLRCYLRGR.
PRV NLRL K LGPFL RC Y L RD T.
. GLCGLDELCSRRRLADIKDIASFVFVILARLANRVERGVAEIDYATLGVGVGEKMHFYL
. GLCGLDDLCSRRRLSD IK DIA SFVLV ILAR LA NR V ERG VSEID YTTV GV GA GETM HFY I  
. GSPTLAELCDHQRLSDVACVPTFMFVMLARIARAVGSGAETVSRDALGPD.GRVLADYV  
. GSPT LAELCDHQRLSDVACVPTFMFVTLARIARAVGSGAEAVSPDALG PA. GHALANYV 
. GLPSLEELCAARRLSLATCPASYM FVMLARLSRAVRSGAECVPLLEVTVG. D A P FEEY I
 PVDELVRRRRLR DV R CIV T YTL V M LA R IA R VV E R GSSCV L PE D L GD S.P V PL EEY V
VZV N L K L K L G PFV R C L L L N R D N D L G S R T L P E L L R Q Q R F S D IT C IT T Y M F V M IA R IA N IW R G S K F V E Y D D IS C N . VQVLQEYT
MDV NLRLKLAPIMMCKYGTE K R SM G D M L R R SA P E D IN D S L T L C L IL L S R IR R V M H R T SG S K Y SY M ID P R . . GCMIDYV
H S V - 1  PG A C M A G L IE IL D T H R Q EC S S R V C EL.TA SH IV A PPY V H G K Y F Y C N SLF
H S V - 2  PG A C M A G LIEILD TH R Q EC S S R V C E L.T A SH TIA PL Y V H G K Y FY C N S LF
E H V - 1  PG ACLAGTLEAIDAHKRRCKADTCSL. VSAYTLVPVYLHGKYFYCNQIF
E H V - 4 PG TCLA G TLE A ID LH K R R CK ESTC SL . V SSYTLVPVYLH GKYFYCNQIF
B H V - 1 PGTCVAGLIDALDTHKQACDSMTCKL. VANFTLVPVYMHGKYFYCNEIF
PRV PG ACLGGIMDALD SHKTGCDAPTCRL. TCSYTLVPVYMHGKYFYCNHLF
VZV PGSCLAGVLEALITHQRECGRVECTLSTWAGHLSDARPYGKYFKCSTFNC
MDV PG ECM TNILRYVDAHTRRCSDPACNL. YISC TL M PIY IH GR YFYC N TL FGM
References
References
Ackerman, M., Braun, D., Pereira, L. & Roizman, B. (1984). Characterisation o f herpes simplex 1 
a  proteins 0, 4 and 27 with monoclonal antibodies. Journal o f  Virology 52, 108-118.
Batterson, W. & Roizman, B. (1983). Characterization o f the herpes simplex virus virion
associated factor responsible for the induction o f alpha genes. Journal o f  Virology 46, 
371-377.
Becker, Y., Dym, H. & Sarov, I. (1968). Herpes simplex DNA. Virology 36, 184-192.
Bell, S., Cranage, M., Borysiewicz, L. & Minson, A. (1990). Induction o f immunoglobulin G Fc 
receptors by recombinant vaccinia viruses expressing glycoproteins E and I o f herpes 
simplex virus type 1. Journal o f Virology 64, 2181-2186.
Bello, L., Davison, A., Glen, M., Whitehouse, A., Rethmeier, N., Schulz, T. & Clements, B.
(1999). The human herpesvirus-8 ORF 57 gene and its properties. Journal o f  General 
Virology 80, 3207-3215.
Bienroth, S., Keller, W. & Wahle, E. (1993). Assembly o f a processive messenger RNA 
polyadenylation complex. EMBO Journal 12, 585-594.
Bilger, A., Fox, C., Wahle, E. & Wickens, M. (1994). Nuclear polyadenylation factors recognise 
cytoplasmic polyadenylation elements. Genes and Development 8, 1106-1116.
Bimboim, H. & Doty, J. (1979). A rapid alkaline extraction procedure for screening recombinant 
plasmid DNA. Nucleic Acids Research 7, 1513-1522.
Bimey, E., Kumar, S. & Krainer, A. (1993). Analysis o f the RNA-recognition motif and RS and 
RGG domains: conservation in metazoan pre-mRNA splicing factors. Nucleic Acids 
Research 21, 5803-5816.
Blaho, J., Mitchell, C. & Roizman, B. (1993). Guanylylation and adenylation o f the a  regulatory 
proteins o f herpes simplex virus require a viral p or y function. Journal o f  Virology 67, 
3891-3900.
Bogerd, H., Fridell, R., Benson, R., Hua, J. & Cullen, B. (1996). Protein sequence requirements 
for function o f the human T-cell leukemia virus type 1 Rex nuclear export signal 
delineated by a novel in vivo randomisation-selection assay. Molecular and Cellular 
Biology 16, 4207-4214.
Bogerd, H., Fridell, R., Madore, S. & Cullen, B. (1995). Identification o f a novel cellular cofactor 
for the Rev/Rex class of retroviral regulatory proteins. Cell 82, 485-494.
Bomsztyk, K., Van Seuningen, I., Suzuki, H., Denisenko, O. & Ostrowski, J. (1997). Diverse 
molecular interactions of the hnRNP K protein. FEBS Letters 403, 113-115.
Booy, F., Newcomb, W., Trus, B., Brown, J., Baker, T. & Steven, A. (1991). Liquid crystalline 
phage-like packaging of encapsidated DNA in herpes simplex virus. Cell 64, 1007-1015.
Boyle, S. M., Ruvolo, V., Gupta, A. K. & Swaminathan, S. (1999). Association with the cellular 
export receptor CRM 1 mediates function and intracellular localisation o f Epstein-Barr 
virus SM protein, a regulator of gene expression. Journal o f  Virology 73, 6872-6881.
Bradford, M. (1976). A rapid and sensitive method for the quantification of microgram quantities 
of protein utilizing the principle o f protein dye binding. Analytical Biochemistry 72, 248- 
254.
Bridge, E., Carmo-Fonseca, M., Lamond, A. & Petersson, U. (1993). Nuclear organisation of 
splicing snRNPs in adenovirus-infected cells. Journal o f Virology 67, 5792-5802.
Brown, S., Ritchie, D. & Subak-Sharpe, J. (1973). Genetic studies with herpes simplex virus type 
1, the isolation of temperature sensitive mutants, their arrangment in complementation 
groups and recombination analysis leading to a linkage map. Journal o f  General Virology 
18, 329-346.
XI
References
Bruni, R. & Roizman, B. (1996). Open reading frame P - a herpes simplex virus gene repressed 
during productive infection encodes a protein that binds a splicing factor and reduces 
synthesis o f viral proteins made from spliced mRNA. Proceedings o f National Academy 
o f Sciences. USA 93, 10423-10427.
Bryant, H., Wadd, S., Filhol, O., Scott, J., Hsieh, T., Everett, R., & Clements, B. (1999). The 
Multifunctional Herpes Simplex Virus IE63 Protein Interacts with Heterogeneous 
Ribonucleoprotein K and with Casein Kinase 2. Journal o f  Biological Chemistry. 274: 
28991-28998.
Buckmaster, A., Scott, S., Sanderson, M., Boursnell, M., Ross, N. & Binns, M. (1988). Gene 
sequence and mapping data from Marek's disease virus and herpesvirus o f turkeys: 
Implications for herpes classification. Journal o f  General Virology 1988, 2033-2042.
Buisson, M., Hans, F., Kusters, I., Duran, N. & Sergeant, A. (1999). The C-terminal region but not 
the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA 
splicing and transport. Journal o f  Virology 73, 4090-4100.
Burke, R. (1993). Current status of HSV vaccine development. In The human herpesviruses.
Edited by B. Roizman, R. Whitley & C. Lopez. New York: Raven Press.
Bustello, X., Suen, K., Michael, W., Dreyfuss, G. & Barbacid, M. (1995). Association of the vav 
proto-oncogene product with poly (rC)- specific RNA-binding proteins. Molecular Cell 
Biology 15, 1324-1332.
Caceres, J., Screaton, G. & Krainer, A. (1998). A specific subset o f SR proteins shuttles
continuously between the nucleus and the cytoplasm. Genes and Development 12, 55-66.
Cao, W., Jamison, S. & Garcia-Bianco, M. (1997). Both phosphorylation and dephosphorylation 
of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA 3, 1456-1467.
Carmo-Fonseca, M., Pepperkok, R., Carvalho, M. & Lamond, A. (1992). Transcription dependent 
co-localisation of the U1,U2,U4/U6, and U5 snRNPs in coiled bodies. Journal o f Cell 
Biology 117, 1-14.
Challberg, M. (1991). Herpes simplex virus DNA replication. Seminars in Virology 2, 247-256.
Champion-Amaud, P. & Reed, R. (1996). The prespliceosome components SAP49 and SAP 145 
interact in a complex implicated in tethering U2 snRNP to the branch site. Genes and 
Development#, 1974-1983.
Chapman, C., Harris, J., Hardwicke, M., Sandri-Goldin, R., Collins, M. & Latchman, D. (1992). 
Promoter-independent activation o f heterologous virus gene expression by the herpes 
simplex virus immediate-early protein ICP27. Virology 186, 573-578.
Chen, F., MacDonald, C. & Wilusz, J. (1995). Cleavage site determinants in the mammalian 
polyadenylation signal. Nucleic Acid Research 23, 2614-2620.
Chen, J. & Silverstein, S. (1992). Herpes simplex viruses with mutations in the gene encoding 
ICP0 are defective in gene expression. Journal o f  Virology 66, 2916-2927.
Chen, M., Yang, J., Wu, C., Middeldorp, J., & Chen, J. (1998a). Physical association between the 
EBV protein EBNA 1 and P32/TAP/hyaluronectin. Journal o f  Biomedical Science 5, 173- 
179.
Chen, Z., Li, Y. & Krug, R. (1998b). Chimeras containing influenza NS1 and HIV-1 Rev protein 
sequences: Mechanism o f their inhibition of nuclear export o f Rev- protein-RNA 
complexes. Virology 241, 234-250.
Chen, Z., Li, Y., Krug, R., (1999). Influenza A virus NS1 protein targets poly (A) - binding protein 
II of the cellular 3-end processing machinery. EMBO Journal 18. 2273-2283.
Chou, J., Chen, J., Gross, M. & Roizman, B. (1995). Association o f M(r) 90,000 phosphoprotein 
with PKR in cells exhibiting enhanced phosphorylation o f translation initiation factor 
eLF-2 alpha and premature shut off of host protein synthesis after infection with gamma 1 
35.5 mutants o f herpes simplex virus 1. Proceedings o f  the National Academy o f Sciences 
USA 92, 10516-10520.
References
Chou, J. & Roizman, B. (1990). The herpes simplex virus type 1 gene ICP34.5 which maps in
inverted repeats is conserved in several limited passage isolates but not in strain 17 syn. 
Journal o f Virology 64, 1014-1020.
Clements, B. & Brown, M. (1997). Herpesviruses. In Principles o f medical biology. JAI press. 
393-414.
Clements, J., Watson, R. & Wilkie, N. (1977). Temporal regulation o f herpes simplex virus type 1 
transcription: location o f transcripts on the viral genome. Cell 12, 275-285.
Coen, D., Kosz-Vnenchak, M., Jacobson, J., Leib, D., Bogard, C., Schaffer, P., Tyler, K. & Knipe, 
D. (1989). Thymidine kinase negative herpes simplex viral mutants establish latency in 
mouse trigeminal ganglia but do not reactivate. Proceedings o f  the National Academy o f 
Sciences USA 86, 4736-4740.
Collier, B., Goobar-Larsson, L., Sokolowski, M. & Schwartz, S. (1998). Translational inhibition in 
vitro o f human papillomavirus type 16 L2 mRNA mediated through interaction with 
heterogeneous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. Journal o f  
Biological Chemistry 273, 22648-22656.
Colwill, K., Pawson, T., Andrews, B., Prasad, J., Manley, J., Bell, J. & Duncan, P. (1996). The
Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intracellular 
distrabution. EMBO Journal 15, 265-275.
Cook, M. & Stevens, J. (1973). Pathogenesis o f hepetic neuritis and ganglionitis in mice: evidence 
of intra-axonal transport o f infection. Infection and Immunity 7, 272-288.
Cooper, M., Goodwin, D., Hall, K., Stevenson, A., Meredith, D., Markham, A., Whitehouse, A., 
(1999). The gene product encoded by ORF57 of herpes virus saimiri regulates the 
redistribution of the splicing factor SC-35. Journal o f General Virology 80. 1311-1316.
Costanzo, F., Campadelli-Fiume, G., Foa-Thomas, L. & Cassai, E. (1977). Evidence that herpes
simplex virus DNA is transcribed by cellular RNA polymerese II. Journal o f Virology 21, 
996-1001.
Cross, A., Hope, G. & Marsden, H. (1987). Generation and properties of the glycoprotein E-
related 32K/34K/35K/ and 55K/57K polypeptides encoded by herpes simplex virus type 
1. Journal o f  General Virology 68, 2093-2104.
Cullen, B. (1998a). Posttranscriptional regulation by the HIV-1 Rev protein. Seminars in Virology 
8, 327-334.
Cullen, B. (1998b). Retroviruses as model systems for the study o f nuclear RNA export pathways. 
Virology 249, 203-210.
Curtin, K. & Knipe, D. (1993). Altered properties o f the herpes simplex virus ICP8 binding protein 
in cells infected with ICP27 mutant viruses. Virology 196, 1-14.
Dahmus, M. (1981). Purification and properties o f calf thymus casein kinase-I and kinase-II. 
Journal o f  Biological Chemistry 256, 3319-3325.
Dantonel, J., Murthy, K., Manley, J. & Tora, L. (1997). CPSF links transcription and mRNA 3' 
end formation. Nature 389, 399-402.
Dargan, D., Patel, A. & Subak-Sharpe, J. (1995). PREPs:herpes simplex virus type-1 specific
particles produced by infectious cells when viral DNA replication is blocked. Journal o f  
Virology 69, 4924-4932.
Davison, A. (1993). Herpesvirus genes. Reviews in Medical Virology 3, 237-244.
De Bryn Kops, A. & Knipe, D. (1994). Preexisting nuclear architecture defines the intranuclear 
location of herpesvirus DNA replication structures. Journal o f Virology 68, 3512-3526.
Deb, T. & Datta, K. (1996). Molecular cloning of human fibroblast hyaluronic acid-binding
protein confirms its identity with P-32, a protein co-purified with splicing factor SF2 - 
Kyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2. 
Journal o f Biological Chemistry 271, 2206-2212.
References
Defechereux, P., Debrus, S., Baudoux, L., Rentier, B. & Piette, J. (1997). Varicella-zoster virus 
open reading frame 4 encodes an immediate early protein with posttranscriptional 
regulatory properties. Journal o f Virology 71, 7073-7079.
Defechereux, P., Melen, L., Baudoux, L., Merville-Louis, M., Rentier, B. & Piette, J. (1993).
Characterisation o f the regulatory functions o f varicella-zoster virus open reading frame 4 
gene product. Journal o f  Virology 67,4379-4385.
Dejgaard, K., Leffers, H., Rasmussen, H., Madsen, P., Kruse, T., Gesser, B., Nilesen, H. & Celis,
J. (1994). Identification, molecular cloning, expression and chromosome mapping of a 
family o f tranformation upregulated hnRNP-K proteins derived by alternative splicing. 
Journal o f Molecular Biology 236, 33-48.
Denisenko, O., O'Neill, B., Ostrowski, J., Seuningen, I. & Bomsztyk, K. (1996). Zikl, a
transcriptional repressor that interacts with the heterogeneous nuclear ribonucleoprotein 
particle K protein. Journal o f Biological Chemistry 271, 27701-27706.
Dennis, D. & Smiley, J. (1984). Transactivation o f a late herpes simplex virus promoter.
Molecular and Cellular Biology 4, 544-551.
DesJardins, E. & Hay, N. (1993). Repeated CT elements bound by zinc finger proteins control the 
absolute and relative activities of the two principal human c-myc promoters. Molecular 
and Cellular Biology 13, 5710-5724.
Dixon, R. & Schaffer, P. (1980). Fine structure mapping and functional analysis o f temperature 
sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early 
protein VP 175. Journal o f  Virology 36, 189-203.
Dobrowolska, G., Lozeman, F., Dongxia, L. & Krebs, E. (1999). CK2, a protein kinase o f the next 
millennium. Molecular and Cellular Biochemistry 191, 3-12.
Dolan, A., Jamieson, F., Cunningham, C., Barnett, B., McGeoch, D. (1998). The genome sequence 
of herpes simplex virus type 2. Journal o f  virology 72, 2010-2021.
Dreyfuss, G., Choi, Y. & Adam, S. (1984). Characterisation o f heterogeneous nuclear RNA-
protein complexes in vivo with monoclonal antibodies. Molecular and Cellular Biology 4, 
1104-1114.
Dreyfuss, G., Matunis, J., Pinol-Roma, S. & Burd, C. (1993). hnRNP proteins and the biogenesis 
o f mRNA. Annual Reviews in Biochemistry 62, 289-321.
Dubin, G., Frank, I. & Friedman, H. (1990). Herpes simplex virus type 1 encodes two Fc receptors 
which have different binding characteristics for monomeric IgG and IgG complexes. 
Journal o f  Virology 64, 2725-2731.
Eagle, H. (1959). Amino acid metabolism in mammalian cell cultures. Science 130, 432.
Edgadi, M., Hayes, C. & Smiley, J. (1999). The herpes simplex virus VHS protein induces
endoribonucleolytic cleavage o f target RNAs in cell extracts. Journal o f  Virology 73. 
7153-7164.
Elliot, D., Stutz, F., Lescure, A. & Roshbash, M. (1994). mRNA nuclear export. Current Opinions 
in Genetics and Development 4, 305-309.
Elshiekh, N., Harris-Hamilton, E. & Bachenheimer, S. (1991). Differential dependence o f herpes 
simplex virus immediate early gene expression on de novo infected cell protein synthesis. 
Journal o f Virology 65, 6430-6437.
Epstein, M. (1962). Observations on the mode o f release of herpes virus from infected Hela cells. 
Journal o f  Cell Biology 12, 589-597.
Evans, J., Lock, K., Levine, B., Champness, J., Sanderson, M., Summers, W., McLeish, P. & 
Buchan, A. (1998). Herpes viral thymidine kinases: laxity and resistance by design. 
Journal o f  General Virology 79, 2083-2092.
Everett, R. & Dunlop, M. (1984). Transactivation o f plasmid bome promoters by adenovirus and 
several herpes group viruses. Nucleic Acids Research 12, 5969.
xiv
References
Everett, R. (1984). Trans activation of transcription by herpes virus products: requirement for two 
HSV-1 immediate-early polypeptides for maximum activity. EMBO Journal 13, 3135- 
3141.
Everett, R., Cross, A. & Orr, A. (1993a). A truncated form of herpes-simplex virus type-1
immediate-early protein Vmwl 10 is expressed in a cell-type dependent manner. Virology 
197, 751-756.
Everett, R., Cross, A., Tyler, J. & Orr, A. (1993b). An epitope within the DNA-binding domain of 
the herpes-simplex virus immediate-early protein V m w l75 is conserved in the varicella- 
zoster virus gene 62 protein. Journal o f General Virology 74, 1955-1958.
Faber, S. & Wilcox, K. (1986). Association o f herpes simplex virus regulatory protein ICP4 with 
specific nucleotide sequences in DNA. Nucleic Acids Research 14, 6067-6083.
Faken, S. (1994). Perichromatin fibrils are in situ forms o f nascent transcripts. Trends in Cell 
Biology 4, 86-90.
Faken, S., Leser, G. & Martin, T. (1984). Ultrastructural distribution o f nuclear ribonuclear
proteins as visualised by immunocytochemistry on thin sections. Journal o f Cell Biology 
98, 358-363.
Feild, H. & Wildy, P. (1978). The pathogenicity o f thymidine kinase deficient mutants o f herpes 
simplex virus in mice. Journal ofHygine 81, 267-277.
Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W. & Luhrmann, R. (1995). The HIV-1 Rev 
activation domain is a nuclear export signal that accesses an export pathway used by 
specific cellular RNAs. Cell 82, 475-483.
Fomerod, M., Ohno, M., Yoshida, M. & Mattaj, I. (1997a). CRM1 is an export receptor for 
leucine rich nuclear export signals. Cell 90, 1051-1060.
Fomerod, M., Van Deursen, J., Van Baal, S, Reynolds, A., Davis, D., Murti, K., Fransen, J. & 
Grosveld, G. (1997b). The human homolougue o f yeast Crml is in a dynamic 
subcomplex with Can/Nup214 and a novel pore component Nup88. EMBO Journal 16, 
807-816.
Fortes, P., Beloso, A. & Ortin, J. (1994). Influenza vims NS1 protein inhibits pre-mRNA splicing 
and blocks mRNA nucleocytoplasmic transport. EMBO Journal 13, 704-712.
Fortes, P., Lamond, A. I. & Ortin, J. (1995). Influenza vims NS1 protein alters the subnuclear
localisation of cellular splicing components. Journal o f General Virology 76, 1001-1007.
Fox, A., Kowalski, K., King, G., MacKay, J. & Crossley, M. (1998). Key residues characteristic of  
GATA N-fmgers are recognised by FOG. Journal o f Biological Chemistry 273, 33595- 
33603.
Fridell, R. A., Fischer, U., Luhrmann, R., Meyer, B. E., Meinkoth, J. L., Malim, M. H. & Cullen,
B. R. (1996). Amphibian transcription factor III A proteins contain a sequence element 
functionally equivalent to the nuclear export signal o f human immunodeficiency vims 
type 1 Rev. Proceedings ofNational Adacemy o f Science, USA 93, 2936-2940.
Friedman, H., Glorioso, J., Cohen, G., Hastings, J., Harris, S. & Eisenberg, R. (1986). Binding of 
complement component C3b to glycoprotein C o f Herpes Simplex Vims 1: mapping of 
gC-binding sites and demonstration of conserved C3b binding in low passage clinical 
isolates. Journal o f Virology 60, 470-475.
Fu, X. (1995). The superfamily of arginine/serine rich splicing factors. RNA 1, 663-680.
Fu, X. & Maniatis, T. (1992). The 35-Kda mammalian splicing factor SC35 mediates specific
interactions between U1 and U2 small nuclear ribonucleoprotein- particles at the 3' splice 
site. Proceedings o f the National Academy o f Sciences, USA 89, 1725-1729.
Fu, X., Mayeda, A., Maniatia, T. & Krainer, A. (1992). General splicing factors SF2 and SC35
have equivalent activities in vitro and both affect alternative 5' and 3' splice site selection. 
Proceedings o f the National Academy o f Sciences, USA 89, 11224.
Ge, H. & Manley, J. (1990). A protein factor, ASF, controls alternative splicing o f SV40 early pre- 
mRNA in vitro. Cell 62, 25-34.
xv
References
Ghebrehiwet, B., Lim, B., Peerschke, E., Willis, A. & Reids, K. (1994). Isolation, cDNA cloning 
and over expression of a 33KD cell surface glycoprotein that binds to the globular heads 
o f Clq. Journal o f Experimental Medicine 179, 1809-1821.
Gilmartin, G. M., Fleming, E. S. & Oetjen, J. (1992). Activation o f HIV-1 pre-mRNA 3'
processing in vitro requires an upstream element and TAR. EMBO Journal 11, 4419- 
4428.
Gozani, O., Patton, J. & Reed, R. (1994). A novel set o f spliceosome associated proteins (SAPs)
and the essential splicing factor PSF bind stabily to pre-mRNA prior to catalytic step II of 
the splicing reaction. EMBO Journal 13, 3356.
Gozani, O. & Potashkin, J. (1998). A potential role for U2AF-SAP155 interactions in recruiting 
U2 snRNP to the branch site. Molecular and Cellular Biology 18, 4752-4760.
Greaves, R. & O'Hare, P. (1989). Separation of requirements for protein-DNA complex assembly 
from those for functional activity in the herpes simplex virus regulatory protein Vmw65. 
Journal o f  Virology 63, 1641-1650.
Green, M. (1991). Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. 
Annual Reviews in Cell Biology 7, 559-599.
Guerra, B. & Issinger, O. (1999). Protein Kinase CK2 and its role in cellular proliferation, 
development and pathology. Electrophoresis 20, 391-408.
Gui, J., Tronchere, H., Chandler, S. & Fu, X. (1994). Purification and characterisation o f a kinase 
specific for the serine- argine-rich pre-mRNA splicing factors. Proceedings o f the 
National Academy o f Sciences, USA 91, 10824-10828.
Guzowski, J. & Wagner, E. (1993). Mutational analysis o f the herpes simplex virus type 1 strict 
late UL38 promoter/leader reveals two regions critical in transcriptional regulation. 
Journal o f  Virology 67, 5098-5108.
Hageman, C., Kalmes, A., Wixier, V., Wixier, L., Schuster, T. & Rapp, U. (1997). The regulatory 
subunit o f protein kinase CK2 is a specific A-Raf activator. FEBS Letters 403, 200-202.
Hann, L., Cook, W., Uprichard, S. & Knipe, C. (1998). The role of herpes simplex virus ICP27 in 
the regulation o f UL24 gene expression by differential polyadenylation. Journal o f  
Virology 72, 7709-7714.
Hardwicke, M. A. & Sandri-Goldin, R. M. (1994). The herpes simpex virus regulatory protein 
ICP27 contributes to the decrease in cellular mRNA levels during infection. Journal o f 
Virology 68, 4797-4810.
Hardwicke, M., Vaughan, P., Sekulovich, R., O'Conner, R. & Sandri-Goldin, R. (1989). The
regions important for the activator and repressor function o f herpes simplex virus type 1 
alpha protein ICP27 map to the C-terminal half o f the molecule. Journal o f  Virology 63, 
4590-4602.
Hardy, W. R. & Sandri-Goldin, R. M. (1994). Herpes simplex virus inhibits host cell splicing, and 
regulatory protein ICP27 is required for this effect. Journal o f  Virology 68, 7790-7799.
Hassan, A. B. & Cook, P. R. (1994). Does transcription by RNA polymerase play a direct role in 
the initiation o f replication? Journal o f Cell Science 107, 1381-1387.
Hathaway, G. & Traugh, J. (1979). Cyclic nucleotide - independent protein kinases from rabbit 
reticulocytes. Journal o f Biological Chemistry 254, 762-768.
Heriche, J., Lebrin, F., Rabilloud, T., Leroy, D., Chambaz, E. & Goldberg, Y. (1997). Regulation 
of protein phosphatase 2A by direct interaction with casein kinase 2 alpha. Science 276, 
952-955.
Herwald, H., Dedio, J., Kellner, R., Loos, M. & Muller-Esterl, W. (1996). Isolation and
characterisation of the kininogen-binding protein p33 from endothelial cells - identity 
with the gClq receptor. Journal o f Biological Chemistry 271, 13040-13047.
xvi
References
Hibbard, M. & Sandri-Goldin, R. (1995). Arginine-rich regions succeeding the nuclear-
localization region of the herpes simplex virus type 1 regulatory protein ICP27 are 
required for efficient nuclear localisation and late gene expression. Journal o f Virology 
69, 4656-4667.
Honess, R. & Roizman, B. (1974). Regulation of herpesvirus macromolecular synthesis I. Cascade 
regulation o f the synthesis o f three groups of viral proteins. Journal o f  Virology 14, 8-19.
Honess, R. & Roizman, B. (1975). Regulation of herpesvirus macromolecular synthesis: sequential 
transition of polypeptide synthesis requires functional viral polypeptides. Proceedings o f 
the National Academy o f  Sciences, USA 72, 1276-1280.
Hope, T., Klein, N., Elder, M. & Parslow, T. (1992). Trans dominant inhibition o f human 
immunodeficiency virus type 1 Rev occurs though formation o f inactive protein 
complexes. Journal o f  Virology 66, 1849-1855.
Hozak, P., Hassan, B., Jackson, D. & Cook, P. (1993). Visualisation o f replication factories 
attached to a nucleoskeleton. Cell 73, 361-373.
Hsieh, T., Matsumoto, M., Chou, H., Schneider, R., Hwang, S., Lee, A. & Lai, M. (1998).
Hepatitis C virus core protein interacts with heterogenous ribnucleoprotein K. Journal o f 
Biological Chemistry 273, 17651-17659.
Huang, S. & Spector, D. (1991). Nascent pre-mRNA transcripts are associated with nuclear 
regions enriched in splicing factors. Genes and Development 5, 2288-2302.
Hutchinson, L., Browne, H., Wargent, V., Davis-Poynter, N., Primorac, S., Goldsmith, K.,
Minson, A. & Johnson, D. (1992). A novel herpes simplex glycoprotein, gL, forms a 
complex with glycoprotein H (gH) and effects normal folding and surface expression of 
gH. Journal o f Virology 66, 2240-2250.
Inchauspe, G., Nagpal, S. & Ostrove, J. (1989). Mapping of two viaricella zoster virus encoded 
genes that activate the expression of viral early and late genes. Virology 173, 700-709.
Ingram, A., Phelan, A., Dunlop, J. & Clements, J. (1996). Immediate early protein IE63 o f herpes 
simplex virus type 1 binds RNA directly. Journal o f General Virology 77, 1847-1851.
Issinger, O. (1993). Casein kinases: Pleiotrotrophic mediators of cellular regulation. 
Pharmacological Therapy 59, 1-30.
Izaurralde, E. & Adam, S. (1998). Transport of macromolecules between the nucleus and the 
cytoplasm. RNA 4, 351-364.
Jang, K. & Latchman, D. (1992). The herpes simplex virus immediate early protein ICP27
stimulates the transcription of cellular Alu repeated sequences by increasing the activity 
o f transcription factor TFIIIC. Biochemical Journal 284, 667-673.
Jiang, J., Zhang, Y., Krainer, A. & Rui-Ming, X. (1999). Crystal structure of human p32 a 
doughnut-shaped acidic mitochondrial matrix protein. Proceedings o f  the National 
Academy o f  Sciences, USA 96, 3572.
Johnson, D., Frame, M., Ligas, M., Crosss, A. & Stow, N. (1988). Herpes simplex virus
immunoglobulin G Fc receptor activity depends on a complex o f 2 viral glycoproteins gE 
and gl. Journal o f  Virology 62, 1347-1354.
Kalderon, D., Richardson, W., Markham, A. & Smith, A. (1984). Sequence requirements for 
nuclear localisation o f SV40 large T antigen. Nature 311, 33-38.
Kamma, H., Portman, D. & Dreyfuss, G. (1995). Cell-type-specific expression o f hnRNP proteins. 
Experimental Cell Research 221, 187-196.
Kanopka, A., Muhlemann, O., Petersen-Mahrt, S., Estmer, C.,Thrmalm, C. & Akusjarvi, G.
(1998). Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR 
proteins. Nature 393, 185-187.
Karr, B. & Read, G. (1999). The virion host shut off function o f herpes simplex virus degrades the 
5' end of a target mRNA before the 3' end. Virology 264. 195-204
xvii
References
Kastner, B., Komstadt, U., Bach, M. & Luhrmann, R. (1992). Structure o f the small nuclear RNP 
particle-Ul - identification of the 2 structural protuberances with RNP-Antigens- and 
RNP- Antigens-70k. Journal o f Cell Biology 116, 839-849.
Katze, M. & Krug, R. (1984). Metabolism and expression o f RNA polymerase II transcripts in 
influenza virus-infected cells. Molecular and Cellular Biology 4, 2198-2206.
Kim, J., Cha, J., Marshak, D. & Bae, Y. (1996). Interaction o f the P subunit o f casein kinase II
with ribosomal protein L5. Biochemical and Biophysical Research Communications 226, 
180-186.
Kjems, J., Frankel, A. & Sharp, P. (1991). Specific regulation o f messenger RNA splicing in vitro 
by a peptide from HIV-1 Rev. Cell 67, 169-178.
Kjems, J. & Sharp, P. (1993). The basic domain o f Rev from HIV-1 specifically blocks the entry 
of U4/U6 U5 small nuclear ribonucleoprotein in spliceosome assembly. Journal o f  
Virology 67, 4769-4776.
Krainer, A. & Maniatis, T. (1985). Multiple protein factors including the small nuclear
ribonucleoproteins U1 and U2 are necessary for pre-mRNA splicing in vitro. Cell 42, 
725-736.
Krainer, A. R., Conway, G. & Kozak, D. (1990a). The essential pre-mRNA splicing factor SF2 
influences 5' splice site selection by activating proximal sites. Cell 62, 35-42.
Krainer, A. R., Conway, G. & Kozak, D. (1990b). Purification and characterisation of SF2, a 
human pre-mRNA splicing factor. Genes and Development 4, 1158-1171.
Krehan, A. & Pyerin, W. (1999). Intermolecular contact sites in protein kinase CK2. Molecular 
and Cellular Biochemistry 191, 21-28.
Rristensson, K., Lycke, E., Roytta, M., Svennerholm, B. & Vahlne, A. (1986). Neuritic transport 
o f herpes simplex virus in rat sensory neurons in vitro. Effects o f substances interacting 
with microtubular function and axonal flow. Journal o f  General Virology 67, 2023-2028.
Kwong, A. & Kruper, J. (1988). Herpes simplex virus virion host shut off function. Journal o f 
Virology 62,912-921.
Ladomery, M. (1997). Multifunctional proteins suggest connections between transcriptional and 
post-transcriptional processes. BioEssays 19, 903-909.
Laemmli, U. (1970). Cleavage of structural proteins during the assembly o f the head of 
bacteriophage T4. Nature 211, 680-685.
Lamonde, A. & Eamshaw, W. (1998). Structure and function in the nucleus. Science 280, 547- 
552.
Laurent, A., Madjar, J. & Greco, A. (1998). Translational control o f viral and host protein 
synthesis during the course of herpes simplex virus type 1 infection: evidence that 
initiation of translation is the limiting step. Journal o f General Virology 79, 2765-2775.
Lee, M., Mori, S. & Raychaudhuri, P. (1996). Trans activation by the hnRNP K protein involves 
an increase in RNA synthesis from the reporter genes. Journal o f Biological Chemistry 
111, 3420-3427.
Lee, N., Cozzikorto, J., Wainwright, N. & Testa, D. (1984). Cloning with tandem gene systems for 
high level gene expression. Nucleic Acids Research 12, 6797-6812.
Legrain, P. & Rosbash, M. (1989). Some cis and trans acting mutants for splicing target pre- 
mRNA to the cytoplasm. Cell 57, 573-583.
Leib, D., Coen, D., Bogard, C., Hicks, K., Yager, D. & Knipe, D. (1989a). Immediate early gene 
mutants define different stages in the establishment and reactivation o f herpes simplex 
latency, journal o f Virology 63, 759-768.
Leib, D. A., Bogard, C., Kosz-Vnenchak, M., Hicks, K., Coen, D., Knipe, D. & Schaffer, P.
(1989b). A deletion mutant of the latency associated transcript of herpes simplex virus 
type-1 reactivates from the latent infection. Journal o f  Virology 63, 2893-2900.
xviii
References
Leppard, K. (1998). Regulated RNA processing and RNA transport during adenovirus infection. 
Seminars in Virology 8, 301-307.
Leroy, D., Filhol, O., Quintaine, N., Sarrouilhe, D., LoueMackenbach, P., Chambaz, E. & Cochet,
C. (1999). Dissecting subdomains involved in multiple functions o f the CK2 beta subunit. 
Molecular and Cellular Biochemistry 191, 43-50
Lim, B., Reid, K., Ghebrehiwet, B., Peerschke, E., Leigh, L. & Preissner, K. (1996). The binding 
protein for globular heads of complement Clq, gClqR - functional expression and 
characterisation as a novel vitronectin binding factor. Journal o f  Biological Chemistry 
271, 26739-26744.
Lindquester, G., Greenamoyer, C., Anton, E., OBrian, J., Pellett, P. & Dambaugh, T. (1997). 
Comparison o f a 20kb region of human herpesvirus 6B with other human 
betaherpesviruses reveals conserved replication genes and adjacent divergent open 
reading frames. Archives o f  Virology 142, 193-204.
Litchfield, D., Lozeman, F., Cicirelli, M., Harrylock, M., Ericsson, L., Piening, C. & Krebs, E. 
(1991). Phosphorylation o f the beta subunit o f casein kinase II in human A431 cells.
Identification o f the autophosphorylation site and site phosphorylated by p34c<^ c .^ 
Journal o f  Biological Chemistry 266, 20380-20389.
Lopez, C., Arvin, A. & Ashley, R. (1993). Immunity to herpesvirus infections in humans. In The 
human herpesviruses. Edited by B. Roizman, R. Whitley & C. Lopez. New York: Raven 
press.
Luo, Y., Yu, H. & Peterlin, B. (1994). Cellular protein modulates effects of human 
immunodeficiency virus type 1 Rev. Journal o f Virology 68, 3850-3856.
Lutz, C., Murthy, K., Schek, N., O'Connor, J., Manley, J. & Alwine, J. (1996). Interaction between 
the U1 snRNP-A protein and the 160-kD subunit o f cleavage-polyadenylation factor 
increases polyadenylation efficiency in vitro. Genes and development 10, 325-337.
MacDonald, C., Wilusz, J. & Shenk, T. (1994). The 64 kilodalton subunit o f the CstF
polyadenylation factor binds to pre-mRNA downstream of the cleavage site and 
influences cleavage site location. Molecular and Cellular Biology 14, 6647-6654.
MacKay, J. & Crossley, M. (1998). Zinc fingers are sticking together. Trends in Biological 
Science 23, 1-4.
MacPherson, I. & Stoker, M. (1962). Polyoma transformation of hamster cell clones - an 
investigation o f genetic factors affecting cell competence. Virology 16, 147-151.
Maldarelli, F., Xiang, C., Chamoun, G. & Zeichner, S. (1998). The expression o f the essential
nuclear splicing factor SC35 is altered by human immunodeficiency virus infection. Virus 
Research 53, 39-51.
Malim, M., Hauber, J., Le, S., Maizel, J. & Cullen, B. (1989). The HIV-1 transactivator acts
through a structured target sequence to activate nuclear export of unspliced viral mRNA. 
Nature 338, 254-257.
Manley, J. (1995). A complex protein assembly catalyses polyadenylation o f mRNA precursors. 
Current Opinions in Genetics and Development 5, 222-228.
Manley, J. & Tacke, R. (1996). SR proteins and splicing control. Genes and Development 10, 
1569-1579.
Martin, G. & Keller, W. (1996). Mutational analysis o f mammalian poly(A) polymerase identifies 
a region for primer binding and a catalytic domain, homologous to the family X 
polymerases, and to other nucleotidyltransferases. EMBO Journal 15, 2593-2603.
Martin, T., Barghusen, S., Leser, G. & Spear, P. (1987). Redistribution o f the nuclear
ribonucleoprotein antigens during herpes simplex virus infection. Journal o f Cellular 
Biology 105, 2069-2082.
xix
References
Masse, T., Garcin, D., Jacquemont, B. & Madjar, J. (1990a). Herpes simplex type 1 induced
stimulation of ribosomal protein phosphorylation is inhibited in neomycin treated human 
epidermal carcinoma 2 cells and in ras-transformed cells. European Journal o f  
Biochemistry 194, 287-291.
Masse, T., Garcin, D., Jacquemont, B. & Madjar, J. (1990b). Ribosome and protein modifications 
after infection of human epidermoid carcinoma cells with herpes simplex virus type 1. 
Molecular and General Genetics 220, 1-12.
Nastainczyk, W., Schmidtspaniol, I., Boldyreff, B. & Issinger, O. (1995). isolation and
characterization o f a monoclonal anti-protein kinase CK2 beta-subunit antibody of the 
IgG class for the direct-detection of CK2 beta-subunit in tissue-cultures o f various 
mammalian-species and human tumors. Hybridoma 14, 335-339.
Mattaj, I. (1994). Splicing in space. Nature 372, 727-728.
Matthews, D. & Russell, W. (1998). Adenovirus core protein V interacts with p32 - a protein 
which is associated with both the mitocondria and the nucleus. Journal o f General 
Virology 79, 1677-1685.
Matunis, M. J., Michael, W. M. & Dreyfuss, G. (1992). Characterisation and primary structure of  
the poly (C) binding heterogeneus nuclear ribonucleaoprotein complex K protein. 
Molecular Cell Biology 12, 164-171.
Maul, G. G., Ishov, A. M. & Everett, R. D. (1996). Nuclear domain 10 as pre-existing potential 
replication start sites o f herpes simplex virus type 1. Virology 217, 67-75.
Mayeda, A., Zahler, A. M., Krainer, A. R. & Roth, M. B. (1992). Two members o f a conserved 
family o f phosphoproteins are involved in pre-mRNA splicing. Proceedings o f  the 
National Academy o f Sciences 89, 1301-1304.
McCarthy, A. M., McMahan, L. & Schaffer, P. A. (1989). Herpes simplex virus type 1 ICP27
deletion mutants exhibit altered patterns o f transcription and are DNA deficient. Journal 
o f Virology 63, 18-27.
McGeoch, D., Dolan, A., Donald, S. & Brauer, D. (1986). Complete DNA sequence o f the short 
repeat region in the genome of herpes simplex type 1. Nucleic Acids Research 14, 1727- 
1745.
McGeoch, D., Dalrymple, M., Davison, A., Dolan, A., Frame, M., McNab, D., Perry, L., Scott, J. 
& Taylor, P. (1988). The complete DNA sequence of the long unique region in the 
genome o f HSV-1. Journal o f General Virology 69, 1531-1574.
McGregor, F., Phelan, A., Dunlop, J. & Clements, J. B. (1996). Regulation o f herpes simplex virus 
type 1 poly(A) site usage and the action o f the immediate-early protein IE63 in the early- 
late switch. Journal o f  Virology 70, 1931-1940.
McKnight, S. & Tijan, R. (1986). Transcriptional selectivity of viral genes in mammalian cells. 
Cell 46, 253-262.
McLauchlan, J., Phelan, A., Loney, C., Sandri-Goldin, R. M. & Clements, J. B. (1992). Herpes 
simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' 
processing. Journal o f Virology 66, 6939-6945.
McLauchlan, J., Simpson, S. & Clements, J. (1989). Herpes simplex virus induces a processing 
factor that stimulates poly (A) site usage. Cell 59, 1093-1105.
McMahan, L. & Schaffer, P. (1990). The repressing and enhancing functions of the herpes simplex 
virus regulatory protein ICP27 map to C-terminal regions and are required to modulate 
viral gene expression very early in infection. Journal o f Virology 64, 3471-3485.
Mears, W. & Rice, S. (1996). The RGG box motif o f the herpes simplex virus ICP27 protein 
mediates an RNA-binding activity and determines in vivo methylation. Journal o f  
Virology 70, 7445-7453.
Mears, W., Lam, V. & Rice, S. (1995). Identification o f nuclear and nucleolar localisation signals 
in the herpes simplex virus regulatory protein ICP27. Journal o f Virology 69, 935-947.
xx
References
Mears, W. & Rice, S. (1998). The Herpes simplex virus immediate-early protein ICP27 shuttles 
between nucleus and cytoplasm. Virology 242, 128-137.
Meredith, M., Orr, A., Elliott, M. & Everett, R. (1995). Separation o f sequence requirements for 
HSV-1 Vmw 110 multimerisation and interaction with a 135-kDa cellular protein. 
Virology 209, 174-187.
Meredith, M., Orr, A. & Everett, R. (1994). Herpes simplex type 1 immediate early protein
Vmwl 10 bind s strongly and specifically to a 135kDa cellular protein. Virology 200, 457- 
469.
Mermound, J., Cohen, P. & Lamond, A. (1992). Ser/Thr-specific protein phosphatases are required 
for both catalytic steps o f pre-mRNA splicing. Nucleic Acids Research 20, 5263-5269.
Mermound, J., Cohen, P. & Lamond, A. (1994). Regulation of mammalian spliceosome assembly 
by a protein phosphorylation mechanism. EMBO Journal 13, 5679-5688.
Michael, N. & Roizman, B. (1989). The binding o f herpes simplex major regulatory protein to 
viral DNA. Proceedings o f the National Academy o f Sciences, USA 86, 9808-9817.
Michael, N., Spector, D., Mavromara-Nazos, P., Kristie, T. & Roizman, B. (1988). The DNA- 
binding properties o f the major regulatory protein a4 o f herpes simplex virus. Science 
239, 1531-1534.
Michael, W., Choi, M. & Dreyfuss, G. (1995). A nuclear export signal in hnRNP A L A  signal 
mediated, temperature-dependent nuclear protein export pathway. Cell 83, 415-422.
Michael, W., Eder, P. & Dreyfuss, G. (1997). The K nuclear shuttling domain: A novel signal for 
nuclear import and nuclear export in the hnRNP K protein. EMBO Journal 16, 3587- 
3598.
Michelotti, E., Michelotti, G., Aronsohn, A. & Levens, D. (1996). Heterogeneous nuclear
ribonucleoprotein K is a transcription factor. Molecular and Cellular Biology 16, 2350- 
2360.
Misteli, T., Caceres, J. & Spector, D. (1997). The dynamics of a pre-mRNA splicing factor in 
living cells. Nature 387, 523.
Misteli, T. & Spector, D. (1997). Protein phosphorylation and the nuclear organisation o f pre- 
mRNA splicing. Trends in Cell Biology 7, 135-138.
Mitchell, C., Blaho, J., McCormick, L. & Roizman, B. (1997). The nucleotidylylation of herpes 
simplex virus 1 regulatory protein a22 by human casein kinase II. Journal o f Biological 
Chemistry 272, 25394-.
Morgan, C., Rose, H. & Mednis, B. (1959). Electron microscopic observations on the development 
of herpes simplex virus. Journal o f Experimental Medicine 110, 643-656.
Moriuchi, H., Moriuchi, M., Debrus, S., Piette, J. & Cohen, J. (1995). The acidic amino terminal 
region o f varicella-zoster virus open reading frame 4 protein is required for 
transactivation and can functionally replace the corresponding region o f HSV-1 ICP27. 
Virology 207, 376-382.
Moriuchi, H., Moriuchi, M., Smith, H. & Cohen, J. (1994). Varicella-zoster virus open reading 
frame 4 is functionally distinct and does not complement herpes simplex virus type 1 
ICP27. Journal o f  Virology 68, 1987-1992.
Mullen, M., Gerstberger, S., Ciufo, D., Mosca, J. & Hayward, G. (1995). Evaulation of co­
localization interactions between the IE110, IE175, and IE63 transactivator proteins of 
herpes simplex virus within subcellular punctate structures. Journal o f  Virology 69, 476- 
491.
Murchie, M. & McGeoch, D. (1982). DNA sequence analysis o f an immediate early gene region 
of the herpes simplex virus type 1 genome (map coordinates 0.950-0.978). Journal o f 
General Virology 62, 1-15.
Murthy, K. & Manley, J. (1995). The 160 KD subunit o f human cleavage and polyadenylation 
specificity factor coordinates pre-mRNA 3' end formation. Genes and Development 9, 
2672-2683.
xxi
References
Muta, T., Dongchon, K., Kitajima, S., Fujiwara, T. & Hamaski, N. (1997). p32 protein, a splicing 
factor 2-associated protein, is localised in mitochondrial matrix and is functionally 
important in maintaining oxidative phosphorylation. Journal o f  Biological Chemistry 272, 
24363-24370.
Nakielny, S. & Dreyfuss, G. (1997). The hnRNP C proteins contain a nuclear retention signal that 
can override nuclear export signals. Journal o f  Cell Biology 134, 1365-1373.
Nemeroff, M., Barabino, S., Li, Y., Keller, W. & Krug, R. (1998). Influenza virus NS1 protein
interacts with the cellular 30kDa subunit o f CPSF and inhibits 3' end formation of cellular 
pre-mRNAs. Molecular Cell 1. 991-1000.
Neuberger, M. & Williams, G. (1988). The intron requirement for immunoglobulin gene
expression is dependent upon the promoter. Nucleic Acids Research 16, 6713-6724.
Newcomb, W., Homa, F., Thomsen, D., Ye, Z. & Brown, J. (1994). Cell-free assembly of herpes 
simplex virus capsid. Journal o f Virology 68, 6059-6063.
Nikolakaki, E., Simos, G., Georgatos, S. & Giannakouros, T. (1996). A nuclear envelope
associated kinase phosphorylates arginine-serine motifs and modulates interactions 
between the lamin B receptor and other nuclear proteins. Journal o f Biological Chemistry 
271, 8365-8372.
Niwa, M., Rose, S. & Berget, S. (1990). In vitro polyadenylation is stimulated by the presence of 
an upstream intron. Genes and Development 4, 1552-1559.
O'Hare, P. (1993). The virion transcription activator of herpes simplex virus. Seminars in Virology 
4, 145-155.
O'Hare, P. & Hayward, G. (1985). Evidence for a direct role for both the 175,000- and 110,000- 
molecular-weight immediate-early proteins o f herpes simplex virus in the transactivation 
o f delayed-early promoters. Journal o f Virology 53, 751-760.
Ohtsuki, K., Maekawa, T., Harada, S., Karino, A., Morikawa, Y. & Ito, M. (1998). Biochemical 
characterization o f HIV-1 Rev as a potent activator o f casein kinase II in vitro. FEBS 
Letters 428, 235-240.
O'Keefe, R., Mayeda, T., Sadowski, C., Krainer, A. & Spector, D. (1994). Disruption o f pre- 
mRNA splicing in vivo results in reorganisation of splicing factors. Journal o f Cell 
Biology 124, 249-260.
Olson, L., Buescher, E. & Artenstein, M. (1967). Herpes infections of the human central nervous 
system. New England Journal o f Medicine 277, 1271-1277.
O'Neil, R , Talon, J. & Palese, P. (1998). The influenza virus NEP (NS2 protein) mediates the 
nuclear export o f viral ribonucleoproteins. EMBO Journal 17, 288-296.
Ostareck, D. H., Ostareck-Lederer, A., Wilm, M., Thiele, B. J., Mann, M. & Hentze, M. W.
(1997). mRNA silencing in erythroid differentiation: hnRNP K and hnRNP El regulate 
15-lipoxygenase translation from the 3' end. Cell 89, 597-606.
Ostrowski, J., Seuningen, I. V., Seger, R., Rouch, C. T., Sleath, P. R., McMullen, B. A. &
Bomsztyk, K. (1994). Purification, cloning and expression o f a murine phosphoprotein 
that binds the kB motif in vitro identifies it as the homolog o f the human heterogeneous 
nuclear ribonucleoprotein K protein. Journal o f Biological Chemistry 269, 17626-17634.
Padgett, R., Konarska, M., Grabowski, P., Hardy, S. & Sharp, P. (1984). Lariat RNAs as
intermediates and products in the splicing of messenger RNA precursors. Science 225, 
898-903.
Pande, N, Petoski, M. & Wagner, E. (1998). Functional modules important for activated
expression o f early genes of herpes simplex virus type 1 are clustered upstream o f the 
TATA box. Virology 246. 147-157.
Panagiotidis, C., Lium, E. & Silverstein, S. (1997). Physical and functional interactions between 
herpes simplex virus immediate-early proteins ICP4 and ICP27. Journal o f Virology 71, 
1547-1557.
References
Papavassiliou, A., Wilcox, K. & Silverstein, S. (1991). The interaction o f ICP4 with cell/infected 
cell factors and its state o f phosphorylation modulate differential recognition of leader 
sequences in herpes simplex virus DNA. EMBO Journal 10, 397-406.
Pereira, L., Wolff, M., Fenwick, M. & Roizman, B. (1977). Regulation o f herpesvirus
macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and 
HSV-2 infected cells. Virology 77, 733-749.
Perera, L., Mosca, J., Ruyechan, W. & Hay, J. (1992). Regulation o f varicella-zoster virus gene 
expression in human T lymphocytes. Journal o f  Virology 66, 5298-5304.
Perry, L. & McGeoch, D. (1988). The DNA sequences o f the long repeat region and adjoining 
parts o f the long unique region in the genome o f herpes simplex type 1. Journal o f  
General Virology 69, 2831-2846.
Peterson-Mahrt, S., Estmer, C., Ohrmalm, C., Mathews, D., Russell, W. & Akusjarvi, G. (1999).
The splicing factor associated protein p32, regulates RNA splicing by inhibiting ASF/SF2 
RNA binding and phosphorylation. EMBO Journal 18, 1014-1024.
Phelan, A., Carmo-Fonseca, M., McLauchlan, J., Lamond, A. & Clements, J. (1993). A herpes 
simplex virus type 1 immediate-early gene product, IE63, regulates small nuclear 
ribonucleoprotein distribution. Proceedings o f National Academy o f  Sciences, USA 90, 
9056-9060.
Phelan, A. & Clements, J. (1997). Herpes simplex virus type 1 immediate early protein IE63
shuttles between nuclear compartments and the cytoplasm. Journal o f  General Virology 
78,3327-3331.
Phelan, A., Dunlop, J. & Clements, J. (1996). Herpes simplex virus type 1 protein IE63 affects the 
nuclear export o f virus intron-containing transcripts. Journal o f  Virology 70, 5255-5265.
Phelan, A., Dunlop, J., Patel, A., Stow, N. & Clements, J. (1997). Nuclear sites o f herpes simplex 
virus type 1 DNA replication and transcription colocalize at early times postinfection and 
are largely distinct from RNA processing factors. Journal o f  Virology 71, 1124-1132.
Pinol-Roma, S. (1997). hnRNP proteins and the nuclear export o f mRNA. Cell and Developmental 
Biology 8, 57-63.
Pinol-Roma, S., Choi, Y., Matunis, J. & Dreyfuss, G. (1988). Immunoprecipitation of
heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding 
proteins. Genes and Development 2, 215-227.
Pinol-Roma, S. & Dreyfuss, G. (1991). Transcription dependent and transcription independent 
nuclear transport o f hnRNP proteins. Science 253, 312-314.
Proudfoot, N. (1996). Ending the message is not so simple. Cell 87, 779-781.
Pugh, B. & Tijian, B. (1990). Mechanism of transcriptional activation by SP1 - Evidence for co­
activators. Cell 61, 777-789.
Qiu, Y., Nemeroff, M. & Krug, R. (1995). The influenza virus NS1 protein binds to a specific 
region in human U6snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during 
splicing. RNA 1, 304-316.
Qui, Y. & Krug, R. (1994). The influenza NS1 protein is a poly (A)-binding protein that inhibits 
nuclear export o f mRNAs containing poly (A). Journal o f  Virology 68, 2425-2432.
Quiagen Ltd (1995). Quiagen plasmid handbook: Unit 1 Tillingboume Court, Dorking Surrey.
Quinlan, M., Chen, I. & Knipe., D. (1984). The intranuclear location o f a herpes simplex virus
DNA binding protein is determined by the status o f viral DNA replication. Cell 36, 857- 
868 .
Quinlan, M. & Knipe, D. (1985). Stimulation of expression of a herpes simplex virus DNA- 
binding protein by two viral functions. Molecular Cell Biology 5, 957-963.
Quinn, J. P., McGregor, R. A., Fiskerstand, C. E., Davey, C., Allan, J. & Dalziel, R. G. (1998). 
Identification o f a novel multifunctional structural domain in herpes simplex type 1 
genome: implications for viral latency. Journal o f General Virology 79, 2529-2532.
xxiii
References
Randall, G. & Roizman, B. (1997). Transcription of the depressed open reading frame P of herpes 
simplex virus 1 precludes the expression o f the antisense y j 34.5 Gene and may account 
for the attenuation of the mutant virus. Journal o f Virology 71, 7750-7757.
Read, G. & Frenkel, N. (1983). Herpes simplex virus mutants defective in the virion associated 
host shut off polypeptide synthesis and exhibiting abnormal synthesis o f  (immediate 
early) viral polypeptides. Journal o f  Virology 46, 498-512.
Rice, S. & Knipe, D. (1988). Gene specific transactivation by herpes simplex virus type 1 alpha 
protein ICP27. Journal o f  Virology 62, 3814-3823.
Rice, S. & Knipe, D. (1990). Genetic evidence for two distinct transactivation functions of the 
herpes simplex virus a  protein ICP27. Journal o f Virology 64, 1704-1715.
Rice, S. & Lam, V. (1994). Amino acid substitution mutations in the herpes simplex virus ICP27 
protein define an essential gene regulation function. Journal o f  Virology 68, 823-833.
Rice, S., Lam, V. & Knipe, D. (1993). The acidic amino-terminal region of herpes simplex virus 
type 1 alpha protein ICP27 is required for an essential lytic function. Journal o f Virology 
67, 1778-1787.
Richards, S., Carey, K. & Macara, I. (1997). Requirement of guanosine triphosphate-bound Ran 
for signal mediated nuclear protein export. Science 276, 1842-1844.
Rixon, F. (1993). Structure and assembly o f herpesviruses. Seminars in Virology 4, 135-144.
Roberts, M., Boundy, A., O'Hare, P., Pizzomo, M., Ciufo, D. & Hayward, G. (1988). Direct 
correlation between a negative autoregulatory response element at the cap site of the 
herpes simplex type 1 IE175 (a4) promoter and a specific binding site for the IE175 
(ICP4) protein. Journal o f  Virology 62, 4307-4320.
Rock, D. (1993). The molecular basis o f latent infections by alphaherpes viruses. Seminars in 
Virology 4, 157-165.
Rock, D. & Fraser, N. (1983). Detection o f HSV-1 genome in central nervous system of latently 
infected mice. Nature 302, 523-525.
Rodahl, E. & Stevens, J. (1992). Differential accumulation o f herpes simplex virus type 1 latency 
associated transcripts in sensory and autonomic ganglia. Virology 189, 385-388.
Roizman, B. (1993). The family herpesviridae: a brief introduction. In The humanherpes viruses. 
Edited by B. Roizman, R. Whitley & C. Lopez. New York: Raven Press.
Roizman, B. (1996). Herpesviridae. In Virology, 3 edn, pp. 2221-2230. Edited by B. Fields, D. 
Knipe & P. Howley. Philadelphia: Raven Press.
Roizman, B., Carmichael, L. & Deinhardt, F. (1981). Herpesviridae. definition, provisional 
nomenclature and taxonomy. Intervirology 16, 201-217.
Roizman, B. & Furlong, D. (1974). The replication of herpesviruses. In Comprehensive Virology, 
pp. 229-403. Edited by H. Fraenkel & R. Wagner. New York: Raven Press.
Roizman, B., Norrild, B., Chan, C. & Pereira, L. (1984). Identification and preliminary mapping 
with monoclonal antibodies o f a herpes simplex virus type 2 glycoprotein lacking a 
known type 1 counterpart. Virology 133, 242-247.
Roizman, B. & Sears, A. (1987). An inquiry into the mechanism o f herpes simplex latency.
Annual Reviews in microbiology 41, 543-571.
Roizman, B. & Sears, A. (1996). Herpes simplex viruses and their replication. In Virology, 3 edn, 
pp. 2231-2296. Edited by B. Fields, D. Knipe & P. Howley. Philadelphia: Raven press.
Ruskin, B., Krainer, A., Maniatis, T. & Green, M. (1984). Excision o f an intact intron as a novel 
lariat structure during pre-mRNA splicing in vitro. Cell 38, 317-331.
Ruvolo, V., Wang, E., Boyle, S. & Swaminathan, S. (1998). The Epstein Barr virus nuclear protein 
SM is both a post transcriptional inhibitor and activator of gene expression. Proceedings 
o f the National Academy o f Sciences, USA 95. 8852-8857
xx iv
References
Saavedra, C., Felber, B. & Izaurralde, E. (1997). The simian retrovirus 1 constitutive transport 
element, unlike HIV-1 RRE, utilises factors required for the export o f cellular mRNAs. 
Current Biology 7, 619-628.
Sacks, W., Greene, C., Aschman, D. & Schaffer, P. (1985). Herpes simplex virus type 1 ICP27 is 
an essential regulatory protein. Journal o f Virology 55, 796-805.
Sakaoka, H., Kurita, K., Iida, Y., Takada, S., Umene, K., Kim, Y., Ren, C. & Nahmias, A. (1994). 
Quantitative analysis o f genome polymorphism o f herpes simplex type 1 strains from six 
countries: Studies o f molecular evolution and molecular epidemiology of the virus. 
Journal o f  General Virology 75, 513-527.
Sanders, P., Wilkie, N. & Davidson, A. (1982). Thymidine kinase deletion mutants of HSV-1. 
Journal o f  General Virology 63, 277-295.
Sandri-Goldin, R. (1998). Interactions between a herpes simplex virus regulatory protein and RNA 
processing pathways. Methods-A Companion to Methods in Enzymology 16, 95-104.
Sandri-Goldin, R. (1998). ICP27 mediates HSV RNA export by shuttling through a leucine-rich 
nuclear export signal and binding viral intronless RNAs through an RGG motif. Genes 
and Development 12, 868-879.
Sandri-Goldin, R. & Hibbard, M. (1996). The herpes simplex virus type 1 regulatory protein
ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be 
required for this interaction. Journal o f Virology 70, 108-118.
Sandri-Goldin, R., Hibbard, M. & Hardwicke, M. (1995). The C-terminal repressor region of 
herpes simplex virus type 1 ICP27 is required for the redistribution o f small nuclear 
ribonucleoprotein particles and splicing factor SC35; however, these alterations are not 
sufficient to inhibit host cell splicing. Journal o f Virology 69, 6063-6076.
Sandri-Goldin, R. & Mendoza, G. (1992). A herpesvirus regulatory protein appears to act post- 
transcriptionally by affecting mRNA processing. Genes and Development 6, 848-863.
Schaffer, H., Beauchamp, L., deMiranda, P., Elion, G., Bauer, D. & Collins, P. (1979). P.9-(2-
hydroxyethoxymethyl) guanine activity against viruses o f the herpes group. Nature 272, 
583-585.
Schenk, P., Pietschman, S., Gelderblom, H. & Pauli, G. (1988). Monoclonal antibodies against
herpes simplex type 1 nuclei defining and localising the ICP8 protein, 65K DNA binding 
protein and polypeptides of the ICP35 family. Journal o f General Virology 69, 99-111.
Schrang, J., Venkataram-Prasad, B., Rixon, F. & Chiu, W. (1989). Three dimensional structure of 
the HSV-1 nucleocapsid. Cell 56, 651-660.
Schullery, D., Ostrowski, J., Denisenko, O., Stempka, L., Shnyreva, M., Suzuki, H., Gschwendt,
M. & Bomsztyk, K. (1999). Regulated Interaction of protein kinase C5 with the 
heterogeneous nuclear ribonucleoprotein K protein. Journal o f  Biological Chemistry 274, 
15101-15109.
Sears, A., Halliburton, I., Meignier, B., Silver, S. & Roizman, B. (1985). Herpes simplex virus 1 
mutant deleted in the a22 gene: growth and gene expression in permissive and restrictive 
cells and establishment o f latency in mice. Journal o f  Virology 55, 338-346.
Sederati, F., Izumi, K., Wagner, E. & Stevens, J. (1989). Herpes simplex type 1 latency associated 
transcription plays no role in establishment or maintenance o f a latent infection in murine 
sensory neurons. Journal o f  Virology 63, 4455-4458.
Seghezzi, W., Chua, K., Shanahan, F., Gozani, O., Reed, R., Lees, E. (1998). Cyclin E associates 
with components o f the pre-mRNA splicing machinery in mammalian cells. Molecular 
and Cellular Biology 18, 4526- 4536.
Sekulovich, R., Leary, K. & Sandri-Goldin, R. (1988). The herpes simplex virus type 1 alpha
protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 
and ICP0. Journal o f Virology 62,4510-4522.
xxv
References
Semmes, O., Chen, L., Sarisky, R., Gao, Z., Zhong, L. & Hayward, S. (1998). Mta has properties 
o f an RNA export protein and increase cytoplasmic accumulation of Epstein-Barr virus 
replication gene mRNA. Journal o f  Virology 72, 9526-9534.
Shepard, A., Tolentino, P. & DeLuca, N. (1990). /ra«s-dominant inhibition o f herpes simplex 
virus transcriptional regulatory protein ICP4 by heterodimer formation. Journal o f  
Virology 64, 3916-3926.
Showalter, S., Zweig, M. & Hampar, B. (1981). Monoclonal anibodies to herpes simplex type 1 
proteins including the immediate early protein ICP4. Infection and Immunity 34, 684- 
692.
Siliciano, P., Jones, M. & Guthrie, C. (1987). Saccharomycyes cerevisiae has a U1 like small 
nuclear RNA with unexpected properties. Science 237, 1484-1487.
Simos, G. & Georgatos, S. (1994). The lamin B receptor-associated protein p34 shares sequence 
homology and antigenic determinants with the splicing factor 2-associated protein p32. 
FEBSLetters 346, 225-228.
Singh, M., Fraefel, C., Bello, L., Lawrence, W. & Schwyer, M. (1996). Identification and
characterization o f BICP27, an early protein o f bovine herpesvirus 1 which may stimulate 
mRNA 3' processing. Journal o f  General Virology 77, 615-625.
Siomi, H., Choi, M., Siomi, M., Nussbaum, R. & Dreyfuss, G. (1994). Essential role for KH
domains in RNA binding: impaired RNA binding by a mutation in the KH domain of 
FMR1 that causes fragile X syndrome. Cell 77, 33-39.
Siomi, H. & Dreyfuss, G. (1995). A nuclear localisation domain in the hnRNP A1 protein. Journal 
o f Cell Biology 129, 551-560.
Smith, C., Bates, P., Rivera-Gonzales, R., Gu, B. & Deluca, N. (1993). ICP4, the major
transcriptional regulatory protein o f herpes simplex virus type 1 forms a tripartite 
complex with TATA binding protein and TFIIB. Journal o f  Virology 67, 4676-4687.
Smith, C. A. & Johnson, K. S. (1988). Single step purification of polypeptides expressed in 
Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
Smith, I., Hardwicke, M. & Sandri-Goldin, R. (1992). Evidence that the herpes simplex virus 
immediate early protein ICP27 acts post-transcriptionally during infection to regulate 
gene expression. Virology 186, 74-86.
Smith, I., Sekulovich, R., Hardwicke, M. & Sandri-Goldin, R. (1991). Mutations in the activation 
region o f herpes simplex virus regulatory protein ICP27 can be trans dominant. Journal 
o f  Virology 65, 3656-3666.
Soliman, T., Sandri-Goldin, R. & Silverstein, S. (1997). Shuttling o f the herpes simplex virus type 
1 regulatory protein ICP27 between the nucleus and the cytoplasm mediates the 
expression of late proteins. Journal o f Virology 71, 9188-9197.
Spear, P. (1993). Entry o f aiphaherpesviruses into cells. Seminars in Virology 4, 167-180.
Spear, P. & Roizman, B. (1972). Proteins specified by herpes simplex virus. Purification and 
structural proteins of the virion. Journal o f Virology 9, 143-160.
Steiner, I., Spivack, J., Lirette, R., Brown, S., MacLean, A., Subak-Sharp, J. & Fraser, N. (1989). 
Herpes simplex virus type 1 latency associtated transcripts are evidently not essential for 
latent infection. EMBO Journal 8, 505-511.
Steinmetz, E. (1997). Pre-mRNA processing and the CTD o f RNA polymerase II: the tail that 
wags the dog? Cell 89, 491-494.
Stevens, J., Haarr, L., Porter, D., Cook, M. & Wagner, E. (1988). Prominence of the herpes 
simplex virus associated transcript in trigeminal ganglia from seropositive humans. 
Journal o f Infectious Diseases 158, 117-123.
Stow, N. (1992). Herpes simplex virus type 1 origin dependent DNA replication in insect cells 
using recombinant baculovirus. Journal o f General Virology 73, 313-321.
xxvi
References
Stow, N., Hammarsten, O., Arbukle, M. & Elias, P. (1993). Inhibition o f HSV-1 DNA replication 
by mutant forms o f the ori binding protein. Virology 196, 413-419.
Struhl, K. (1991). Acid connections. Current Biology 1, 188-191.
Studier, F., Rosenburg, A., Dunn, J. & Dubendorff, J. (1990). The use o f T7 RNA polymerase to 
direct expression of cloned genes. Methods in Enzymeology 185, 60-89.
Su, L. & Knipe, D. (1989). Herpes simplex virus alpha protein ICP27 can inhibit or augment viral 
gene transactivation. Virology 170, 496-504.
Sun, Q., Mayeda, R., Hampson, A., Krainer, A. & Rottman, F. (1993). General splicing factor
SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes 
and Development 7, 2598-2608.
Szilagyi, J. & Cunningham, C. (1991). Identification and characterisation o f a novel non-infectious 
herpes simplex related particle. Journal o f  General Virology 72, 661-668.
Takagaki, Y., Ryner, L. & Manley, J. (1989). Four factors are required for 3' end cleavage of pre- 
mRNAs. Genes and Development 3 , 1711-1724.
Takimoto, M., Tomonaga, T., Matunis, M., Avigan, M., Krutzsch, H., Dreyfuss, G. & Levens, D. 
(1993). Journal o f  Biological Chemistry 268, 18249-18258.
Tange, T., Jensen, T. & Kjems, J. (1996). In Vitro interaction between human immunodeficiency 
virus Type 1 Rev protein and Splicing Factor ASF/SF2-associated Protein p32. Journal o f 
Biological Chemistry 271, 10066-10072.
Tatman, J., Preston, V., Nicholson, P., Elliott, R. & Rixon, F. (1994). Assembly o f herpes simplex 
virus type 1 capsids using a panel o f recombinant baculoviruses. Journal o f  General 
Virology 15, 1101-1113.
Tazi, J., Komstadt, U., Rossi, F., Jeanteur, P., Cathala, G., Brunei, C. & Luthermann, R. (1993). 
Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing. Nature 363, 283- 
286.
Tenser, R. & Dunston, M. (1979). Herpes simplex thymidine kinase expression in infection of 
trigeminal ganglion. Virology 99, 417-422.
Tomonaga, T. & Levens, D. (1995). Heterogeneous nuclear ribonucleoprotein K is a DNA binding 
transactivator. Journal o f Biological Chemistry 270, 4875-4881.
Tomonaga, T., Michelotti, G., Libutti, D., Uy, A., Sauer, B. & Levens, D. (1998). Unrestraining 
genetic processes with a protein-DNA hinge. Molecular Cell 1, 759-764.
Towbin, H., Staehelin, T. & Gorden, J. (1979). Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 
Proceedings o f the National Academy o f Sciences, USA 76, 4350-4354.
Tsieh, T., Matsumoto, M., Chou, H., Schneider, R., Hwang, S., Lee, A. & Lai, M. (1998).
Hepatitis C Virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. 
Journal o f Biological Chemistry 273, 17651-17659.
Uprichard, S. & Knipe, D. (1996). Herpes simplex ICP27 mutant viruses exhibit reduced 
expression o f specific DNA replication genes. Journal o f  Virology 70, 1969-1980.
Van Driel, R., Wansink, D., Van Steensel, B., Grande, M., Schul, W. & De Jong, L. (1995).
Nuclear domains and the nuclear matrix. Internatioanl Reviews in Cytology 162, 151-189.
Van Seuningen, I., Ostrowski, J. & Bomsztyk, K. (1995a). Description of an II-1-responsive
kinase that phosphorylates the K-protein - enhancement of phosphorylation by selective 
DNA and RNA Motifs. Biochemistry 34, 5644-5650.
Van Seuningen, I., Ostrowski, J., Bustelo, X., Sleath, P. & Bomsztyk, K. (1995b). The K protein 
domain that recruits the interleukin 1-responsive K protein kinase lies adjacent to a 
cluster o f c-Src and Vav SH3-binding sites. Journal o f  Biological Chemistry 270, 26976- 
26985.
Varani, G. & Nagai, K. (1998). RNA recognition by RNP proteins during RNA processing.
Annual Reviews in Biophysics and Biomolecular Structure 27, 407-445.
xxvii
References
Vaughan, P., Thibault, K., Hardwicke, M. & Sandri-Goldin, R. (1992). The herpes simplex virus 
immediate early protein ICP27 encodes a potential metal binding domain and binds zinc 
in vitro. Virology 189, 377-384.
Vogel, U., Kunerl, M. & Scholtissek, C. (1994). Influenza A virus late mRNAs are specifically
retained in the nucleus in the presence o f a methyltransferase or a protein kinase inhibitor. 
Virology 198, 227-233.
Vogelstein, B. & Gillespie, D. (1979). Preparative and analytical purification of DNA from 
agarose. Virus Genes 2, 335-346.
Wagner, E. (1985). Individual HSV transcripts: Characterisation of specific genes. In The 
herpesviruses. Edited by B. Roizman. New York: Plenum Press.
Wahle, E. (1995). Poly(A) tail length is caused by the termination o f processive synthesis. Journal 
o f Biological Chemistry 270, 2800-2808.
Wagner, E., Petroski, M., Pande, N., Lieu, P. & Rice, M. (1998). Analysis o f factors influencing 
kinetics of herpes simplex virus transcription utilizing recombinant virus. Methods: A 
Companion to Methods in Enzymology 16. 105-116.
Wahle, E., Lustig, A., Jeno, P. & Maurer, P. (1993). Mammalian Poly (A) binding protein II. 
Journal o f Biological Chemistry 268, 2937-2945.
Wang, J. & Manley, J. (1995). Overexpression o f the SR proteins ASF/SF2 and SC35 influences 
alternative splicing in vivo in a diverse number o f ways. RNA 1, 335-346.
Wang, Y., Finan, J., Middeldorp, J. & Hayward, S. (1997). p32/Tap, a cellular protein that 
interacts with EBNA-1 o f Epstein-Barr virus. Virology 236, 18-29.
Watson, R. & Clements, J. (1980). A herpes simplex type 1 function is continuously required for E 
and L virus RNA synthesis. Nature 285. 329-330.
Warholm, M., Guthenberg, C. & Mannarvik, B. (1983). Molecular and catalytic properties of
glutathione transferase p from human liver: an enzyme efficiently conjugating epoxides. 
Biochemistry 22, 3610-3617.
Weinheimer, S. & McKnight, S. (1987). Transcriptional and post transcriptional controls establish 
the cascade o f herpes simplex virus protein synthesis. Journal o f Molecular Biology 195, 
819-833.
Wen, W., Meinkoth, J., Tsien, R. & Taylor, S. (1995). Identification o f a signal for rapid export of 
proteins from the nucleus. Cell 82, 463-473.
Weng, Z., Thomas, S., Rickies, R., Taylor, J., Brauer, A., Seidel-Dugan, C., Michael, W., 
Dreyfuss, G. & Brugge, J. (1994). Identification o f Src, Fyn and Lyn SH3-binding 
proteins: implications for a function of SH3 domains. Molecular Cell Biology 14, 4509- 
4521.
Wentworth, B. & Alexander, E. (1971). Seroepidemiology o f infections due to members of the 
herpes group. American Journal o f Epidemiology 94, 496-507.
Whitehouse, A., Cooper, M. & Meredith, D. (1998). The immediate-early gene product encoded 
by open reading frame 57 of herpesvirus saimiri modulates gene expression at the 
posttranscriptional level. Journal o f Virology 72, 857-861.
Whitley, R. (1996). Herpes Simplex Viruses. In Virology, 3 edn, pp. 2297-2342. Edited by B. 
Fields, D. Knipe & P. Howley. Philadelphia: Raven Publishers.
Wikens, M., Anderson, P. & Jackson, R. (1997). Life and death in the cytoplasm: messages from 
the 3' end. Current Opinions in Genetics and Development 7, 220-232.
Wilcox, K., Kohn, A., Skylanskaya, E. & Roizman, B. (1980). Herpes simplex virus
phosphoproteins. I. Phospshate cycles on and off some viral polypeptides and can alter 
their affinity for DNA. Journal o f  Virology 33, 167-182.
Wildy, P., Russell, W. & Home, R. (1960). The morphology o f herpes vims. Virology 12, 204- 
222 .
xxv iii
References
Williams, R. & Leppard, K. (1996). Human immunodeficiency virus type 1 Rev dependent effects 
on late gene expression o f recombinant human adenovirus. Virus Genes 13, 111-120.
Winkler, M., Rice, S. & Stammeringer, T. (1994). UL69 of human cytomegalovirus, an open
reading frame with homology to ICP27 o f herpes simplex virus, encodes a transactivator 
of gene expression. Journal o f Virology 68, 3943-3954.
Winkler, M. & Stamminger, T. (1996). A specific subform o f the human cytomegalovirus
transactivator protein pUL69 is contained within the tegument o f virus particles. Journal 
o f Virology 70, 8984-8987.
Wolff, B., Sanglier, J. & Wang, Y. (1997). Leptomycin B is an inhibitor o f nuclear export:
Inhibition o f nucleo-cytoplasmic translocation o f the human immunodeficency virus type 
1 (HIV-1) Rev protein and Rev-dependent mRNA. Chemical Biology 4, 139-147.
Wu, J. & Maniatis, T. (1993). Specific interactions between proteins implicated in splice site 
selection and regulated alternative splicing. Cell 75.
Xiao, S. & Manley, J. (1997). Phosphorylation of the ASF/SF2 RS domain affects both protein- 
protein and protein-RNA interactions and is necessary for splicing. Genes and 
Development 11, 334-344.
Yao, F. & Courtney, R. (1992). Association o f ICPO but not ICP27 with purified virions o f herpes 
simplex virus type 1 .Journal o f  Virology 66, 2709-2716.
Yao, F. & Schaffer, P. (1994). Physical interaction between the herpes simplex virus type 1
immediate -early regulatory proteins ICPO and ICP4. Journal o f  Virology 68, 8158-8168.
York, I., Roop, C., Andrews, D., Riddell, S., Graham, F. & Johnson, D. (1994). A cytosolic herpes 
simplex protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77, 525-535.
Yu, L., Loewenstein, P. M., Zhang, Z. & Green, M. (1995a). In vitro interaction o f the human 
immunodeficiency virus type 1 Tat transactivator and the general transcription factor 
TFIIB with the cellular protein TAP. Journal o f  Virology 69, 3017-3023.
Yu, L., Zhang, Z., Loewenstein, P. M., Desai, K., Tang, Q., Mao, D., Symington, J. S. & Green,
M. (1995b). Molecular cloning and characterisation of a cellular protein that interacts 
with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong 
transcriptional activation domain. Journal o f  Virology 69, 3007-3016.
Zachar, Z., Kramer, J., Mims, I. & Bingham, P. (1993). Evidence for channelled diffusion of pre- 
mRNAs during nuclear RNA transport in metazoans. Journal o f  Cell Biology 121, 729- 
742.
Zandomeni, E. & Weinman, R. (1984). Inhibitory effect o f 5,6-dichloro-l-|3-D-
ribofuranosylbenzimidazole on a protein kinase. Journal o f  Biological Chemistry 259, 
14804-14811.
Zhang, G., Taneja, K., Singer, R. & Green, M. (1994). Localization o f pre-mRNA splicing in 
mammalian nuclei. Nature 372, 809-812.
Zhao, J., Hyman, L. & Moore, C. (1999). Formation o f mRNA 3' ends in eukaryotes: mechanism, 
regulation, and interrelationships with other steps in mRNA synthesis. Microbiology and 
Molecular Biology Reviews 63, 405-445.
Zhi, Y. & Sandri-Goldin, R. (1999). Analysis o f the phosphorylation sites of herpes simplex virus 
type 1 regulatory protein ICP27. Journal o f  Virology 73, 3246-3257.
Zhi, Y., Sciabica, K. & SandriGoldin, R. (1999). Self interaction of the herpes simplex virus type 1 
regulatory protein ICP27. Virology 257, 341-351.
Zhou, Z., Venkataram-Prasad, B., Jakana, J., Rixon, F. & Chiu, W. (1994). Protein subunit 
structures in the herpes simplex virus A capsid determined from 400kV Spot scan 
electron cryomicroscopy. Journal o f Molecular Biology 242, 456-469.
Zhu, Z. & Schaffer, P. (1995). Intracellular localisation of the herpes simplex virus type 1 major 
transcriptional regulatory protein, ICP 4, is affected by ICP27. Journal o f  Virology 69, 
49-59.
xxix
References
Zuo, P. & Manley, J. (1994). The human splicing factor ASF/SF2 can specifically recognise pre- 
mRNA 5' splice sites. Proceedings o f the National Academy o f Sciences 91, 3363-3367.
xxxi
